No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4qv5E, 1.0000, 0.00, 1.000, 231, 231, YCP BETA5-M45I MUTANT
2, 4qv5S, 0.9999, 0.00, 1.000, 231, 231, YCP BETA5-M45I MUTANT
3, 4qv4S, 0.9999, 0.04, 1.000, 231, 231, YCP BETA5-M45T MUTANT
4, 4qv4E, 0.9999, 0.04, 1.000, 231, 231, YCP BETA5-M45T MUTANT
5, 4qv3S, 0.9999, 0.05, 1.000, 231, 231, YCP BETA5-M45V MUTANT
6, 4qv3E, 0.9999, 0.05, 1.000, 231, 231, YCP BETA5-M45V MUTANT
7, 4qv1S, 0.9999, 0.06, 1.000, 231, 231, YCP BETA5-M45A MUTANT
8, 4qv1E, 0.9999, 0.06, 1.000, 231, 231, YCP BETA5-M45A MUTANT
9, 4qvnS, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
10, 4qvnE, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
11, 4qv8S, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-C52F MUTANT
12, 4qv8E, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-C52F MUTANT
13, 4qv7S, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-A50V MUTANT
14, 4qv7E, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-A50V MUTANT
15, 4qv0S, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
16, 4qv0E, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
17, 5l6bS, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
18, 5l6bE, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
19, 5l6aS, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
20, 5l6aE, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
21, 5l63S, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
22, 5l63E, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
23, 5l5wS, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
24, 5l5wE, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
25, 5l5uS, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
26, 5l5uE, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
27, 5l5hS, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
28, 5l5hE, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
29, 5l5bS, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
30, 5l5bE, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
31, 5czaS, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
32, 5czaE, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
33, 5bxnS, 0.9997, 0.08, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
34, 5bxnE, 0.9997, 0.08, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
35, 5bxlS, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
36, 4qzzS, 0.9997, 0.08, 1.000, 231, 231, YCP IN COMPLEX WITH OMURALIDE
37, 4qzzE, 0.9997, 0.08, 1.000, 231, 231, YCP IN COMPLEX WITH OMURALIDE
38, 4qwuS, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
39, 4qwuE, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
40, 4qw1S, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
41, 4qw1E, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
42, 4qvlS, 0.9997, 0.09, 1.000, 231, 231, YCP IN COMPLEX WITH BORTEZOMIB
43, 4qvlE, 0.9997, 0.09, 1.000, 231, 231, YCP IN COMPLEX WITH BORTEZOMIB
44, 4qv9S, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C63F MUTANT
45, 4qv9E, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C63F MUTANT
46, 4quyS, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A49S-MUTANT
47, 4quyE, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A49S-MUTANT
48, 6gopS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
49, 6gopE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
50, 5m2bS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
51, 5m2bE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
52, 5l6cS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
53, 5l6cE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
54, 5l67S, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
55, 5l67E, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
56, 5l66S, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
57, 5l66E, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
58, 5l65S, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
59, 5l65E, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
60, 5l64S, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
61, 5l64E, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
62, 5l62S, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
63, 5l62E, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
64, 5l61S, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
65, 5l61E, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
66, 5l5xS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
67, 5l5xE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
68, 5l5rS, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
69, 5l5rE, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
70, 5l5pS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
71, 5l5pE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
72, 5l5oS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
73, 5l5oE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
74, 5l5fS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
75, 5l5fE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
76, 5l5dS, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
77, 5l5dE, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
78, 5l5aS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
79, 5l5aE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
80, 5fgaS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
81, 5fgaE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
82, 5fg7S, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
83, 5fg7E, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
84, 5d0wS, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
85, 5d0wE, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
86, 5bxlE, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
87, 4ya4S, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
88, 4ya4E, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
89, 4ya1S, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
90, 4ya1E, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
91, 4y9yS, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
92, 4y9yE, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
93, 4y8rS, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
94, 4y8rE, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
95, 4qvpS, 0.9996, 0.11, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
96, 4qvpE, 0.9996, 0.11, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
97, 5lttS, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
98, 5lttE, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
99, 5l5zS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
100, 5l5zE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
101, 5l5tS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
102, 5l5tE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
103, 5l5sS, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
104, 5l5sE, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
105, 5l5qS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
106, 5l5qE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
107, 5l5jS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
108, 5l5jE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
109, 5l5iS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
110, 5l5iE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
111, 5l55S, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
112, 5l55E, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
113, 5l52S, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
114, 5l52E, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
115, 5cz7E, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
116, 5cz6S, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
117, 5cz6E, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
118, 5cghS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
119, 5cghE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
120, 5cggS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
121, 5cggE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
122, 5cgfS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
123, 5cgfE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
124, 5ahjS, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
125, 5ahjE, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
126, 4y8mS, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
127, 4y8mE, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
128, 4r00S, 0.9995, 0.11, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
129, 4r00E, 0.9995, 0.11, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
130, 4qz0S, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
131, 4qz0E, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
132, 4qw6S, 0.9995, 0.13, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
133, 4qw6E, 0.9995, 0.13, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
134, 4qvyS, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
135, 4qvyE, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
136, 4qvwS, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
137, 4qvwE, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
138, 4quxS, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT
139, 4quxE, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT
140, 5l68S, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
141, 5l68E, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
142, 5l5yS, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
143, 5l5yE, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
144, 5l5eS, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
145, 5l5eE, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
146, 5fggS, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
147, 5fggE, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
148, 5fg9S, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
149, 5fg9E, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
150, 5d0zS, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
151, 5d0zE, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
152, 5d0vS, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
153, 5d0vE, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
154, 5d0sS, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
155, 5d0sE, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
156, 5cz7S, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
157, 4z1lS, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
158, 4z1lE, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
159, 4qz4S, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
160, 4qz4E, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
161, 4qwxS, 0.9994, 0.13, 1.000, 231, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
162, 4qwxE, 0.9994, 0.13, 1.000, 231, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
163, 4qwlS, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
164, 4qwlE, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
165, 4qwfS, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
166, 4qwfE, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
167, 4qw5S, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
168, 4qw5E, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
169, 5l69S, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
170, 5l69E, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
171, 5l60S, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
172, 5l60E, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
173, 5l5vS, 0.9993, 0.14, 1.000, 231, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
174, 5l5vE, 0.9993, 0.14, 1.000, 231, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
175, 5jhrS, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
176, 5jhrE, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
177, 4ya9S, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
178, 4ya9E, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
179, 4y8pS, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
180, 4y8pE, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
181, 4y77S, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
182, 4y77E, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
183, 4qz6S, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
184, 4qz6E, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
185, 4qz3S, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
186, 4qz3E, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
187, 4qw7S, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
188, 4qw7E, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
189, 4qvqS, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
190, 4qvqE, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
191, 4qv6S, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49V MUTANT
192, 4qv6E, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT
193, 5jhsS, 0.9992, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
194, 5jhsE, 0.9992, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
195, 5cz9S, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
196, 5cz9E, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
197, 5cgiS, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
198, 5cgiE, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
199, 5bouS, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
200, 5bouE, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
201, 4ya7S, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
202, 4ya7E, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
203, 4y75S, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
204, 4y75E, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
205, 4qz7S, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
206, 4qz7E, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
207, 4qz5S, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
208, 4qz2S, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
209, 4qz2E, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
210, 5fgfS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
211, 5fgfE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
212, 5dkjS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
213, 5dkjE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
214, 5d0tS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
215, 5d0tE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
216, 4y9zS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
217, 4y9zE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
218, 4y8tS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
219, 4y8tE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
220, 4y8kS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
221, 4y8kE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
222, 4y6vS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
223, 4y6vE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
224, 4rurS, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
225, 4rurE, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
226, 4r17S, 0.9991, 0.17, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
227, 4qzwS, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
228, 4qzwE, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
229, 4qz5E, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
230, 5fgeS, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
231, 5fgeE, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
232, 5cz8S, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
233, 5cz8E, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
234, 4y8sS, 0.9990, 0.17, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
235, 4y8sE, 0.9990, 0.17, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
236, 4y82S, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
237, 4y82E, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
238, 4r18S, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
239, 4r18E, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
240, 4r17E, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
241, 4qwrS, 0.9990, 0.17, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
242, 4qwrE, 0.9990, 0.17, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
243, 4qw4S, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH CARFILZOMIB
244, 4qw4E, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH CARFILZOMIB
245, 4qvmS, 0.9990, 0.18, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
246, 4qvmE, 0.9990, 0.18, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
247, 4no8S, 0.9990, 0.18, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
248, 4no8E, 0.9990, 0.18, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
249, 4no1S, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
250, 4no1E, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
251, 4nnnS, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH MG132
252, 4nnnE, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH MG132
253, 5lajS, 0.9989, 0.18, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
254, 5lajE, 0.9989, 0.18, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
255, 5l54S, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
256, 5l54E, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
257, 5d0xS, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
258, 5d0xE, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
259, 4ya2S, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
260, 4ya2E, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
261, 4y8uS, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
262, 4y8uE, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
263, 4y8nS, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
264, 4y8nE, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
265, 4y8lS, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
266, 4y8lE, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
267, 4y8jS, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
268, 4y8jE, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
269, 4y8hS, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
270, 4y8hE, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
271, 4y8gS, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
272, 4y8gE, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
273, 4y74S, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
274, 4y74E, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
275, 4y6aS, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
276, 4y6aE, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
277, 4y69S, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
278, 4y69E, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
279, 4qltS, 0.9989, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
280, 4qltE, 0.9989, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
281, 5fhsS, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
282, 5fhsE, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
283, 4y8qS, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
284, 4y8qE, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
285, 4y81S, 0.9988, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
286, 4y81E, 0.9988, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
287, 4y70S, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
288, 4y70E, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
289, 4qz1S, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
290, 4qz1E, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
291, 4qw0S, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
292, 4qw0E, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
293, 4qlsS, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
294, 4qlsE, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
295, 4qlqS, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
296, 4qlqE, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
297, 5laiS, 0.9987, 0.20, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
298, 5laiE, 0.9987, 0.20, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
299, 5fgiS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
300, 5fgiE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
301, 5fghS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
302, 5fghE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
303, 4ya5S, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
304, 4ya5E, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
305, 4y8oS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
306, 4y8oE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
307, 4y8iS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
308, 4y8iE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
309, 4y84S, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
310, 4y84E, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
311, 4y7xS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
312, 4y7xE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
313, 4y7wS, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
314, 4y7wE, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
315, 4r02S, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
316, 4r02E, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
317, 4qzxS, 0.9987, 0.20, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
318, 4qzxE, 0.9987, 0.20, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
319, 4no9S, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
320, 4no9E, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
321, 5fgdS, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
322, 5fgdE, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
323, 5cz5S, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
324, 5cz5E, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
325, 4y80S, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
326, 4y80E, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
327, 4y7yS, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
328, 4y7yE, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
329, 4qwiS, 0.9986, 0.21, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
330, 4qwiE, 0.9986, 0.21, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
331, 4nnwS, 0.9986, 0.21, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
332, 4nnwE, 0.9986, 0.21, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
333, 4y6zS, 0.9985, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
334, 4y6zE, 0.9985, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
335, 4qxjS, 0.9985, 0.22, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
336, 4qxjE, 0.9985, 0.21, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
337, 5dkiS, 0.9984, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
338, 5dkiE, 0.9984, 0.22, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
339, 4qluS, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
340, 4qluE, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
341, 4qbyS, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
342, 4qbyE, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
343, 4no6S, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
344, 4no6E, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
345, 4qwkS, 0.9983, 0.23, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
346, 4qwkE, 0.9983, 0.23, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
347, 4qlvS, 0.9983, 0.23, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
348, 4qlvE, 0.9983, 0.23, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
349, 5cz4S, 0.9982, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
350, 5cz4E, 0.9982, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
351, 4y78S, 0.9982, 0.24, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
352, 4y78E, 0.9982, 0.24, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
353, 4ltcS, 0.9982, 0.25, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
354, 4ltcE, 0.9982, 0.25, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
355, 4qw3S, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
356, 4qw3E, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
357, 4qvvS, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
358, 4qvvE, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
359, 4ya3S, 0.9979, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
360, 4ya3E, 0.9979, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
361, 4qwsE, 0.9979, 0.26, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
362, 4qwjE, 0.9979, 0.26, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
363, 4ya0E, 0.9978, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
364, 4qwsS, 0.9978, 0.26, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
365, 4qwjS, 0.9978, 0.26, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
366, 4jsqS, 0.9978, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
367, 4jsqE, 0.9978, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
368, 4ya0S, 0.9977, 0.27, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
369, 4jsuS, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
370, 4jsuE, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
371, 3un4S, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
372, 3un4E, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
373, 4inrE, 0.9976, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
374, 4hnpS, 0.9976, 0.28, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
375, 4eu2F, 0.9976, 0.27, 1.000, 232, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
376, 4jt0S, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
377, 4jt0E, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
378, 4intS, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
379, 4intE, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
380, 4inrS, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
381, 3nzjS, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
382, 3nzjE, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
383, 3gpwS, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
384, 3gpwE, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
385, 3gptS, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
386, 3gptE, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
387, 3nzxS, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
388, 3nzxE, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
389, 3hyeS, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
390, 3hyeE, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
391, 4qwgS, 0.9973, 0.29, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
392, 4qwgE, 0.9973, 0.29, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
393, 4j70S, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
394, 4inuE, 0.9973, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
395, 3un8S, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
396, 3un8E, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
397, 3nzwS, 0.9973, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
398, 3nzwE, 0.9973, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
399, 4q1sS, 0.9972, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
400, 4j70E, 0.9972, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
401, 4hnpE, 0.9972, 0.30, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
402, 3tddS, 0.9972, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
403, 3tddE, 0.9972, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
404, 3mg0S, 0.9972, 0.31, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
405, 4inuS, 0.9971, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
406, 2fakS, 0.9971, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
407, 2fakE, 0.9971, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
408, 4x6zT, 0.9970, 0.31, 0.996, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
409, 4lqiS, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
410, 4lqiE, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
411, 4gk7S, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
412, 4gk7E, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
413, 4fzcS, 0.9970, 0.32, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
414, 4fzcE, 0.9970, 0.32, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
415, 3mg0E, 0.9970, 0.32, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
416, 3shjS, 0.9969, 0.32, 1.000, 233, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
417, 3shjE, 0.9969, 0.32, 1.000, 233, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
418, 2gplS, 0.9969, 0.32, 1.000, 233, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
419, 2gplE, 0.9969, 0.32, 1.000, 233, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
420, 4x6zF, 0.9968, 0.32, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
421, 3okjS, 0.9968, 0.33, 1.000, 233, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
422, 3okjE, 0.9968, 0.32, 1.000, 233, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
423, 3d29S, 0.9968, 0.33, 1.000, 233, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
424, 3d29E, 0.9968, 0.33, 1.000, 233, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
425, 2f16S, 0.9968, 0.33, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
426, 2f16E, 0.9968, 0.33, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
427, 4hrdS, 0.9967, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
428, 4hrdE, 0.9967, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
429, 4fzgS, 0.9967, 0.33, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
430, 4fzgE, 0.9967, 0.33, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
431, 4eu2T, 0.9967, 0.33, 1.000, 232, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
432, 4q1sE, 0.9966, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
433, 4hrcE, 0.9965, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
434, 3dy3S, 0.9965, 0.34, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
435, 2zcyS, 0.9965, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
436, 2zcyE, 0.9965, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
437, 3dy4S, 0.9964, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
438, 3dy4E, 0.9964, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
439, 3dy3E, 0.9964, 0.34, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
440, 3gpjS, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
441, 3gpjE, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
442, 3e47S, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
443, 3e47E, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
444, 3bdmS, 0.9963, 0.35, 1.000, 233, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
445, 3bdmE, 0.9963, 0.35, 1.000, 233, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
446, 4hrcS, 0.9961, 0.36, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
447, 3mg4E, 0.9961, 0.37, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
448, 5nifF, 0.9960, 0.36, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
449, 4zzgF, 0.9960, 0.35, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
450, 1rypT, 0.9960, 0.36, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
451, 1rypF, 0.9960, 0.37, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
452, 5nifT, 0.9956, 0.38, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
453, 3wxrT, 0.9956, 0.38, 0.996, 232, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
454, 4zzgT, 0.9955, 0.38, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
455, 3mg4S, 0.9954, 0.40, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
456, 1g65E, 0.9953, 0.40, 0.996, 233, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
457, 1g65S, 0.9951, 0.40, 0.996, 233, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
458, 3wxrF, 0.9950, 0.41, 0.996, 232, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
459, 3oeuE, 0.9949, 0.43, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
460, 3oevE, 0.9947, 0.43, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
461, 3sdkS, 0.9946, 0.43, 0.996, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
462, 3mg8S, 0.9946, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
463, 3mg8E, 0.9946, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
464, 3sdkE, 0.9944, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
465, 3oevS, 0.9944, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
466, 3mg6E, 0.9944, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
467, 3mg7E, 0.9943, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
468, 3oeuS, 0.9942, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
469, 3mg7S, 0.9942, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
470, 3mg6S, 0.9940, 0.46, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
471, 1jd2E, 0.9939, 0.45, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
472, 1jd2Z, 0.9933, 0.47, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
473, 4g4sF, 0.9923, 0.50, 1.000, 234, 231, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
474, 3sdiE, 0.9918, 0.37, 0.996, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
475, 1z7qT, 0.9918, 0.52, 1.000, 234, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
476, 1z7qF, 0.9918, 0.52, 1.000, 234, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
477, 3sdiS, 0.9908, 0.40, 0.996, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
478, 1g0uE, 0.9906, 0.41, 0.996, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
479, 1g0uS, 0.9901, 0.43, 0.996, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
480, 1fntT, 0.9900, 0.57, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
481, 1fntF, 0.9900, 0.57, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
482, 4v7oT, 0.9893, 0.60, 1.000, 234, 231, 
483, 4v7oNA, 0.9893, 0.60, 1.000, 234, 231, 
484, 4v7oF, 0.9893, 0.59, 1.000, 234, 231, 
485, 4v7oBB, 0.9893, 0.60, 1.000, 234, 231, 
486, 5mp9f, 0.9867, 0.66, 1.000, 231, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
487, 5mp9F, 0.9866, 0.66, 1.000, 233, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
488, 3jcpOA, 0.9856, 0.69, 0.996, 233, 231, 
489, 3jcpO, 0.9856, 0.69, 0.996, 233, 231, 
490, 5mpaf, 0.9818, 0.69, 0.996, 233, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
491, 3jcoOA, 0.9777, 0.77, 1.000, 231, 231, 
492, 3jcoO, 0.9777, 0.86, 0.996, 233, 231, 
493, 3unhS, 0.9727, 0.86, 0.996, 233, 231, MOUSE 20S IMMUNOPROTEASOME
494, 3unhE, 0.9727, 0.86, 0.996, 233, 231, MOUSE 20S IMMUNOPROTEASOME
495, 3unfS, 0.9725, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
496, 3unfE, 0.9725, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
497, 5mpaF, 0.9718, 0.81, 0.533, 238, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
498, 3unbS, 0.9715, 0.81, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
499, 1iruT, 0.9714, 0.98, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
500, 1iruF, 0.9714, 0.83, 0.533, 238, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
501, 4r67v, 0.9713, 0.84, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
502, 4r67T, 0.9713, 0.84, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
503, 4r67h, 0.9713, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
504, 4r67F, 0.9713, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
505, 5gjqG, 0.9711, 0.83, 0.528, 238, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
506, 5gjqm, 0.9710, 0.83, 0.528, 238, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
507, 3unbu, 0.9709, 0.83, 0.528, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
508, 4r3oT, 0.9708, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
509, 4r3oF, 0.9707, 0.84, 0.533, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
510, 3unbE, 0.9704, 0.84, 0.528, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
511, 3unbg, 0.9703, 0.85, 0.528, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
512, 5gjrX, 0.9702, 0.86, 0.533, 238, 229, 
513, 5gjrLA, 0.9702, 0.87, 0.533, 238, 229, 
514, 3uneE, 0.9698, 0.85, 0.528, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
515, 3uneS, 0.9690, 0.85, 0.528, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
516, 5lf4E, 0.9689, 0.86, 0.533, 238, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
517, 5lf3E, 0.9689, 0.89, 0.533, 238, 229, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
518, 5lf0E, 0.9689, 0.79, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
519, 3uneu, 0.9689, 0.79, 0.531, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
520, 5wvkT, 0.9688, 0.79, 0.531, 233, 228, 
521, 5lf7E, 0.9687, 0.89, 0.533, 238, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
522, 5lf6E, 0.9687, 1.04, 0.996, 233, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
523, 5lezE, 0.9686, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
524, 3uneg, 0.9686, 0.80, 0.531, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
525, 5lf7S, 0.9685, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
526, 5lf1E, 0.9685, 0.89, 0.533, 238, 229, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
527, 5leyE, 0.9685, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
528, 5lexE, 0.9685, 0.80, 0.531, 233, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
529, 5le5S, 0.9684, 0.81, 0.531, 233, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
530, 5lf6S, 0.9683, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
531, 5lf4S, 0.9683, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
532, 5lf0S, 0.9683, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
533, 5le5E, 0.9683, 0.80, 0.531, 237, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
534, 5lf3S, 0.9682, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
535, 5leyS, 0.9681, 0.81, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
536, 5lf1S, 0.9680, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
537, 5wvkAA, 0.9675, 0.81, 0.531, 235, 228, 
538, 5l4gT, 0.9674, 0.81, 0.531, 237, 228, 
539, 5lezS, 0.9673, 1.05, 0.996, 233, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
540, 6avoL, 0.9671, 0.91, 0.528, 238, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
541, 5lexS, 0.9671, 0.83, 0.531, 237, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
542, 6avoG, 0.9670, 0.92, 0.528, 234, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
543, 5l4gF, 0.9630, 0.83, 0.531, 235, 228, 
544, 5vfsF, 0.9591, 0.92, 0.528, 234, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
545, 5vfsEA, 0.9586, 1.03, 0.528, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
546, 5mpbF, 0.9581, 1.06, 0.528, 238, 229, 
547, 5vfuW, 0.9576, 2.14, 0.262, 240, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
548, 5vftL, 0.9576, 1.07, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
549, 5t0cX, 0.9571, 1.21, 1.000, 231, 231, 
550, 5t0cDB, 0.9571, 1.09, 0.528, 238, 229, 
551, 5a5bF, 0.9570, 1.09, 0.528, 238, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
552, 4cr3F, 0.9570, 1.09, 0.528, 238, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
553, 5vfoL, 0.9566, 1.09, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
554, 5vfqF, 0.9563, 1.22, 0.996, 233, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
555, 4cr2F, 0.9560, 1.22, 0.996, 233, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
556, 5vfol, 0.9553, 1.10, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
557, 5vfrl, 0.9549, 1.11, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
558, 5vfrL, 0.9541, 2.16, 0.270, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
559, 5vfqEA, 0.9541, 1.25, 0.996, 233, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
560, 5vfpDA, 0.9541, 1.13, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
561, 5vfpF, 0.9538, 1.13, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
562, 5mpbT, 0.9531, 1.14, 0.528, 238, 229, 
563, 5vftl, 0.9518, 1.14, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
564, 5vfuKA, 0.9517, 1.15, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
565, 5t0gL, 0.9511, 1.15, 0.528, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
566, 5m32S, 0.9511, 1.29, 1.000, 233, 231, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
567, 5mpcF, 0.9510, 1.19, 0.528, 238, 229, 
568, 5m32E, 0.9500, 1.19, 0.528, 238, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
569, 5mpcT, 0.9481, 1.19, 0.528, 238, 229, 
570, 5t0jL, 0.9433, 1.21, 0.533, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
571, 5wviG, 0.9423, 1.33, 1.000, 231, 231, 
572, 5t0hL, 0.9422, 1.24, 0.537, 234, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
573, 6epcF, 0.9390, 1.37, 0.996, 233, 231, GROUND STATE 26S PROTEASOME (GS2)
574, 5wviZ, 0.9377, 1.30, 0.528, 238, 229, 
575, 6epeF, 0.9354, 1.43, 0.996, 233, 231, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
576, 4cr4F, 0.9328, 1.31, 0.528, 238, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
577, 5t0iL, 0.9325, 1.42, 0.533, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
578, 6epfF, 0.9298, 1.49, 0.996, 233, 231, GROUND STATE 26S PROTEASOME (GS1)
579, 5ln3F, 0.9231, 1.49, 0.533, 238, 229, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
580, 1z7qQ, 0.9174, 1.62, 0.970, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
581, 1z7qC, 0.9174, 1.55, 0.528, 238, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
582, 6epdF, 0.9167, 1.59, 0.533, 238, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
583, 1fntC, 0.9111, 1.60, 0.524, 233, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
584, 1fntQ, 0.9110, 1.64, 0.308, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
585, 4g4sE, 0.9108, 1.64, 0.308, 243, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
586, 5gjqn, 0.9101, 1.76, 0.533, 238, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
587, 5lexT, 0.9097, 1.66, 0.310, 241, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
588, 5lf7T, 0.9094, 1.66, 0.310, 241, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
589, 5gjrMA, 0.9093, 1.75, 0.345, 249, 226, 
590, 5le5T, 0.9092, 1.99, 0.270, 243, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
591, 5lezT, 0.9089, 1.96, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
592, 5lf1T, 0.9088, 1.97, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
593, 5gjqX, 0.9087, 1.99, 0.270, 243, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
594, 4eu2O, 0.9087, 1.97, 0.265, 240, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
595, 5leyT, 0.9086, 1.97, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
596, 5gjrY, 0.9085, 1.98, 0.265, 240, 226, 
597, 5lf4T, 0.9084, 2.00, 0.270, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
598, 3wxrO, 0.9083, 1.95, 0.223, 241, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
599, 3unbT, 0.9083, 1.98, 0.265, 240, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
600, 5lf3T, 0.9080, 2.00, 0.270, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
601, 4eu2A, 0.9080, 1.98, 0.265, 240, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
602, 3mg6U, 0.9080, 1.92, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
603, 5lf6T, 0.9079, 2.00, 0.265, 244, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
604, 5lf0T, 0.9079, 1.98, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
605, 3sdkU, 0.9079, 1.92, 0.223, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
606, 3unbv, 0.9078, 1.94, 0.223, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
607, 1z7qE, 0.9078, 1.99, 0.265, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
608, 3oevU, 0.9077, 1.99, 0.265, 240, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
609, 3mg7U, 0.9077, 1.94, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
610, 3oeuU, 0.9076, 2.01, 0.265, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
611, 3mg8U, 0.9076, 1.63, 0.347, 245, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
612, 1z7qS, 0.9076, 1.95, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
613, 4hnpU, 0.9075, 1.95, 0.227, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
614, 4r3oU, 0.9074, 1.94, 0.223, 243, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
615, 3un8U, 0.9074, 1.95, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
616, 4r3oG, 0.9073, 1.64, 0.347, 245, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
617, 3uneh, 0.9068, 1.91, 0.219, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
618, 3oevG, 0.9068, 2.03, 0.270, 245, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
619, 3mg6G, 0.9068, 1.95, 0.219, 243, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
620, 1ya7G, 0.9068, 2.03, 0.270, 245, 226, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
621, 3mg7G, 0.9067, 2.05, 0.265, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
622, 4hrcU, 0.9066, 1.96, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
623, 3uneT, 0.9066, 1.96, 0.223, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
624, 4qv9U, 0.9065, 1.62, 0.335, 227, 224, YCP BETA5-C63F MUTANT
625, 4qv9G, 0.9065, 1.95, 0.223, 243, 229, YCP BETA5-C63F MUTANT
626, 4inrU, 0.9065, 1.91, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
627, 5fggU, 0.9064, 2.06, 0.265, 244, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
628, 4qv3U, 0.9064, 1.91, 0.219, 241, 228, YCP BETA5-M45V MUTANT
629, 4qv3G, 0.9064, 1.91, 0.219, 241, 228, YCP BETA5-M45V MUTANT
630, 3oeuG, 0.9064, 1.96, 0.219, 243, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
631, 5fggG, 0.9063, 1.90, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
632, 5d0sU, 0.9063, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
633, 5l55U, 0.9062, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
634, 5d0sG, 0.9062, 1.95, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
635, 4ltcU, 0.9062, 1.90, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
636, 4intU, 0.9062, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
637, 3mg4U, 0.9062, 1.91, 0.219, 241, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
638, 1ya7F, 0.9062, 1.91, 0.219, 241, 228, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
639, 5l55G, 0.9061, 1.97, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
640, 5ahjU, 0.9061, 1.96, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
641, 5ahjG, 0.9061, 2.00, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
642, 4qwlU, 0.9061, 1.61, 0.335, 227, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
643, 4qwlG, 0.9061, 1.91, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
644, 4jsqG, 0.9061, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
645, 4g4sA, 0.9061, 1.91, 0.219, 241, 228, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
646, 3un8G, 0.9061, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
647, 3mg8G, 0.9061, 1.91, 0.219, 241, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
648, 5nifA, 0.9060, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
649, 5l52U, 0.9060, 1.84, 0.220, 241, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
650, 4x6zO, 0.9060, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
651, 3wxrA, 0.9060, 1.96, 0.223, 243, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
652, 3uneF, 0.9060, 1.96, 0.219, 241, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
653, 5l52G, 0.9059, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
654, 5fgfU, 0.9059, 1.90, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
655, 5cggU, 0.9059, 1.97, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
656, 4zzgA, 0.9059, 2.06, 0.265, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
657, 4r67U, 0.9059, 1.91, 0.219, 241, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
658, 4r02T, 0.9059, 1.91, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
659, 4hrcF, 0.9059, 1.91, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
660, 3un4U, 0.9059, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
661, 5l4gG, 0.9058, 2.05, 0.270, 245, 226, 
662, 5fgfG, 0.9058, 2.01, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
663, 5cggG, 0.9058, 2.03, 0.295, 244, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
664, 4zzgO, 0.9058, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
665, 4r67w, 0.9058, 2.21, 0.264, 242, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
666, 4r67i, 0.9058, 1.92, 0.219, 241, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
667, 4r67G, 0.9058, 1.91, 0.219, 241, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
668, 3un4G, 0.9058, 1.96, 0.223, 242, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
669, 3sdkG, 0.9058, 2.05, 0.270, 245, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
670, 5jhrU, 0.9057, 2.05, 0.270, 245, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
671, 5jhrG, 0.9057, 2.06, 0.270, 245, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
672, 5czaU, 0.9057, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
673, 5czaG, 0.9057, 1.96, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
674, 5cgfU, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
675, 5cgfG, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
676, 4y8hU, 0.9057, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
677, 4y8hG, 0.9057, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
678, 4qv7U, 0.9057, 1.93, 0.219, 241, 228, YCP BETA5-A50V MUTANT
679, 4qv7G, 0.9057, 1.93, 0.219, 241, 228, YCP BETA5-A50V MUTANT
680, 4jsuU, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
681, 4jsuG, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
682, 4fzcU, 0.9057, 1.92, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
683, 5fhsU, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
684, 5fhsG, 0.9056, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
685, 5fg7U, 0.9056, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
686, 5fg7G, 0.9056, 2.01, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
687, 5d0zU, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
688, 5d0zG, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
689, 5d0wU, 0.9056, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
690, 5d0wG, 0.9056, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
691, 5cz8U, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
692, 5cz8G, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
693, 4qz6U, 0.9056, 1.92, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
694, 4nnnU, 0.9056, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH MG132
695, 4lqiU, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
696, 4inrG, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
697, 4fzcG, 0.9056, 1.92, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
698, 5cz9U, 0.9055, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
699, 4qz6G, 0.9055, 2.02, 0.223, 243, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
700, 4quyU, 0.9055, 1.97, 0.219, 243, 228, YCP BETA5-A49S-MUTANT
701, 4quyG, 0.9055, 2.01, 0.223, 243, 229, YCP BETA5-A49S-MUTANT
702, 4nnnG, 0.9055, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH MG132
703, 4j70U, 0.9055, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
704, 4j70G, 0.9055, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
705, 4fzgU, 0.9055, 1.92, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
706, 4fzgG, 0.9055, 1.91, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
707, 3tddU, 0.9055, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
708, 3shjU, 0.9055, 2.03, 0.223, 243, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
709, 5m2bT, 0.9054, 2.01, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
710, 5l5bU, 0.9054, 2.01, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
711, 5l5bG, 0.9054, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
712, 5cz9G, 0.9054, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
713, 4z1lU, 0.9054, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
714, 4y8rU, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
715, 4y8rG, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
716, 4y8kG, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
717, 4r00U, 0.9054, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
718, 4r00G, 0.9054, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
719, 4lqiG, 0.9054, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
720, 3tddG, 0.9054, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
721, 3shjG, 0.9054, 1.93, 0.219, 241, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
722, 2f16U, 0.9054, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
723, 5l63T, 0.9053, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
724, 5l63F, 0.9053, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
725, 5l5hT, 0.9053, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
726, 5l5hF, 0.9053, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
727, 5fgaU, 0.9053, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
728, 4z1lG, 0.9053, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
729, 4ya7U, 0.9053, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
730, 4ya4U, 0.9053, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
731, 4ya4G, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
732, 4y8kU, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
733, 4qv5U, 0.9053, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
734, 4no9U, 0.9053, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
735, 4no9G, 0.9053, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
736, 4no1U, 0.9053, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
737, 4no1G, 0.9053, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
738, 4jsqU, 0.9053, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
739, 2fakU, 0.9053, 1.91, 0.219, 241, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
740, 2f16G, 0.9053, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
741, 5fgaG, 0.9052, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
742, 4zzgU, 0.9052, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
743, 4ya7G, 0.9052, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
744, 4ya1U, 0.9052, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
745, 4ya1G, 0.9052, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
746, 4y8pU, 0.9052, 2.01, 0.300, 244, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
747, 4x6zG, 0.9052, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
748, 4r18T, 0.9052, 1.93, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
749, 4r18F, 0.9052, 1.93, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
750, 4qv5G, 0.9052, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
751, 4q1sU, 0.9052, 2.18, 0.294, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
752, 4jt0U, 0.9052, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
753, 4jt0G, 0.9052, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
754, 4hrdU, 0.9052, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
755, 3unbh, 0.9052, 1.98, 0.223, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
756, 2fakG, 0.9052, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
757, 5l64T, 0.9051, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
758, 5l64F, 0.9051, 1.95, 0.219, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
759, 5l61T, 0.9051, 2.06, 0.270, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
760, 5l61F, 0.9051, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
761, 5l5rT, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
762, 5l5rF, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
763, 5l5pT, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
764, 5l5pF, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
765, 5l5oT, 0.9051, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
766, 5l5oF, 0.9051, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
767, 5jhsU, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
768, 5jhsG, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
769, 4y8sU, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
770, 4y8sG, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
771, 4y8pG, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
772, 4qzxU, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
773, 4qzxG, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
774, 4qz3U, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
775, 4qwrU, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
776, 4qwrG, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
777, 4qw7U, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
778, 4qw7G, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
779, 4qw5U, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
780, 4qw5G, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
781, 4qv8U, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT
782, 4qv8G, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT
783, 4qv4U, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45T MUTANT
784, 4qv4G, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45T MUTANT
785, 4qv1U, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-M45A MUTANT
786, 4no6U, 0.9051, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
787, 4inuG, 0.9051, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
788, 3nzxU, 0.9051, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
789, 3e47U, 0.9051, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
790, 1iruU, 0.9051, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
791, 1iruG, 0.9051, 1.97, 0.219, 243, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
792, 5nifU, 0.9050, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
793, 5l6cT, 0.9050, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
794, 5l6cF, 0.9050, 2.05, 0.265, 245, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
795, 5l69T, 0.9050, 2.05, 0.265, 245, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
796, 5l69F, 0.9050, 2.01, 0.300, 244, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
797, 4ya2U, 0.9050, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
798, 4y9zU, 0.9050, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
799, 4y9zG, 0.9050, 2.04, 0.295, 243, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
800, 4y8lU, 0.9050, 2.04, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
801, 4y8lG, 0.9050, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
802, 4qz5U, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
803, 4qz3G, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
804, 4qz0U, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
805, 4qz0G, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
806, 4qwuU, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
807, 4qwuG, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
808, 4qv5T, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
809, 4qv5F, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
810, 4qv1G, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-M45A MUTANT
811, 4qv0U, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
812, 4qv0G, 0.9050, 2.04, 0.300, 243, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
813, 4qluU, 0.9050, 2.04, 0.300, 243, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
814, 4no8U, 0.9050, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
815, 4no8G, 0.9050, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
816, 4no6G, 0.9050, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
817, 3e47G, 0.9050, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
818, 6gopU, 0.9049, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
819, 5l6aT, 0.9049, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
820, 5l6aF, 0.9049, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
821, 5l67T, 0.9049, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
822, 5l67F, 0.9049, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
823, 5l62T, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
824, 5l62F, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
825, 5l5tT, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
826, 5l5tF, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
827, 5l5sT, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
828, 5l5sF, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
829, 5l5jT, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
830, 5l5jF, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
831, 5l5bT, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
832, 5l5bF, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
833, 5fgeU, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
834, 5d0vU, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
835, 4ya2G, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
836, 4y7yU, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
837, 4qzzU, 0.9049, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH OMURALIDE
838, 4qzzG, 0.9049, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH OMURALIDE
839, 4qz5G, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
840, 4qwjU, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
841, 4qwjG, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
842, 4qw6U, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
843, 4qv6T, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49V MUTANT
844, 4qv6F, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49V MUTANT
845, 4qluG, 0.9049, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
846, 4ltcG, 0.9049, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
847, 4inuU, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
848, 3nzxG, 0.9049, 2.06, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
849, 3mg0U, 0.9049, 1.92, 0.219, 241, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
850, 2gplU, 0.9049, 1.99, 0.223, 243, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
851, 5l5yT, 0.9048, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
852, 5l5yF, 0.9048, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
853, 5l5qT, 0.9048, 2.03, 0.227, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
854, 5l5qF, 0.9048, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
855, 5l5iF, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
856, 5l5dT, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
857, 5l5dF, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
858, 5fgeG, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
859, 5d0vG, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
860, 5cgiU, 0.9048, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
861, 5bxnT, 0.9048, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
862, 5bxnF, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
863, 4ya9F, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
864, 4y7yG, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
865, 4qw6G, 0.9048, 2.06, 0.298, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
866, 3okjU, 0.9048, 2.06, 0.298, 243, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
867, 3gpwU, 0.9048, 2.04, 0.300, 243, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
868, 2gplG, 0.9048, 1.93, 0.219, 241, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
869, 1fntE, 0.9048, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
870, 6gopG, 0.9047, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
871, 5l68T, 0.9047, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
872, 5l68F, 0.9047, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
873, 5l5uU, 0.9047, 1.62, 0.344, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
874, 5l5uG, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
875, 5d0wT, 0.9047, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
876, 5cz5U, 0.9047, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
877, 5cgiG, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
878, 5bxlU, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
879, 5bxlG, 0.9047, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
880, 4r02F, 0.9047, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
881, 4hrdF, 0.9047, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
882, 3unev, 0.9047, 1.94, 0.219, 241, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
883, 3okjG, 0.9047, 1.94, 0.219, 241, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
884, 3gpwG, 0.9047, 2.06, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
885, 1rypU, 0.9047, 2.07, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
886, 1fntS, 0.9047, 2.08, 0.270, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
887, 5m2bF, 0.9046, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
888, 5lttU, 0.9046, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
889, 5lttG, 0.9046, 2.06, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
890, 5lexF, 0.9046, 1.62, 0.344, 244, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
891, 5l60T, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
892, 5l5wT, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
893, 5l5wF, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
894, 5l5uT, 0.9046, 1.98, 0.267, 239, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
895, 5l5uF, 0.9046, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
896, 5fg9U, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
897, 5fg9G, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
898, 5d0wF, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
899, 5cz5G, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
900, 4ya4T, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
901, 4ya4F, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
902, 4y9yU, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
903, 4y8tU, 0.9046, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
904, 4y8tT, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
905, 4y8tG, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
906, 4y8tF, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
907, 4y8gT, 0.9046, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
908, 4y8gF, 0.9046, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
909, 4y7wU, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
910, 4v7oIA, 0.9046, 2.03, 0.300, 243, 227, 
911, 4qzwU, 0.9046, 2.21, 0.294, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
912, 4qltU, 0.9046, 2.21, 0.294, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
913, 4qltG, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
914, 4qlsU, 0.9046, 2.06, 0.223, 243, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
915, 4qlsG, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
916, 4ltcF, 0.9046, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
917, 3unhT, 0.9046, 1.93, 0.219, 241, 228, MOUSE 20S IMMUNOPROTEASOME
918, 3unhF, 0.9046, 1.93, 0.219, 241, 228, MOUSE 20S IMMUNOPROTEASOME
919, 3hyeU, 0.9046, 1.93, 0.219, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
920, 5lajT, 0.9045, 2.20, 0.294, 244, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
921, 5lajF, 0.9045, 1.93, 0.267, 244, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
922, 5l6bT, 0.9045, 1.93, 0.267, 244, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
923, 5l6bF, 0.9045, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
924, 5l66T, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
925, 5l66F, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
926, 5l60F, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
927, 5l5vT, 0.9045, 2.07, 0.298, 243, 228,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
928, 5l5vF, 0.9045, 2.07, 0.298, 243, 228,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
929, 5l5rU, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
930, 5l54U, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
931, 5cz7T, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
932, 5cz7F, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
933, 5bxnG, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
934, 5bxlT, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
935, 4y9yG, 0.9045, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
936, 4y8qU, 0.9045, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
937, 4y8qG, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
938, 4y8mU, 0.9045, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
939, 4y8jU, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
940, 4y8jG, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
941, 4y8gU, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
942, 4y8gG, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
943, 4y7wG, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
944, 4y70U, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
945, 4y70G, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
946, 4v7oO, 0.9045, 1.93, 0.219, 241, 228, 
947, 4v7oA, 0.9045, 1.93, 0.219, 241, 228, 
948, 4qzwG, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
949, 4qwiU, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
950, 4qwiG, 0.9045, 2.06, 0.223, 243, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
951, 4qvpU, 0.9045, 2.28, 0.288, 244, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
952, 4qvpG, 0.9045, 2.06, 0.223, 243, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
953, 4qvnU, 0.9045, 2.06, 0.342, 250, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
954, 4qvnT, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
955, 4qvnG, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
956, 4qvnF, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
957, 4qv3F, 0.9045, 1.94, 0.219, 241, 228, YCP BETA5-M45V MUTANT
958, 4q1sG, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
959, 4q1sF, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
960, 4ltcT, 0.9045, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
961, 4hnpF, 0.9045, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
962, 3nzwU, 0.9045, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
963, 3nzjU, 0.9045, 2.04, 0.300, 243, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
964, 3hyeG, 0.9045, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
965, 6gopT, 0.9044, 2.04, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
966, 5nifO, 0.9044, 2.20, 0.294, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
967, 5lezF, 0.9044, 2.02, 0.300, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
968, 5l5rG, 0.9044, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
969, 5l54G, 0.9044, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
970, 5czaT, 0.9044, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
971, 5czaF, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT
972, 5cz7U, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
973, 5cz7G, 0.9044, 1.98, 0.267, 239, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
974, 5bxnU, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
975, 5bxlF, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
976, 4y8mG, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
977, 4y77U, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
978, 4y77G, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
979, 4v7oWA, 0.9044, 1.94, 0.219, 241, 228, 
980, 4qvlT, 0.9044, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH BORTEZOMIB
981, 4qvlF, 0.9044, 2.06, 0.298, 243, 228, YCP IN COMPLEX WITH BORTEZOMIB
982, 4nnwU, 0.9044, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
983, 4nnwG, 0.9044, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
984, 4intG, 0.9044, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
985, 4hnpT, 0.9044, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
986, 4eu2U, 0.9044, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
987, 3nzjG, 0.9044, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
988, 3gptU, 0.9044, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
989, 3gptG, 0.9044, 1.92, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
990, 3bdmU, 0.9044, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
991, 6gopF, 0.9043, 2.06, 0.295, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
992, 5lajU, 0.9043, 2.08, 0.294, 244, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
993, 5l6aU, 0.9043, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
994, 5l6aG, 0.9043, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
995, 5l65T, 0.9043, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
996, 5l65F, 0.9043, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
997, 5l5fT, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
998, 5l5fF, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
999, 5l5aT, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1000, 5l5aF, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1001, 5fgiU, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1002, 5fgiG, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1003, 5fgdU, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1004, 5fgdG, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1005, 4ya1T, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1006, 4ya1F, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1007, 4y8uU, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1008, 4y8uG, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1009, 4y8rT, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1010, 4y8rF, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1011, 4y80U, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1012, 4y80G, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1013, 4r02U, 0.9043, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1014, 4qvyT, 0.9043, 1.95, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1015, 4qvyF, 0.9043, 2.06, 0.298, 243, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1016, 4quyT, 0.9043, 2.06, 0.298, 243, 228, YCP BETA5-A49S-MUTANT
1017, 4quyF, 0.9043, 1.93, 0.219, 241, 228, YCP BETA5-A49S-MUTANT
1018, 4q1sT, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1019, 3un8T, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1020, 3nzwG, 0.9043, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1021, 3d29U, 0.9043, 2.07, 0.298, 243, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1022, 3bdmG, 0.9043, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1023, 1rypG, 0.9043, 2.06, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1024, 5lajG, 0.9042, 2.05, 0.295, 244, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1025, 5d0tU, 0.9042, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1026, 4zzgG, 0.9042, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1027, 4ya9U, 0.9042, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1028, 4ya9G, 0.9042, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1029, 4y82U, 0.9042, 2.06, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1030, 4y82G, 0.9042, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1031, 4qz4U, 0.9042, 1.95, 0.219, 241, 228, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1032, 4qz2U, 0.9042, 2.03, 0.300, 244, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1033, 4qwfT, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1034, 4qwfF, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1035, 4qw1U, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1036, 4qw1G, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1037, 4qvlU, 0.9042, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH BORTEZOMIB
1038, 4qv4T, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-M45T MUTANT
1039, 4qv4F, 0.9042, 2.06, 0.295, 243, 227, YCP BETA5-M45T MUTANT
1040, 4qv1T, 0.9042, 2.06, 0.295, 243, 227, YCP BETA5-M45A MUTANT
1041, 4qv1F, 0.9042, 1.94, 0.219, 241, 228, YCP BETA5-M45A MUTANT
1042, 3un8F, 0.9042, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1043, 3nzjT, 0.9042, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1044, 3d29G, 0.9042, 2.07, 0.298, 243, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1045, 1ya7C, 0.9042, 2.07, 0.298, 243, 228, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1046, 1rypO, 0.9042, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1047, 5l6bU, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1048, 5l6bG, 0.9041, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1049, 5l5zT, 0.9041, 2.08, 0.294, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1050, 5l5zF, 0.9041, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1051, 5fg7T, 0.9041, 1.64, 0.335, 227, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1052, 5fg7F, 0.9041, 2.08, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1053, 5d0tG, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1054, 5cz6T, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1055, 5cz6F, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1056, 5cghU, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1057, 5cghG, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1058, 5ahjT, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1059, 5ahjF, 0.9041, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1060, 4y9yT, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1061, 4y7xU, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1062, 4y75U, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1063, 4y75T, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1064, 4y75F, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1065, 4r17U, 0.9041, 2.08, 0.298, 243, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1066, 4r00T, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1067, 4r00F, 0.9041, 1.94, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1068, 4qzzT, 0.9041, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH OMURALIDE
1069, 4qzzF, 0.9041, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH OMURALIDE
1070, 4qz4G, 0.9041, 2.08, 0.298, 243, 228, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1071, 4qz2G, 0.9041, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1072, 4qw1T, 0.9041, 2.05, 0.300, 243, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1073, 4qw1F, 0.9041, 2.05, 0.300, 243, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1074, 4qvqT, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1075, 4qvqF, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1076, 4qvlG, 0.9041, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH BORTEZOMIB
1077, 4qv9T, 0.9041, 1.94, 0.219, 241, 228, YCP BETA5-C63F MUTANT
1078, 4qv9F, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-C63F MUTANT
1079, 4qv6U, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-A49V MUTANT
1080, 4qbyT, 0.9041, 2.02, 0.300, 243, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1081, 4qbyF, 0.9041, 2.02, 0.300, 243, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1082, 3nzjF, 0.9041, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1083, 1ya7B, 0.9041, 2.06, 0.298, 243, 228, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1084, 1rypA, 0.9041, 2.06, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1085, 5nifG, 0.9040, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1086, 5l67U, 0.9040, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1087, 5l67G, 0.9040, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1088, 5l5xT, 0.9040, 2.08, 0.294, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1089, 5l5iT, 0.9040, 1.65, 0.335, 227, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1090, 5fgaF, 0.9040, 2.08, 0.223, 243, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1091, 5fg9F, 0.9040, 2.04, 0.300, 244, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1092, 5cghT, 0.9040, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1093, 5cghF, 0.9040, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1094, 4ya9T, 0.9040, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1095, 4y9yF, 0.9040, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1096, 4y8mT, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1097, 4y8mF, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1098, 4y8kT, 0.9040, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1099, 4y8kF, 0.9040, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1100, 4y7xG, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1101, 4y75G, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1102, 4x6zA, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1103, 4r17T, 0.9040, 2.07, 0.298, 243, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1104, 4r17G, 0.9040, 2.06, 0.295, 243, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1105, 4r17F, 0.9040, 2.06, 0.295, 243, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1106, 4qvwT, 0.9040, 1.94, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1107, 4qvwF, 0.9040, 1.93, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1108, 4qv6G, 0.9040, 1.93, 0.219, 242, 228, YCP BETA5-A49V MUTANT
1109, 4quxT, 0.9040, 2.23, 0.293, 243, 229, YCP BETA5-A49T-MUTANT
1110, 4quxF, 0.9040, 1.94, 0.219, 241, 228, YCP BETA5-A49T-MUTANT
1111, 4no6T, 0.9040, 2.23, 0.293, 243, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1112, 4no6F, 0.9040, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1113, 4hnpG, 0.9040, 2.07, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1114, 4gk7U, 0.9040, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1115, 4g4sC, 0.9040, 2.07, 0.298, 243, 228, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1116, 3mg8R, 0.9040, 2.07, 0.298, 243, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1117, 3mg4G, 0.9040, 2.04, 0.300, 243, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1118, 3dy4U, 0.9040, 2.04, 0.300, 243, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1119, 5lttT, 0.9039, 2.01, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1120, 5lttF, 0.9039, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1121, 5l5xF, 0.9039, 1.54, 0.311, 237, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1122, 5l5hU, 0.9039, 1.65, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1123, 5l5hG, 0.9039, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1124, 5l5eU, 0.9039, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1125, 5l4gU, 0.9039, 2.08, 0.298, 243, 228, 
1126, 5fggT, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1127, 5fggF, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1128, 5fgaT, 0.9039, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1129, 5fg9T, 0.9039, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1130, 5bouT, 0.9039, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1131, 5bouF, 0.9039, 2.05, 0.265, 241, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1132, 4ya2T, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1133, 4ya2F, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1134, 4y82F, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1135, 4y81T, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1136, 4y78U, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1137, 4y78G, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1138, 4qz7U, 0.9039, 2.22, 0.294, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1139, 4qw6T, 0.9039, 2.22, 0.294, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1140, 4qw6F, 0.9039, 2.05, 0.300, 243, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1141, 4qvyU, 0.9039, 2.06, 0.295, 243, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1142, 4qvpT, 0.9039, 1.94, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1143, 4qvpF, 0.9039, 1.94, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1144, 4qv7T, 0.9039, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT
1145, 4qv7F, 0.9039, 2.22, 0.285, 243, 228, YCP BETA5-A50V MUTANT
1146, 4qv0T, 0.9039, 2.22, 0.285, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1147, 4qv0F, 0.9039, 1.95, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1148, 4quxU, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-A49T-MUTANT
1149, 4qlsT, 0.9039, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1150, 4qlsF, 0.9039, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1151, 4lqiT, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1152, 4intT, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1153, 4inrT, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1154, 4hrcT, 0.9039, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1155, 4gk7G, 0.9039, 2.23, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1156, 3dy4G, 0.9039, 2.23, 0.294, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1157, 3d29T, 0.9039, 2.08, 0.298, 244, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1158, 1ya7A, 0.9039, 2.23, 0.293, 244, 229, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1159, 1g65T, 0.9039, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1160, 5l5oU, 0.9038, 2.06, 0.295, 244, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1161, 5l5oG, 0.9038, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1162, 5l5eT, 0.9038, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1163, 5l5eG, 0.9038, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1164, 5l5eF, 0.9038, 1.64, 0.335, 227, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1165, 5l5aU, 0.9038, 2.06, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1166, 5l5aG, 0.9038, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1167, 4ya7T, 0.9038, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1168, 4ya7F, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1169, 4y8pT, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1170, 4y8pF, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1171, 4y81F, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1172, 4y77T, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1173, 4y6vF, 0.9038, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1174, 4r18U, 0.9038, 2.07, 0.298, 243, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1175, 4r18G, 0.9038, 2.08, 0.298, 243, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1176, 4qz7G, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1177, 4qxjU, 0.9038, 2.06, 0.295, 243, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1178, 4qxjG, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1179, 4qwxU, 0.9038, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1180, 4qwxG, 0.9038, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1181, 4qwlT, 0.9038, 1.95, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1182, 4qwlF, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1183, 4qwkU, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1184, 4qvyG, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1185, 4qvqU, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1186, 4qv8T, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-C52F MUTANT
1187, 4qv8F, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-C52F MUTANT
1188, 4quxG, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-A49T-MUTANT
1189, 4qlvU, 0.9038, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1190, 4qlvG, 0.9038, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1191, 4jsqT, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1192, 4jsqF, 0.9038, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1193, 4intF, 0.9038, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1194, 4g4sG, 0.9038, 1.95, 0.219, 241, 228, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1195, 3hyeT, 0.9038, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1196, 3hyeF, 0.9038, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1197, 3gptT, 0.9038, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1198, 3gptF, 0.9038, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1199, 3gpjU, 0.9038, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1200, 3d29F, 0.9038, 2.24, 0.293, 246, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
1201, 2zcyF, 0.9038, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1202, 5l65U, 0.9037, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1203, 5l64U, 0.9037, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1204, 5l64G, 0.9037, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1205, 5l61U, 0.9037, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1206, 5l61G, 0.9037, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1207, 5l5fU, 0.9037, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1208, 5l5fG, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1209, 5l55T, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1210, 5jhrT, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1211, 5jhrF, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1212, 5fgeT, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1213, 5cgfT, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1214, 5cgfF, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1215, 4y84U, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1216, 4y77F, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1217, 4y74U, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1218, 4y74G, 0.9037, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1219, 4y6vT, 0.9037, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1220, 4qwuF, 0.9037, 2.07, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1221, 4qwkG, 0.9037, 1.94, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1222, 4qw4T, 0.9037, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH CARFILZOMIB
1223, 4qw4F, 0.9037, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH CARFILZOMIB
1224, 4qvqG, 0.9037, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1225, 4qv3T, 0.9037, 2.08, 0.298, 243, 228, YCP BETA5-M45V MUTANT
1226, 4qlqU, 0.9037, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1227, 4nnnT, 0.9037, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH MG132
1228, 4nnnF, 0.9037, 2.03, 0.295, 243, 227, YCP IN COMPLEX WITH MG132
1229, 4inrF, 0.9037, 2.04, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1230, 4gk7T, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1231, 4gk7F, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1232, 4eu2G, 0.9037, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1233, 3unfT, 0.9037, 2.07, 0.298, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1234, 3unfF, 0.9037, 2.07, 0.298, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1235, 3gpjG, 0.9037, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1236, 3dy3T, 0.9037, 2.08, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1237, 3dy3F, 0.9037, 2.08, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1238, 2fakT, 0.9037, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1239, 1g65F, 0.9037, 1.92, 0.271, 244, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1240, 5lf0F, 0.9036, 1.92, 0.271, 244, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1241, 5l6cU, 0.9036, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1242, 5l65G, 0.9036, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1243, 5l63U, 0.9036, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1244, 5l62U, 0.9036, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1245, 5l62G, 0.9036, 2.06, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1246, 5l5xU, 0.9036, 2.08, 0.271, 239, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1247, 5l5xG, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1248, 5l5pU, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1249, 5l5pG, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1250, 5l55F, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1251, 5fgeF, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1252, 5cz6U, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1253, 5cz6G, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1254, 5cggT, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1255, 5cggF, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1256, 4y84G, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1257, 4y7xT, 0.9036, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1258, 4x6zU, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1259, 4rurT, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1260, 4rurF, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1261, 4qz6T, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1262, 4qz6F, 0.9036, 1.94, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1263, 4qz0T, 0.9036, 2.06, 0.300, 243, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1264, 4qwuT, 0.9036, 2.25, 0.293, 244, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1265, 4qvwU, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1266, 4qvvU, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1267, 4qvvG, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1268, 4qlqG, 0.9036, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1269, 4lqiF, 0.9036, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1270, 4hrdT, 0.9036, 2.08, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1271, 4hrcG, 0.9036, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1272, 3wxrQ, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1273, 3oeuD, 0.9036, 1.95, 0.219, 241, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1274, 3dy3U, 0.9036, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1275, 2zcyT, 0.9036, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1276, 2fakF, 0.9036, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1277, 1ya7D, 0.9036, 2.01, 0.223, 243, 229, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1278, 5lf1F, 0.9035, 1.75, 0.308, 244, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1279, 5leyF, 0.9035, 1.68, 0.341, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1280, 5l6cG, 0.9035, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1281, 5l66U, 0.9035, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1282, 5l63G, 0.9035, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1283, 5dkjU, 0.9035, 1.66, 0.335, 227, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1284, 5d0sT, 0.9035, 2.09, 0.267, 239, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1285, 5d0sF, 0.9035, 2.08, 0.271, 239, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1286, 4y8sT, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1287, 4y8sF, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1288, 4y8iU, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1289, 4y8iG, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1290, 4y80F, 0.9035, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1291, 4y7xF, 0.9035, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1292, 4y6aU, 0.9035, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1293, 4y6aG, 0.9035, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1294, 4qz5T, 0.9035, 1.94, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1295, 4qz4T, 0.9035, 1.95, 0.219, 241, 228, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1296, 4qz4F, 0.9035, 2.06, 0.295, 243, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1297, 4qz3T, 0.9035, 2.06, 0.300, 243, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1298, 4qz3F, 0.9035, 1.95, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1299, 4qz0F, 0.9035, 1.96, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1300, 4qwxF, 0.9035, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1301, 4qwrT, 0.9035, 2.24, 0.293, 243, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1302, 4qwrF, 0.9035, 2.24, 0.293, 243, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1303, 4qwfU, 0.9035, 2.08, 0.298, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1304, 4qvwG, 0.9035, 2.08, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1305, 4qbyU, 0.9035, 2.23, 0.285, 243, 228, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1306, 4qbyG, 0.9035, 2.09, 0.294, 243, 228, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1307, 4no9T, 0.9035, 2.06, 0.300, 243, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1308, 4no1T, 0.9035, 2.06, 0.300, 243, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1309, 4no1F, 0.9035, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1310, 4lqiP, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1311, 4lqiB, 0.9035, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1312, 3tddF, 0.9035, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1313, 3okjT, 0.9035, 2.09, 0.298, 243, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1314, 3okjF, 0.9035, 2.09, 0.298, 243, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1315, 3dy4T, 0.9035, 2.09, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1316, 2zcyU, 0.9035, 1.73, 0.308, 244, 224, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1317, 5nifE, 0.9034, 1.73, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1318, 5lf7F, 0.9034, 2.08, 0.298, 244, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1319, 5lf4F, 0.9034, 2.07, 0.298, 244, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1320, 5l66G, 0.9034, 2.07, 0.298, 244, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1321, 5l5wU, 0.9034, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1322, 5l5vU, 0.9034, 2.07, 0.223, 243, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1323, 5l5vG, 0.9034, 1.59, 0.342, 236, 222,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1324, 5fgiF, 0.9034, 2.08, 0.271, 239, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1325, 5dkjG, 0.9034, 2.08, 0.267, 239, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1326, 5d0zT, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1327, 5d0zF, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1328, 4z1lT, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1329, 4z1lF, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1330, 4y9zT, 0.9034, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1331, 4y9zF, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1332, 4y8nT, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1333, 4y8nF, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1334, 4y8hT, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1335, 4y8hF, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1336, 4y74T, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1337, 4y74F, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1338, 4y6zF, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1339, 4y6aT, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1340, 4y6aF, 0.9034, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1341, 4y69U, 0.9034, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1342, 4y69G, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1343, 4qwxT, 0.9034, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1344, 4qwfG, 0.9034, 2.23, 0.285, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1345, 4no9F, 0.9034, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1346, 4nnwT, 0.9034, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1347, 4nnwF, 0.9034, 1.96, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1348, 4hrdG, 0.9034, 1.96, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1349, 4fzcP, 0.9034, 2.09, 0.294, 243, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1350, 3dy4F, 0.9034, 1.94, 0.219, 241, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1351, 3dy3G, 0.9034, 2.09, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1352, 6avoQ, 0.9033, 2.08, 0.298, 243, 228, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1353, 6avoJ, 0.9033, 2.08, 0.298, 243, 228, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1354, 5l5wG, 0.9033, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1355, 5l5tU, 0.9033, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1356, 5l5qU, 0.9033, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1357, 5l5qG, 0.9033, 2.06, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1358, 5fgiT, 0.9033, 1.99, 0.271, 239, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1359, 5d0xU, 0.9033, 1.99, 0.271, 239, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1360, 4y6zU, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1361, 4y6zG, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1362, 4y69T, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1363, 4y69F, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1364, 4r18P, 0.9033, 2.23, 0.285, 243, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1365, 4qz5F, 0.9033, 1.96, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1366, 4qw0U, 0.9033, 1.95, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1367, 4j70R, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1368, 4j70D, 0.9033, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1369, 4fzcB, 0.9033, 2.08, 0.298, 243, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1370, 3tddT, 0.9033, 1.74, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1371, 3nzwT, 0.9033, 2.24, 0.293, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1372, 3nzwF, 0.9033, 1.96, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1373, 3mg0T, 0.9033, 1.67, 0.341, 242, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1374, 2zcyG, 0.9033, 1.67, 0.341, 242, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1375, 1z7qU, 0.9033, 1.74, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1376, 1z7qG, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1377, 1jd22, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1378, 1jd21, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1379, 5lf3F, 0.9032, 2.07, 0.300, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1380, 5l5zU, 0.9032, 2.07, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1381, 5l5tG, 0.9032, 2.18, 0.294, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1382, 5l5dU, 0.9032, 2.18, 0.294, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1383, 5l5dG, 0.9032, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1384, 5fgfT, 0.9032, 2.07, 0.291, 244, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1385, 5fgfF, 0.9032, 2.08, 0.271, 239, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1386, 5dkjT, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1387, 5dkjF, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1388, 5d0xG, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1389, 4ya5F, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1390, 4y8uT, 0.9032, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1391, 4y8uF, 0.9032, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1392, 4y84T, 0.9032, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1393, 4y84F, 0.9032, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1394, 4y82T, 0.9032, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1395, 4y6vU, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1396, 4y6vG, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1397, 4qw7T, 0.9032, 2.09, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1398, 4qw7F, 0.9032, 2.25, 0.293, 243, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1399, 4qw4U, 0.9032, 2.25, 0.293, 243, 229, YCP IN COMPLEX WITH CARFILZOMIB
1400, 4qw4G, 0.9032, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH CARFILZOMIB
1401, 4qw0G, 0.9032, 1.96, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1402, 4jsuT, 0.9032, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1403, 4jsuF, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1404, 3unbF, 0.9032, 2.09, 0.298, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1405, 3nzxT, 0.9032, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1406, 3nzxF, 0.9032, 1.95, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1407, 3mg0F, 0.9032, 1.96, 0.219, 241, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1408, 3gpwT, 0.9032, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1409, 3gpwF, 0.9032, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1410, 3gpjT, 0.9032, 1.91, 0.271, 244, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1411, 5lajP, 0.9031, 2.22, 0.293, 244, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1412, 5lajB, 0.9031, 2.22, 0.293, 244, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1413, 5laiT, 0.9031, 2.06, 0.300, 244, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1414, 5laiF, 0.9031, 2.23, 0.293, 244, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1415, 5l5zG, 0.9031, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1416, 5l5sU, 0.9031, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1417, 5l5sG, 0.9031, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1418, 5l52T, 0.9031, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1419, 5l52F, 0.9031, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1420, 5d0xT, 0.9031, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1421, 5d0xF, 0.9031, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1422, 5d0tT, 0.9031, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1423, 5d0tF, 0.9031, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1424, 5cz9T, 0.9031, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1425, 5cz9F, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1426, 4ya5T, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1427, 4y8nU, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1428, 4r18B, 0.9031, 2.08, 0.298, 243, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1429, 4qz7T, 0.9031, 2.08, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1430, 4qz7F, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1431, 4qwsU, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1432, 4qwkT, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1433, 4qwkF, 0.9031, 1.96, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1434, 4qw5T, 0.9031, 1.75, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1435, 4qw5F, 0.9031, 2.25, 0.293, 243, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1436, 4qw0T, 0.9031, 2.25, 0.293, 243, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1437, 4qw0F, 0.9031, 1.95, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1438, 4qlvT, 0.9031, 2.23, 0.285, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1439, 4qlvF, 0.9031, 2.23, 0.285, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1440, 4qluT, 0.9031, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1441, 4qluF, 0.9031, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1442, 4no8T, 0.9031, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1443, 4no8F, 0.9031, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1444, 4inuT, 0.9031, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1445, 4inuF, 0.9031, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1446, 3mg7R, 0.9031, 2.07, 0.300, 243, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1447, 3mg4F, 0.9031, 2.07, 0.300, 243, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1448, 3gpjF, 0.9031, 2.08, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1449, 5fgdT, 0.9030, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1450, 5d0vT, 0.9030, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1451, 4ya5U, 0.9030, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1452, 4ya3U, 0.9030, 1.66, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1453, 4y8nG, 0.9030, 2.20, 0.294, 244, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1454, 4y70T, 0.9030, 2.09, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1455, 4y6zT, 0.9030, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1456, 4qz2T, 0.9030, 2.25, 0.293, 243, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1457, 4qz2F, 0.9030, 1.96, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1458, 4qwsG, 0.9030, 1.96, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1459, 4qvmT, 0.9030, 1.96, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1460, 4qvmF, 0.9030, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1461, 4q1sP, 0.9030, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1462, 4j70P, 0.9030, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1463, 4j70B, 0.9030, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1464, 4intP, 0.9030, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1465, 3wxrE, 0.9030, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1466, 3jcpJA, 0.9030, 2.09, 0.298, 243, 228, 
1467, 3jcpJ, 0.9030, 1.73, 0.308, 244, 224, 
1468, 5m2bU, 0.9029, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1469, 5le5F, 0.9029, 1.75, 0.308, 244, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1470, 5jhsT, 0.9029, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1471, 5jhsF, 0.9029, 1.71, 0.341, 239, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1472, 5fghT, 0.9029, 2.00, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1473, 5fgdF, 0.9029, 2.00, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1474, 5d0vF, 0.9029, 2.00, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1475, 4zzgE, 0.9029, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1476, 4ya5G, 0.9029, 2.09, 0.271, 239, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1477, 4ya3G, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1478, 4y8oT, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1479, 4y8oF, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1480, 4y7wT, 0.9029, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1481, 4y70F, 0.9029, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1482, 4qzwT, 0.9029, 1.59, 0.342, 236, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1483, 4qzwF, 0.9029, 1.96, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1484, 4qlqT, 0.9029, 1.97, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1485, 4qlqF, 0.9029, 2.10, 0.294, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1486, 4lqiD, 0.9029, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1487, 4j70T, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1488, 4j70F, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1489, 3mg0G, 0.9029, 2.09, 0.298, 243, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1490, 1jd2F, 0.9029, 2.09, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1491, 5m2bG, 0.9028, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1492, 5l5iU, 0.9028, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1493, 5fghF, 0.9028, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1494, 5cgiT, 0.9028, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1495, 4y8gP, 0.9028, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1496, 4y84P, 0.9028, 2.06, 0.227, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1497, 4y84B, 0.9028, 2.10, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1498, 4y7wF, 0.9028, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1499, 4qz1T, 0.9028, 1.96, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1500, 4qz1F, 0.9028, 2.09, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1501, 4qltT, 0.9028, 2.10, 0.294, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1502, 4qltF, 0.9028, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1503, 4lqiR, 0.9028, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1504, 4jt0T, 0.9028, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1505, 4jt0F, 0.9028, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1506, 4intB, 0.9028, 2.24, 0.289, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1507, 4gk7P, 0.9028, 2.24, 0.289, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1508, 3bdmT, 0.9028, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1509, 3bdmF, 0.9028, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1510, 5l5jU, 0.9027, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1511, 5l5jG, 0.9027, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1512, 5l5iG, 0.9027, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1513, 5cz8D, 0.9027, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1514, 5cz5T, 0.9027, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1515, 5cz5F, 0.9027, 2.10, 0.298, 244, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1516, 5cz4F, 0.9027, 2.10, 0.298, 244, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1517, 5cgiF, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1518, 5bouU, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1519, 5bouG, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1520, 4y8qT, 0.9027, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1521, 4y8qF, 0.9027, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1522, 4y8iT, 0.9027, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1523, 4y8gB, 0.9027, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1524, 4y80T, 0.9027, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1525, 4rurU, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1526, 4rurG, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1527, 4qxjT, 0.9027, 2.10, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1528, 4qwiT, 0.9027, 2.10, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1529, 4qwiF, 0.9027, 2.10, 0.294, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1530, 4qlsP, 0.9027, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1531, 4qlsB, 0.9027, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1532, 4gk7B, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1533, 4fzgP, 0.9027, 1.97, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1534, 3nzjR, 0.9027, 2.05, 0.295, 243, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1535, 3nzjD, 0.9027, 2.09, 0.298, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1536, 1g0uF, 0.9027, 2.09, 0.298, 243, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1537, 5l68U, 0.9026, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1538, 5l68G, 0.9026, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1539, 5l60U, 0.9026, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1540, 5l5yU, 0.9026, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1541, 5cz8R, 0.9026, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1542, 5cz4T, 0.9026, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1543, 4y8lT, 0.9026, 2.01, 0.300, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1544, 4y8lF, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1545, 4y8jT, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1546, 4y8jF, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1547, 4y8iF, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1548, 4y81U, 0.9026, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1549, 4qxjF, 0.9026, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1550, 4qwgF, 0.9026, 2.25, 0.293, 243, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1551, 4qltP, 0.9026, 2.25, 0.293, 243, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1552, 4qltB, 0.9026, 2.25, 0.293, 243, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1553, 4jsuR, 0.9026, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1554, 4jsuD, 0.9026, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1555, 4fzgT, 0.9026, 1.96, 0.219, 241, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1556, 4fzgB, 0.9026, 2.05, 0.295, 243, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1557, 3un4T, 0.9026, 2.08, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1558, 3un4F, 0.9026, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1559, 3mg6D, 0.9026, 1.75, 0.308, 244, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1560, 3jseG, 0.9026, 1.68, 0.341, 242, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1561, 5lf6F, 0.9025, 1.68, 0.341, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1562, 5l60G, 0.9025, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1563, 5l5yG, 0.9025, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1564, 5cz4U, 0.9025, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1565, 5cz4G, 0.9025, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1566, 4y8tP, 0.9025, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1567, 4y8tB, 0.9025, 1.66, 0.335, 227, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1568, 4y8hP, 0.9025, 1.85, 0.272, 239, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1569, 4y8hB, 0.9025, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1570, 4y81G, 0.9025, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1571, 4r02P, 0.9025, 1.97, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1572, 4qz6P, 0.9025, 1.97, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1573, 4qwsT, 0.9025, 1.75, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1574, 4qwsF, 0.9025, 1.75, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1575, 4qwgT, 0.9025, 1.75, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1576, 4qvvT, 0.9025, 1.75, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1577, 4qvvF, 0.9025, 1.96, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1578, 4qvmU, 0.9025, 1.75, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1579, 4fzgF, 0.9025, 1.76, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1580, 3wxrS, 0.9025, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1581, 3sdiU, 0.9025, 2.24, 0.285, 243, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1582, 3oeuR, 0.9025, 2.08, 0.295, 243, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1583, 3mg4T, 0.9025, 2.09, 0.298, 243, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1584, 1rypQ, 0.9025, 2.09, 0.298, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1585, 1g65U, 0.9025, 1.97, 0.219, 241, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1586, 5fhsT, 0.9024, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1587, 5fhsF, 0.9024, 1.72, 0.341, 238, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1588, 4ya0U, 0.9024, 1.82, 0.221, 240, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1589, 4ya0G, 0.9024, 1.73, 0.341, 236, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1590, 4y9zP, 0.9024, 2.07, 0.295, 244, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1591, 4y9zB, 0.9024, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1592, 4y8sP, 0.9024, 2.09, 0.223, 243, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1593, 4y7yT, 0.9024, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1594, 4y7yF, 0.9024, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1595, 4qz6B, 0.9024, 1.97, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1596, 4qz5P, 0.9024, 1.97, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1597, 4qz4P, 0.9024, 1.75, 0.308, 244, 224, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1598, 4qwjD, 0.9024, 1.75, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1599, 4qw3T, 0.9024, 1.76, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1600, 4qw3F, 0.9024, 2.09, 0.298, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1601, 4qvmG, 0.9024, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1602, 3oevR, 0.9024, 1.76, 0.308, 244, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1603, 3mg6R, 0.9024, 1.76, 0.308, 244, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1604, 5laiU, 0.9023, 1.76, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1605, 5l54P, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1606, 5jhsD, 0.9023, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1607, 5fhsR, 0.9023, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1608, 5fhsD, 0.9023, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1609, 5fgiR, 0.9023, 1.67, 0.341, 242, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1610, 5fgiD, 0.9023, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1611, 5fgfR, 0.9023, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1612, 5fgfD, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1613, 4ya3T, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1614, 4ya3F, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1615, 4y8sB, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1616, 4y8iP, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1617, 4y8iB, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1618, 4r02D, 0.9023, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1619, 4qzwR, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1620, 4qzwD, 0.9023, 2.10, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1621, 4qz5B, 0.9023, 2.10, 0.298, 243, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1622, 4qz4B, 0.9023, 1.76, 0.308, 244, 224, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1623, 4qwjR, 0.9023, 1.76, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1624, 4qw7R, 0.9023, 1.76, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1625, 4qw7D, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1626, 4qlvP, 0.9023, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1627, 4qlvB, 0.9023, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1628, 4jsuP, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1629, 4jsuB, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1630, 4jsqP, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1631, 4jsqB, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1632, 4fzcT, 0.9023, 1.50, 0.344, 235, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1633, 3mg7D, 0.9023, 1.76, 0.308, 244, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1634, 2gplP, 0.9023, 1.76, 0.308, 244, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1635, 1g0uT, 0.9023, 1.74, 0.308, 244, 224, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1636, 5laiG, 0.9022, 1.75, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1637, 5l54B, 0.9022, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1638, 5jhsR, 0.9022, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1639, 5fghU, 0.9022, 2.03, 0.300, 244, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1640, 5fghG, 0.9022, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1641, 5dkiT, 0.9022, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1642, 5cz5R, 0.9022, 2.01, 0.300, 242, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1643, 5cz5D, 0.9022, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1644, 4ya9P, 0.9022, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1645, 4ya9B, 0.9022, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1646, 4ya0T, 0.9022, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1647, 4ya0F, 0.9022, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1648, 4y8oU, 0.9022, 2.25, 0.288, 243, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1649, 4y8oG, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1650, 4y8iD, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1651, 4qzxT, 0.9022, 1.76, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1652, 4qzxF, 0.9022, 1.76, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1653, 4qz6R, 0.9022, 2.10, 0.294, 243, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1654, 4qz6D, 0.9022, 2.10, 0.294, 243, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1655, 4qz2R, 0.9022, 1.96, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1656, 4qz2D, 0.9022, 1.96, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1657, 4qz1U, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1658, 4qz1G, 0.9022, 2.10, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1659, 4qwfD, 0.9022, 2.10, 0.298, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1660, 4qw6D, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1661, 4inrP, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1662, 4gk7D, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1663, 4fzcF, 0.9022, 1.51, 0.344, 235, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1664, 3shjT, 0.9022, 1.96, 0.219, 241, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1665, 3shjF, 0.9022, 1.96, 0.219, 241, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1666, 3oevD, 0.9022, 1.51, 0.344, 235, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1667, 3mg8D, 0.9022, 1.51, 0.344, 235, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1668, 3jseF, 0.9022, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1669, 3jseB, 0.9022, 1.68, 0.341, 242, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1670, 3hyeP, 0.9022, 2.03, 0.300, 244, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1671, 3e47T, 0.9022, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1672, 3e47F, 0.9022, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1673, 2gplT, 0.9022, 1.70, 0.341, 242, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1674, 2gplF, 0.9022, 1.70, 0.341, 242, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1675, 2gplB, 0.9022, 1.66, 0.335, 227, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1676, 2f16T, 0.9022, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1677, 2f16F, 0.9022, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1678, 5wvkO, 0.9021, 2.24, 0.293, 244, 229, 
1679, 5l54T, 0.9021, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1680, 5l54F, 0.9021, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1681, 5l54D, 0.9021, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1682, 5fgdR, 0.9021, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1683, 5fgdD, 0.9021, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1684, 5dkiF, 0.9021, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1685, 5d0vD, 0.9021, 1.97, 0.215, 243, 228, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1686, 5d0sD, 0.9021, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1687, 4ya7P, 0.9021, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1688, 4ya7B, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1689, 4y8lR, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1690, 4y8lD, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1691, 4y8iR, 0.9021, 2.25, 0.288, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1692, 4y78T, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1693, 4qz7P, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1694, 4qz7B, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1695, 4qz5D, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1696, 4qxjR, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1697, 4qxjD, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1698, 4qwkR, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1699, 4qwkD, 0.9021, 2.10, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1700, 4qwiR, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1701, 4qwiD, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1702, 4qwfR, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1703, 4qwfP, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1704, 4qwfB, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1705, 4qw6R, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1706, 4qw5R, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1707, 4qw5D, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1708, 4qw4R, 0.9021, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH CARFILZOMIB
1709, 4qw4D, 0.9021, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH CARFILZOMIB
1710, 4qlqP, 0.9021, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1711, 4qlqB, 0.9021, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1712, 4q1sD, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1713, 4intD, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1714, 4gk7R, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1715, 3sdiF, 0.9021, 1.51, 0.344, 235, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1716, 3nzwD, 0.9021, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1717, 3jseD, 0.9021, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1718, 3jseA, 0.9021, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1719, 3hyeB, 0.9021, 1.73, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1720, 3e47P, 0.9021, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1721, 3e47B, 0.9021, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1722, 3dy3B, 0.9021, 2.19, 0.294, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1723, 2gplD, 0.9021, 1.69, 0.341, 242, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1724, 6gopB, 0.9020, 1.66, 0.335, 227, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1725, 5l54R, 0.9020, 1.66, 0.335, 227, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1726, 5fgeD, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1727, 5d0vR, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1728, 5d0sR, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1729, 5cz9R, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1730, 5cz9D, 0.9020, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1731, 5cz8T, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1732, 5cz8F, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1733, 4y8oB, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1734, 4y8jP, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1735, 4y8jB, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1736, 4y84D, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1737, 4y7yR, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1738, 4y7yD, 0.9020, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1739, 4y70P, 0.9020, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1740, 4y70B, 0.9020, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1741, 4x6zQ, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1742, 4r02G, 0.9020, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1743, 4qzxD, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1744, 4qz5R, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1745, 4qz3R, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1746, 4qz3P, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1747, 4qz3D, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1748, 4qz3B, 0.9020, 1.75, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1749, 4qz2P, 0.9020, 1.97, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1750, 4qz2B, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1751, 4qwxP, 0.9020, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1752, 4qwuP, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1753, 4qwuB, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1754, 4qwsD, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1755, 4qwrD, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1756, 4qw6P, 0.9020, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1757, 4qw6B, 0.9020, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1758, 4qv6P, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT
1759, 4qv6B, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT
1760, 4nnnP, 0.9020, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH MG132
1761, 4nnnB, 0.9020, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH MG132
1762, 4jt0R, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1763, 4jt0D, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1764, 4jsqD, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1765, 4inrB, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1766, 3un8P, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1767, 3shjP, 0.9020, 1.76, 0.308, 244, 224, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1768, 3shjD, 0.9020, 1.75, 0.308, 244, 224, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1769, 3jseC, 0.9020, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1770, 3jcoJ, 0.9020, 1.69, 0.341, 242, 223, 
1771, 3hyeD, 0.9020, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1772, 3dy3P, 0.9020, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1773, 6gopP, 0.9019, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1774, 5lajR, 0.9019, 1.75, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1775, 5lajD, 0.9019, 1.69, 0.341, 242, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1776, 5jhrP, 0.9019, 1.67, 0.335, 227, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1777, 5fgeR, 0.9019, 2.01, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1778, 5d0zR, 0.9019, 2.01, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1779, 5d0zD, 0.9019, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1780, 5d0vP, 0.9019, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1781, 5d0vB, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1782, 5cghR, 0.9019, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1783, 5cghD, 0.9019, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1784, 4ya2P, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1785, 4ya2B, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1786, 4y8pP, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1787, 4y8pB, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1788, 4y8oP, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1789, 4y8jR, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1790, 4y8jD, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1791, 4y84R, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1792, 4y7yP, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1793, 4y7yB, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1794, 4y7wP, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1795, 4y7wB, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1796, 4y78F, 0.9019, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1797, 4y78D, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1798, 4y74P, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1799, 4y74B, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1800, 4qzxR, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1801, 4qzwP, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1802, 4qzwB, 0.9019, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1803, 4qz7R, 0.9019, 1.76, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1804, 4qz7D, 0.9019, 2.26, 0.293, 243, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1805, 4qwxB, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1806, 4qwsR, 0.9019, 1.76, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1807, 4qwrR, 0.9019, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1808, 4qwlR, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1809, 4qwlD, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1810, 4qwjT, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1811, 4qwjF, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1812, 4qw4P, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH CARFILZOMIB
1813, 4qw4B, 0.9019, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH CARFILZOMIB
1814, 4qltR, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1815, 4qltD, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1816, 4qlqR, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1817, 4qlqD, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1818, 4q1sR, 0.9019, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1819, 4nnwP, 0.9019, 2.26, 0.293, 243, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1820, 4nnwB, 0.9019, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1821, 4jsqR, 0.9019, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1822, 3shjR, 0.9019, 1.51, 0.344, 235, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1823, 3shjB, 0.9019, 1.51, 0.344, 235, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1824, 3nzwR, 0.9019, 1.50, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1825, 3nzjP, 0.9019, 1.50, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1826, 3nzjB, 0.9019, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1827, 3jseE, 0.9019, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1828, 3jrmG, 0.9019, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1829, 3jcoJA, 0.9019, 1.69, 0.341, 242, 223, 
1830, 2zcyD, 0.9019, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1831, 2gplR, 0.9019, 1.75, 0.308, 244, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1832, 5jhrB, 0.9018, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1833, 5fggR, 0.9018, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1834, 5fggD, 0.9018, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1835, 5cz8P, 0.9018, 1.67, 0.335, 227, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1836, 5cz8B, 0.9018, 1.67, 0.335, 227, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1837, 5cgiP, 0.9018, 2.01, 0.219, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1838, 5cgiB, 0.9018, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1839, 5cggR, 0.9018, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1840, 5cggD, 0.9018, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1841, 4y8sR, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1842, 4y8sD, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1843, 4y8hR, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1844, 4y8hD, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1845, 4y8gD, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1846, 4y80D, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1847, 4y7xR, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1848, 4y7xD, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1849, 4y78R, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1850, 4y75P, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1851, 4y75B, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1852, 4qz0R, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1853, 4qz0P, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1854, 4qz0D, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1855, 4qxjP, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1856, 4qxjB, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1857, 4qlvR, 0.9018, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1858, 4qlvD, 0.9018, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1859, 4qlsD, 0.9018, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1860, 4ltcD, 0.9018, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1861, 4intR, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1862, 3tddP, 0.9018, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1863, 3nzwP, 0.9018, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1864, 3mg0R, 0.9018, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1865, 3hyeR, 0.9018, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1866, 3dy4P, 0.9018, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1867, 3dy4B, 0.9018, 1.51, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1868, 2zcyR, 0.9018, 1.72, 0.341, 242, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1869, 1rypE, 0.9018, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1870, 1rypC, 0.9018, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1871, 5l69P, 0.9017, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1872, 5l69B, 0.9017, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1873, 5fgaP, 0.9017, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1874, 5fgaB, 0.9017, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1875, 5cgiR, 0.9017, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1876, 5cgiD, 0.9017, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1877, 4ya9D, 0.9017, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1878, 4y9zR, 0.9017, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1879, 4y9zD, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1880, 4y8qR, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1881, 4y8qD, 0.9017, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1882, 4y8lP, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1883, 4y8lB, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1884, 4y8gR, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1885, 4y80R, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1886, 4y80P, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1887, 4y80B, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1888, 4r18D, 0.9017, 1.51, 0.344, 235, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1889, 4qz1R, 0.9017, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1890, 4qz1D, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1891, 4qz0B, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1892, 4qw7P, 0.9017, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1893, 4qw7B, 0.9017, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1894, 4qw3U, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1895, 4qw3G, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1896, 4qlsR, 0.9017, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1897, 4nnwR, 0.9017, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1898, 4nnwD, 0.9017, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1899, 3un8D, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1900, 3tddB, 0.9017, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1901, 3nzwB, 0.9017, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1902, 3gpwD, 0.9017, 1.98, 0.219, 241, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1903, 1g65B, 0.9017, 1.98, 0.219, 241, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1904, 5laiP, 0.9016, 1.51, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1905, 5laiB, 0.9016, 1.51, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1906, 5l5iP, 0.9016, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1907, 5l5iB, 0.9016, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1908, 5l52R, 0.9016, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1909, 5l52D, 0.9016, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1910, 5jhrR, 0.9016, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1911, 5jhrD, 0.9016, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1912, 5dsvA, 0.9016, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
1913, 5dkjR, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1914, 5dkjD, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1915, 5d0tD, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1916, 5bouP, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1917, 5bouB, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1918, 4ya9R, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1919, 4y8pR, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1920, 4y8pD, 0.9016, 2.13, 0.265, 244, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1921, 4y7xP, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1922, 4y7xB, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1923, 4y69P, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1924, 4y69B, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1925, 4r18R, 0.9016, 1.77, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1926, 4qz1P, 0.9016, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1927, 4qz1B, 0.9016, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1928, 4qwuD, 0.9016, 1.51, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1929, 4qw0P, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1930, 4qw0B, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1931, 4q1sB, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1932, 4no9P, 0.9016, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1933, 4no9B, 0.9016, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1934, 3mg0D, 0.9016, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1935, 3jrmB, 0.9016, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1936, 3gpwR, 0.9016, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1937, 5l69U, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1938, 5l69G, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1939, 5l65P, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1940, 5l65B, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1941, 5l60P, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1942, 5l60B, 0.9015, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1943, 5jhsP, 0.9015, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1944, 5jhsB, 0.9015, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1945, 5dsvL, 0.9015, 1.97, 0.219, 241, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
1946, 5dkiU, 0.9015, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1947, 5dkiP, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1948, 5dkiG, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1949, 5dkiB, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1950, 5d0tR, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1951, 5cz6P, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1952, 5cghP, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1953, 5cghB, 0.9015, 2.14, 0.265, 245, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1954, 5bxlP, 0.9015, 1.98, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1955, 5bxlB, 0.9015, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1956, 4ya7R, 0.9015, 1.98, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1957, 4ya7D, 0.9015, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1958, 4y9yP, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1959, 4y8kR, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1960, 4y8kD, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1961, 4y7wR, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1962, 4y7wD, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1963, 4y78P, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1964, 4y78B, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1965, 4y77P, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1966, 4y77B, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1967, 4y70R, 0.9015, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1968, 4y70D, 0.9015, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1969, 4rurP, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1970, 4rurB, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1971, 4r17P, 0.9015, 1.77, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1972, 4r17B, 0.9015, 1.77, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1973, 4r02R, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1974, 4qzzP, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH OMURALIDE
1975, 4qzzB, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH OMURALIDE
1976, 4qz4R, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1977, 4qz4D, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1978, 4qwuR, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1979, 4qwkP, 0.9015, 1.76, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1980, 4qw5P, 0.9015, 1.76, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1981, 4qw5B, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1982, 4qvyP, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1983, 4qvyB, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1984, 4qvwP, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1985, 4qvwB, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1986, 4qvqD, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1987, 4qvpR, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1988, 4qvpD, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1989, 4qv0P, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1990, 4qv0B, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1991, 4quyP, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT
1992, 4qluP, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1993, 4qluD, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1994, 4qluB, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1995, 4nnnR, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH MG132
1996, 4nnnD, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH MG132
1997, 4fzcD, 0.9015, 1.76, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1998, 3wxrC, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1999, 3un8B, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2000, 3tddD, 0.9015, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2001, 3mg0B, 0.9015, 1.51, 0.344, 235, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2002, 3jrmD, 0.9015, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2003, 3jrmC, 0.9015, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2004, 3jrmA, 0.9015, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2005, 3dy3D, 0.9015, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2006, 2fakP, 0.9015, 1.75, 0.308, 242, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2007, 2fakB, 0.9015, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2008, 5nifS, 0.9014, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2009, 5l68P, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2010, 5l68B, 0.9014, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2011, 5l5sP, 0.9014, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2012, 5l5sB, 0.9014, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2013, 5l5jP, 0.9014, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2014, 5l5jB, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2015, 5l52P, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2016, 5l52B, 0.9014, 1.73, 0.341, 236, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2017, 5fgfP, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2018, 5fgfB, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2019, 5fgdP, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2020, 5fgdB, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2021, 5fgaD, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2022, 5dsvI, 0.9014, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2023, 5dsvE, 0.9014, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2024, 5dkiD, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2025, 5cz6B, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2026, 5cgfP, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2027, 5cgfD, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2028, 5cgfB, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2029, 4ya4P, 0.9014, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2030, 4ya0P, 0.9014, 2.14, 0.265, 244, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2031, 4ya0B, 0.9014, 2.14, 0.265, 245, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2032, 4y9yB, 0.9014, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2033, 4y82D, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2034, 4y81P, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2035, 4y81B, 0.9014, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2036, 4y6vP, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2037, 4y6vB, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2038, 4v7oU, 0.9014, 1.78, 0.308, 244, 224, 
2039, 4v7oG, 0.9014, 1.78, 0.308, 244, 224, 
2040, 4qwkB, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2041, 4qwiP, 0.9014, 1.52, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2042, 4qwiB, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2043, 4qwgU, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2044, 4qwgG, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2045, 4qw1P, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2046, 4qw1B, 0.9014, 2.28, 0.288, 244, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2047, 4qvqR, 0.9014, 2.28, 0.288, 244, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2048, 4quyB, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT
2049, 4quxP, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT
2050, 4qluR, 0.9014, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2051, 4no9R, 0.9014, 1.97, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2052, 4no9D, 0.9014, 1.97, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2053, 4inrD, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2054, 4hnpR, 0.9014, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2055, 4hnpD, 0.9014, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2056, 3un8R, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2057, 3jrmF, 0.9014, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2058, 3jcpPA, 0.9014, 1.51, 0.344, 235, 221, 
2059, 3dy3R, 0.9014, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2060, 1g65P, 0.9014, 1.52, 0.344, 235, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2061, 5l5zP, 0.9013, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2062, 5l5zB, 0.9013, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2063, 5l5yP, 0.9013, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2064, 5l5yB, 0.9013, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2065, 5l5xP, 0.9013, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2066, 5l5xB, 0.9013, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2067, 5l5wP, 0.9013, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2068, 5l5wB, 0.9013, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2069, 5l5tP, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2070, 5l5tB, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2071, 5l5eP, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2072, 5l5eB, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2073, 5l55R, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2074, 5l55D, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2075, 5fgaR, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2076, 5fg7R, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2077, 5dsvF, 0.9013, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2078, 5dkjP, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2079, 5dkiR, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2080, 5d0xR, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2081, 5d0xD, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2082, 5cz7R, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2083, 5cz7D, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2084, 5cggP, 0.9013, 1.52, 0.348, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2085, 5cgfR, 0.9013, 2.14, 0.265, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2086, 4zzgS, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2087, 4z1lP, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2088, 4z1lB, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2089, 4ya4B, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2090, 4ya2R, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2091, 4ya2D, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2092, 4y8uP, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2093, 4y8uB, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2094, 4y8rP, 0.9013, 1.73, 0.341, 236, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2095, 4y8oR, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2096, 4y8oD, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2097, 4y8nP, 0.9013, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2098, 4y82R, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2099, 4y81R, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2100, 4y81D, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2101, 4y77R, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2102, 4y77D, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2103, 4x6zC, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2104, 4v7oOA, 0.9013, 1.52, 0.344, 235, 221, 
2105, 4v7oCB, 0.9013, 1.77, 0.308, 244, 224, 
2106, 4r02B, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2107, 4qzxP, 0.9013, 1.52, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2108, 4qzxB, 0.9013, 1.52, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2109, 4qwxR, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2110, 4qwxD, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2111, 4qwjP, 0.9013, 1.76, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2112, 4qvvR, 0.9013, 2.28, 0.288, 244, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2113, 4qvvD, 0.9013, 2.28, 0.288, 244, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2114, 4qv8P, 0.9013, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT
2115, 4qv8B, 0.9013, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT
2116, 4quxB, 0.9013, 1.78, 0.308, 244, 224, YCP BETA5-A49T-MUTANT
2117, 4qbyP, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2118, 4fzcR, 0.9013, 1.52, 0.344, 235, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2119, 4eu2Q, 0.9013, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2120, 3tddR, 0.9013, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2121, 3gpwP, 0.9013, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2122, 3dy4D, 0.9013, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2123, 3d29B, 0.9013, 1.77, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2124, 2f16P, 0.9013, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2125, 2f16B, 0.9013, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2126, 1rypS, 0.9013, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2127, 6gopD, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2128, 5l64P, 0.9012, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2129, 5l63P, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2130, 5l63B, 0.9012, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2131, 5l62P, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2132, 5l62B, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2133, 5l61P, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2134, 5l61B, 0.9012, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2135, 5l5dP, 0.9012, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2136, 5l5dB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2137, 5fggP, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2138, 5fggB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2139, 5fgeP, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2140, 5fgeB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2141, 5fg9P, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2142, 5fg9B, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2143, 5dsvN, 0.9012, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2144, 5dkjB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2145, 5cggB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2146, 4z1lD, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2147, 4ya5P, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2148, 4ya5B, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2149, 4y8rB, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2150, 4y8qP, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2151, 4y8qB, 0.9012, 2.14, 0.265, 244, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2152, 4y8nB, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2153, 4y8kP, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2154, 4y8kB, 0.9012, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2155, 4y6zP, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2156, 4y6zB, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2157, 4r00D, 0.9012, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2158, 4qzzR, 0.9012, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH OMURALIDE
2159, 4qzzD, 0.9012, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH OMURALIDE
2160, 4qwjB, 0.9012, 1.78, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2161, 4qw1D, 0.9012, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2162, 4qw0R, 0.9012, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2163, 4qw0D, 0.9012, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2164, 4qvqP, 0.9012, 1.77, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2165, 4qvqB, 0.9012, 1.52, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2166, 4qvmR, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2167, 4qvmD, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2168, 4qvlP, 0.9012, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH BORTEZOMIB
2169, 4qbyB, 0.9012, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2170, 4no6P, 0.9012, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2171, 4no6B, 0.9012, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2172, 4no1R, 0.9012, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2173, 4no1D, 0.9012, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2174, 4ltcR, 0.9012, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2175, 4hrcP, 0.9012, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2176, 3gpwB, 0.9012, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2177, 3dy4R, 0.9012, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2178, 3d29P, 0.9012, 1.76, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2179, 2zcyP, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2180, 2zcyB, 0.9012, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2181, 1g0uU, 0.9012, 1.52, 0.344, 235, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2182, 6gopR, 0.9011, 1.72, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2183, 5l6bP, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2184, 5l6bB, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2185, 5l64B, 0.9011, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2186, 5l5uP, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2187, 5l5uB, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2188, 5l5pP, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2189, 5l5pB, 0.9011, 1.84, 0.221, 240, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2190, 5l5hP, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2191, 5l5hB, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2192, 5l55P, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2193, 5l55B, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2194, 5fhsP, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2195, 5fghR, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2196, 5fghD, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2197, 5czaP, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2198, 5czaB, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2199, 5cz9P, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2200, 5cz9B, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2201, 5bxlD, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2202, 5ahjR, 0.9011, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2203, 5ahjD, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2204, 4z1lR, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2205, 4y82P, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2206, 4y82B, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2207, 4y74R, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2208, 4y74D, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2209, 4r17R, 0.9011, 1.53, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2210, 4r17D, 0.9011, 1.52, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2211, 4r00R, 0.9011, 1.52, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2212, 4qwrP, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2213, 4qwrB, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2214, 4qwlP, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2215, 4qwlB, 0.9011, 1.52, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2216, 4qw1R, 0.9011, 1.52, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2217, 4qvyR, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2218, 4qvyD, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2219, 4qvwD, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2220, 4qvvP, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2221, 4qvnP, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2222, 4qvnB, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2223, 4qvmP, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2224, 4qvmB, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2225, 4qvlD, 0.9011, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BORTEZOMIB
2226, 4qvlB, 0.9011, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BORTEZOMIB
2227, 4qv9P, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-C63F MUTANT
2228, 4qv8D, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT
2229, 4qv1P, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT
2230, 4qv1B, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT
2231, 4no8P, 0.9011, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2232, 4no8B, 0.9011, 1.78, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2233, 4inuP, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2234, 4hnpP, 0.9011, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2235, 3un4P, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2236, 3un4B, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2237, 3sdiT, 0.9011, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2238, 3nzxP, 0.9011, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2239, 3nzxD, 0.9011, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2240, 3nzxB, 0.9011, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2241, 3jrmE, 0.9011, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2242, 3d29R, 0.9011, 1.76, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2243, 3d29D, 0.9011, 1.76, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2244, 1g65G, 0.9011, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2245, 5lttP, 0.9010, 2.22, 0.294, 242, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2246, 5lttB, 0.9010, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2247, 5l6cP, 0.9010, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2248, 5l6cB, 0.9010, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2249, 5l67P, 0.9010, 1.68, 0.335, 227, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2250, 5l67B, 0.9010, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2251, 5l5qP, 0.9010, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2252, 5l5qB, 0.9010, 2.11, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2253, 5l5aP, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2254, 5l5aB, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2255, 5fhsB, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2256, 5fgiP, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2257, 5fgiB, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2258, 5fghP, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2259, 5fghB, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2260, 5fg9R, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2261, 5fg9D, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2262, 5fg7P, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2263, 5fg7D, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2264, 5fg7B, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2265, 5dsvD, 0.9010, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2266, 5dsvB, 0.9010, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2267, 5d0zP, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2268, 5d0zB, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2269, 5d0xP, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2270, 5d0xB, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2271, 5d0wP, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2272, 5d0wB, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2273, 5czaD, 0.9010, 2.14, 0.265, 244, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2274, 5cz5P, 0.9010, 2.14, 0.265, 245, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2275, 5cz5B, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2276, 5cz4P, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2277, 5cz4B, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2278, 5bxlR, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2279, 4ya3P, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2280, 4ya3B, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2281, 4y9yD, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2282, 4y8uR, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2283, 4y8uD, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2284, 4y8rR, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2285, 4y8rD, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2286, 4y6zR, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2287, 4y6zD, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2288, 4y6aP, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2289, 4y6aB, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2290, 4qvwR, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2291, 4qvvB, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2292, 4qvpP, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2293, 4qvpB, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2294, 4qvlR, 0.9010, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH BORTEZOMIB
2295, 4qv9R, 0.9010, 1.52, 0.344, 235, 221, YCP BETA5-C63F MUTANT
2296, 4qv9D, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT
2297, 4qv9B, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT
2298, 4qv8R, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT
2299, 4qv7P, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-A50V MUTANT
2300, 4qv7D, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-A50V MUTANT
2301, 4qv7B, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-A50V MUTANT
2302, 4qv6D, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT
2303, 4qv0D, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2304, 4ltcP, 0.9010, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2305, 4inuB, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2306, 4hrdP, 0.9010, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2307, 3nzxR, 0.9010, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2308, 3mg0P, 0.9010, 1.53, 0.344, 235, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2309, 2fakD, 0.9010, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2310, 1jd2G, 0.9010, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2311, 5m2bP, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2312, 5m2bB, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2313, 5laiR, 0.9009, 1.76, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2314, 5laiD, 0.9009, 1.77, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2315, 5l66P, 0.9009, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2316, 5l66B, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2317, 5l5oP, 0.9009, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2318, 5l5oB, 0.9009, 2.00, 0.219, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2319, 5l5fP, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2320, 5l5fB, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2321, 5d0tP, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2322, 5czaR, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2323, 5cz7P, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2324, 4ya4D, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2325, 4ya1P, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2326, 4ya1B, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2327, 4ya0R, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2328, 4ya0D, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2329, 4y9yR, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2330, 4y8mP, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2331, 4y8mB, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2332, 4y75R, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2333, 4y75D, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2334, 4y69R, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2335, 4y69D, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2336, 4r00P, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2337, 4r00B, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2338, 4qwsP, 0.9009, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2339, 4qwsB, 0.9009, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2340, 4qwgR, 0.9009, 1.52, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2341, 4qwgD, 0.9009, 1.52, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2342, 4qv7R, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A50V MUTANT
2343, 4qv6R, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT
2344, 4qv4P, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-M45T MUTANT
2345, 4qv4B, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-M45T MUTANT
2346, 4qv0R, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2347, 4quyD, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-A49S-MUTANT
2348, 4qbyD, 0.9009, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2349, 4inrR, 0.9009, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2350, 3jcpP, 0.9009, 1.53, 0.344, 235, 221, 
2351, 2f16D, 0.9009, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2352, 5l5rP, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2353, 5l5rB, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2354, 5dsvK, 0.9008, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2355, 5dsvG, 0.9008, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2356, 5d0tB, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2357, 5d0sP, 0.9008, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2358, 5cz7B, 0.9008, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2359, 5cz4R, 0.9008, 2.22, 0.293, 244, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2360, 5cz4D, 0.9008, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2361, 5bouR, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2362, 5bouD, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2363, 4ya5R, 0.9008, 2.14, 0.265, 244, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2364, 4ya5D, 0.9008, 2.14, 0.265, 242, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2365, 4ya4R, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2366, 4ya3R, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2367, 4ya3D, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2368, 4y8mR, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2369, 4y8mD, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2370, 4y6vD, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2371, 4qw3R, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2372, 4qw3D, 0.9008, 1.54, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2373, 4qvnR, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2374, 4qvnD, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2375, 4quyR, 0.9008, 1.54, 0.344, 235, 221, YCP BETA5-A49S-MUTANT
2376, 4quxD, 0.9008, 1.54, 0.344, 235, 221, YCP BETA5-A49T-MUTANT
2377, 4qbyR, 0.9008, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2378, 4no8R, 0.9008, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2379, 4no8D, 0.9008, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2380, 4jt0P, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2381, 4jt0B, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2382, 3mg4D, 0.9008, 1.53, 0.344, 235, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2383, 3gptR, 0.9008, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2384, 3gptD, 0.9008, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2385, 2fakR, 0.9008, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2386, 5l6aP, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2387, 5l6aB, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2388, 5l5vP, 0.9007, 1.52, 0.344, 235, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2389, 5l5vB, 0.9007, 1.76, 0.308, 244, 224,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2390, 5d0sB, 0.9007, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2391, 5cz6R, 0.9007, 1.74, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2392, 5cz6D, 0.9007, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2393, 5bxnR, 0.9007, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2394, 5bxnD, 0.9007, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2395, 4ya1R, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2396, 4ya1D, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2397, 4y8tR, 0.9007, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2398, 4y8tD, 0.9007, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2399, 4y8nR, 0.9007, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2400, 4y8nD, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2401, 4y6vR, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2402, 4y6aR, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2403, 4y6aD, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2404, 4rurR, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2405, 4rurD, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2406, 4qw3P, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2407, 4qw3B, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2408, 4qv5P, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-M45I MUTANT
2409, 4qv5B, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-M45I MUTANT
2410, 4qv3P, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2411, 4qv3D, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2412, 4qv1R, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT
2413, 4qv1D, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-M45A MUTANT
2414, 4quxR, 0.9007, 1.54, 0.344, 235, 221, YCP BETA5-A49T-MUTANT
2415, 4inuD, 0.9007, 1.79, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2416, 4hrcB, 0.9007, 1.79, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2417, 3un4R, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2418, 3un4D, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2419, 3okjD, 0.9007, 1.77, 0.308, 244, 224, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2420, 3jcpLA, 0.9007, 1.53, 0.344, 235, 221, 
2421, 3jcpL, 0.9007, 1.53, 0.344, 235, 221, 
2422, 5l60R, 0.9006, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2423, 5l60D, 0.9006, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2424, 5l5bP, 0.9006, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2425, 5d0wR, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2426, 5d0wD, 0.9006, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2427, 5bxnP, 0.9006, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2428, 5bxnB, 0.9006, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2429, 5ahjP, 0.9006, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2430, 5ahjB, 0.9006, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2431, 4qv4D, 0.9006, 1.75, 0.308, 244, 224, YCP BETA5-M45T MUTANT
2432, 4qv3R, 0.9006, 1.54, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2433, 4qv3B, 0.9006, 1.54, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2434, 4no1P, 0.9006, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2435, 4no1B, 0.9006, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2436, 4hnpB, 0.9006, 1.53, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2437, 3okjR, 0.9006, 1.77, 0.308, 244, 224, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2438, 2f16R, 0.9006, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2439, 5mp9G, 0.9005, 1.77, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2440, 5l62R, 0.9005, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2441, 5l5bB, 0.9005, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2442, 4qv4R, 0.9005, 1.53, 0.344, 235, 221, YCP BETA5-M45T MUTANT
2443, 4fzgR, 0.9005, 1.77, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2444, 4fzgD, 0.9005, 1.77, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2445, 3mg4P, 0.9005, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2446, 1g65D, 0.9005, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2447, 5lttR, 0.9004, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2448, 5lttD, 0.9004, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2449, 5l62D, 0.9004, 2.19, 0.289, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2450, 5l5uR, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2451, 5l5uD, 0.9004, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2452, 4no6R, 0.9004, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2453, 4no6D, 0.9004, 1.71, 0.341, 242, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2454, 4ltcB, 0.9004, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2455, 4hrdD, 0.9004, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2456, 3sdiG, 0.9004, 1.71, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2457, 3gpjR, 0.9004, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2458, 3gpjD, 0.9004, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2459, 3e47D, 0.9004, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2460, 3bdmP, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2461, 3bdmB, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2462, 5mp9g, 0.9003, 1.54, 0.344, 235, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2463, 5l61R, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2464, 5l61D, 0.9003, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2465, 5l5zR, 0.9003, 1.74, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2466, 5l5zD, 0.9003, 1.86, 0.221, 240, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2467, 5l5xR, 0.9003, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2468, 5l5sR, 0.9003, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2469, 5l5sD, 0.9003, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2470, 5l5eR, 0.9003, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2471, 5l5eD, 0.9003, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2472, 4qv5R, 0.9003, 2.24, 0.289, 243, 228, YCP BETA5-M45I MUTANT
2473, 4qv5D, 0.9003, 1.54, 0.344, 235, 221, YCP BETA5-M45I MUTANT
2474, 4hrdR, 0.9003, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2475, 4hrdB, 0.9003, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2476, 5l65D, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2477, 5l63R, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2478, 5l63D, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2479, 5l5xD, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2480, 5l5wR, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2481, 5l5wD, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2482, 5l5iR, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2483, 5l5iD, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2484, 5l5fR, 0.9002, 1.74, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2485, 5l5fD, 0.9002, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2486, 4qwgP, 0.9002, 1.54, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2487, 4qwgB, 0.9002, 1.54, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2488, 3okjP, 0.9002, 1.54, 0.344, 235, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2489, 3e47R, 0.9002, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2490, 5l6cR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2491, 5l6cD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2492, 5l6bR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2493, 5l6bD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2494, 5l67R, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2495, 5l67D, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2496, 5l65R, 0.9001, 1.79, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2497, 5l5yR, 0.9001, 1.79, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2498, 5l5yD, 0.9001, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2499, 5l5vR, 0.9001, 1.70, 0.341, 242, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2500, 5l5vD, 0.9001, 1.54, 0.344, 235, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2501, 5l5tR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2502, 5l5tD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2503, 5l5qR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2504, 5l5pR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2505, 5l5pD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2506, 5l5hR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2507, 5l5hD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2508, 5l5aR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2509, 5l5aD, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2510, 4inuR, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2511, 3okjB, 0.9001, 1.54, 0.344, 235, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2512, 3gptP, 0.9001, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2513, 3gptB, 0.9001, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2514, 3gpjP, 0.9001, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2515, 3gpjB, 0.9001, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2516, 5l68R, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2517, 5l68D, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2518, 5l64R, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2519, 5l64D, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2520, 5l5qD, 0.9000, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2521, 5l5oR, 0.9000, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2522, 5l5oD, 0.9000, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2523, 5l5jR, 0.9000, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2524, 5l5jD, 0.9000, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2525, 5l5bR, 0.9000, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2526, 5l5bD, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2527, 4eu2S, 0.9000, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2528, 1g0uG, 0.9000, 1.54, 0.344, 235, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2529, 5nifQ, 0.8999, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2530, 5l69R, 0.8999, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2531, 5l69D, 0.8999, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2532, 4x6zE, 0.8999, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2533, 4hrcD, 0.8999, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2534, 4eu2E, 0.8999, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2535, 3unbw, 0.8999, 1.54, 0.344, 235, 221, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2536, 5wvkV, 0.8998, 1.54, 0.344, 235, 221, 
2537, 5lf4R, 0.8998, 1.71, 0.341, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2538, 5l6aR, 0.8998, 1.86, 0.221, 240, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2539, 5l6aD, 0.8998, 1.78, 0.308, 242, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2540, 5l66R, 0.8998, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2541, 5l66D, 0.8998, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2542, 5l5rR, 0.8998, 1.75, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2543, 5l5rD, 0.8998, 1.75, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2544, 3bdmD, 0.8998, 1.74, 0.341, 242, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2545, 1z7qO, 0.8998, 1.94, 0.242, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2546, 1z7qA, 0.8998, 1.98, 0.215, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2547, 5lf7R, 0.8997, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2548, 5leyR, 0.8997, 1.54, 0.344, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2549, 5l5dR, 0.8997, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2550, 5l5dD, 0.8997, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2551, 4eu2C, 0.8997, 1.55, 0.344, 235, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2552, 3bdmR, 0.8997, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2553, 1g65R, 0.8997, 1.54, 0.344, 235, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2554, 5m2bR, 0.8996, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2555, 5m2bD, 0.8996, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2556, 5lf3R, 0.8996, 2.04, 0.223, 243, 229, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2557, 4zzgQ, 0.8996, 1.78, 0.318, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2558, 3unbU, 0.8996, 1.77, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2559, 2ku2E, 0.8996, 1.55, 0.344, 235, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2560, 5le5R, 0.8995, 1.55, 0.344, 235, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2561, 3mg4R, 0.8995, 1.78, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2562, 5lezR, 0.8994, 1.72, 0.341, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2563, 4hrcR, 0.8994, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2564, 5lf0R, 0.8993, 1.55, 0.344, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2565, 5lf1R, 0.8992, 1.55, 0.344, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2566, 5lexR, 0.8992, 1.78, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2567, 4r67u, 0.8991, 1.78, 0.308, 242, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2568, 4r67S, 0.8991, 1.94, 0.242, 243, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2569, 4r67E, 0.8991, 1.76, 0.320, 237, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2570, 3mg4B, 0.8991, 1.77, 0.318, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2571, 1iruS, 0.8991, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2572, 1iruE, 0.8991, 1.77, 0.318, 233, 223, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2573, 4r67g, 0.8990, 1.63, 0.342, 242, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2574, 5gjrW, 0.8989, 1.78, 0.318, 233, 223, 
2575, 5gjrKA, 0.8989, 1.78, 0.318, 233, 223, 
2576, 3unbG, 0.8989, 1.77, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2577, 5gjqF, 0.8988, 1.61, 0.320, 234, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2578, 3uneG, 0.8987, 1.61, 0.320, 234, 222, MOUSE CONSTITUTIVE 20S PROTEASOME
2579, 3unbi, 0.8987, 1.61, 0.320, 234, 222, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2580, 5lf6R, 0.8986, 1.79, 0.308, 244, 224, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2581, 4x6zS, 0.8986, 1.85, 0.312, 234, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2582, 1z7qP, 0.8985, 1.85, 0.312, 234, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2583, 1z7qB, 0.8984, 1.61, 0.320, 234, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2584, 4zzgC, 0.8983, 1.62, 0.320, 234, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2585, 5nifC, 0.8982, 1.62, 0.320, 234, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2586, 3jcoLA, 0.8981, 1.93, 0.242, 243, 227, 
2587, 3jcoL, 0.8981, 1.63, 0.324, 234, 222, 
2588, 5lf4D, 0.8980, 1.94, 0.242, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2589, 5leyD, 0.8980, 1.95, 0.242, 243, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2590, 1jd2D, 0.8980, 1.79, 0.318, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2591, 5gjql, 0.8979, 1.64, 0.342, 242, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2592, 5gjrGA, 0.8978, 1.78, 0.283, 249, 226, 
2593, 3jtlG, 0.8978, 1.78, 0.283, 249, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2594, 4r3oS, 0.8977, 1.80, 0.308, 241, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
2595, 4r3oO, 0.8977, 1.80, 0.308, 241, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
2596, 4r3oE, 0.8977, 1.79, 0.308, 244, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
2597, 3uneU, 0.8977, 1.79, 0.308, 244, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
2598, 3jtlD, 0.8977, 1.79, 0.308, 244, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2599, 3jtlC, 0.8977, 1.80, 0.318, 233, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2600, 3jtlB, 0.8977, 1.80, 0.318, 233, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2601, 5vfoM, 0.8976, 1.74, 0.341, 242, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2602, 3jtlF, 0.8976, 1.72, 0.318, 234, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2603, 3jtlA, 0.8976, 1.96, 0.242, 244, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2604, 5vfrM, 0.8975, 1.73, 0.335, 227, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2605, 5lf7D, 0.8975, 1.64, 0.324, 234, 222, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2606, 1jd2Y, 0.8975, 1.97, 0.242, 244, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2607, 1jd2W, 0.8975, 1.63, 0.324, 234, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2608, 5vfqB, 0.8974, 1.95, 0.242, 244, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2609, 5mpaC, 0.8974, 1.73, 0.335, 227, 224, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2610, 5m32T, 0.8974, 1.73, 0.335, 227, 224, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2611, 5lf0D, 0.8974, 1.73, 0.335, 227, 224, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2612, 5lezD, 0.8974, 2.15, 0.270, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2613, 3jtlE, 0.8974, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2614, 5lf1D, 0.8973, 1.73, 0.335, 227, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2615, 1jd2B, 0.8973, 2.14, 0.270, 240, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2616, 5lf3D, 0.8972, 1.81, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2617, 5vfqG, 0.8970, 1.74, 0.341, 242, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2618, 5mp9A, 0.8970, 1.81, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2619, 5lexD, 0.8970, 1.70, 0.290, 230, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2620, 5gjrS, 0.8970, 2.23, 0.333, 250, 225, 
2621, 1ya7E, 0.8970, 1.96, 0.307, 244, 225, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
2622, 5lf6D, 0.8969, 2.13, 0.270, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2623, 5le5D, 0.8969, 1.81, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2624, 5vfpG, 0.8968, 1.80, 0.318, 233, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2625, 4r3oA, 0.8968, 1.73, 0.335, 227, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
2626, 4r67O, 0.8965, 1.82, 0.318, 233, 223, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2627, 3unbf, 0.8965, 1.81, 0.308, 244, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2628, 5vfpEA, 0.8964, 1.82, 0.318, 233, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2629, 5dsvH, 0.8964, 2.15, 0.270, 240, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2630, 4r67q, 0.8964, 2.02, 0.215, 241, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2631, 4r67c, 0.8964, 1.82, 0.318, 233, 223, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2632, 4r67A, 0.8964, 1.97, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2633, 1iruO, 0.8964, 1.74, 0.335, 227, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2634, 5mp9a, 0.8963, 1.82, 0.318, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2635, 1iruA, 0.8963, 1.82, 0.318, 233, 223, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2636, 5vfqFA, 0.8962, 2.00, 0.271, 240, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2637, 5vfom, 0.8961, 2.45, 0.201, 220, 189, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2638, 3unhU, 0.8959, 1.98, 0.242, 244, 227, MOUSE 20S IMMUNOPROTEASOME
2639, 3unhG, 0.8959, 1.98, 0.242, 244, 227, MOUSE 20S IMMUNOPROTEASOME
2640, 5l4gS, 0.8958, 1.81, 0.318, 233, 223, 
2641, 5l4gE, 0.8958, 2.14, 0.265, 240, 226, 
2642, 5gjqB, 0.8958, 1.79, 0.270, 239, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2643, 3jcpNA, 0.8958, 1.98, 0.242, 244, 227, 
2644, 3jcpN, 0.8958, 1.98, 0.242, 244, 227, 
2645, 6avoM, 0.8957, 1.98, 0.242, 244, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2646, 5vfrm, 0.8957, 1.97, 0.242, 244, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2647, 3unei, 0.8957, 2.04, 0.215, 241, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2648, 3unbD, 0.8957, 1.97, 0.242, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2649, 6avoH, 0.8956, 2.16, 0.270, 240, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2650, 5vfoH, 0.8956, 2.15, 0.265, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2651, 5gjqh, 0.8956, 1.98, 0.242, 243, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2652, 5mpcQ, 0.8955, 1.98, 0.242, 243, 227, 
2653, 5vfrH, 0.8954, 1.65, 0.320, 234, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2654, 3sdkR, 0.8954, 1.66, 0.320, 234, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2655, 2ku2D, 0.8954, 1.99, 0.242, 244, 227, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2656, 3unfU, 0.8952, 1.78, 0.341, 242, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2657, 3unfG, 0.8952, 1.78, 0.341, 242, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2658, 3unew, 0.8952, 1.78, 0.341, 242, 223, MOUSE CONSTITUTIVE 20S PROTEASOME
2659, 5mp9C, 0.8951, 1.80, 0.318, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2660, 5lf4B, 0.8951, 2.16, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2661, 5lf0B, 0.8951, 1.98, 0.242, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2662, 5t0cY, 0.8949, 1.82, 0.318, 233, 223, 
2663, 5t0cEB, 0.8949, 1.80, 0.318, 233, 223, 
2664, 5le5B, 0.8948, 1.72, 0.290, 230, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2665, 5mpag, 0.8947, 1.98, 0.242, 244, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2666, 5mp9c, 0.8947, 1.89, 0.308, 244, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2667, 3unbR, 0.8946, 1.72, 0.290, 230, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2668, 3jcoNA, 0.8946, 1.46, 0.347, 232, 219, 
2669, 3jcoN, 0.8946, 1.85, 0.320, 237, 225, 
2670, 5mpac, 0.8945, 1.99, 0.242, 243, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2671, 3unbt, 0.8945, 1.99, 0.242, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2672, 5lf7B, 0.8943, 1.98, 0.242, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2673, 5lf3B, 0.8943, 1.85, 0.308, 244, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2674, 5vfuX, 0.8942, 1.99, 0.333, 248, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2675, 5vftM, 0.8942, 1.99, 0.333, 248, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2676, 5leyB, 0.8942, 2.32, 0.264, 240, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2677, 3unfB, 0.8942, 2.09, 0.230, 240, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2678, 3unfP, 0.8941, 2.32, 0.264, 240, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2679, 5vfsG, 0.8940, 1.99, 0.333, 248, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2680, 5vfpB, 0.8940, 2.32, 0.294, 243, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2681, 5lf1B, 0.8940, 1.86, 0.308, 244, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2682, 5l4gO, 0.8940, 1.83, 0.318, 233, 223, 
2683, 3jcoP, 0.8940, 1.77, 0.341, 242, 223, 
2684, 3jcoPA, 0.8939, 1.77, 0.341, 242, 223, 
2685, 3unfO, 0.8938, 1.77, 0.341, 242, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2686, 3unfA, 0.8938, 1.86, 0.308, 244, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2687, 3c91U, 0.8938, 1.84, 0.318, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2688, 3c91T, 0.8938, 2.00, 0.333, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2689, 3c91S, 0.8938, 2.00, 0.333, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2690, 3c91R, 0.8938, 2.29, 0.265, 240, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2691, 3c91Q, 0.8938, 2.29, 0.265, 240, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2692, 3c91P, 0.8938, 2.00, 0.333, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2693, 3c91O, 0.8938, 1.98, 0.338, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2694, 3c91G, 0.8938, 1.98, 0.338, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2695, 3c91F, 0.8938, 2.12, 0.262, 240, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2696, 3c91E, 0.8938, 1.74, 0.290, 230, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2697, 3c91D, 0.8938, 2.36, 0.315, 239, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2698, 3c91C, 0.8938, 2.00, 0.333, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2699, 3c91B, 0.8938, 1.97, 0.238, 244, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2700, 3c91A, 0.8938, 2.27, 0.293, 244, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
2701, 5lezB, 0.8935, 2.27, 0.293, 244, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2702, 1j2pF, 0.8935, 2.27, 0.293, 244, 229, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2703, 5le5P, 0.8934, 1.75, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2704, 5mp9e, 0.8933, 1.75, 0.294, 230, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2705, 3unhP, 0.8933, 1.78, 0.330, 227, 224, MOUSE 20S IMMUNOPROTEASOME
2706, 3unhO, 0.8933, 1.78, 0.330, 227, 224, MOUSE 20S IMMUNOPROTEASOME
2707, 3unhB, 0.8933, 1.78, 0.330, 227, 224, MOUSE 20S IMMUNOPROTEASOME
2708, 3unhA, 0.8933, 1.78, 0.330, 227, 224, MOUSE 20S IMMUNOPROTEASOME
2709, 1j2pC, 0.8933, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2710, 3sdkD, 0.8932, 1.78, 0.330, 227, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2711, 1j2pG, 0.8932, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2712, 1j2pE, 0.8932, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2713, 1j2pA, 0.8932, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2714, 5wvkU, 0.8931, 1.78, 0.330, 227, 224, 
2715, 5lf6B, 0.8931, 1.78, 0.330, 227, 224, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2716, 1j2pD, 0.8931, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2717, 1j2pB, 0.8931, 1.78, 0.330, 227, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2718, 5lexB, 0.8930, 1.78, 0.330, 227, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2719, 3uneD, 0.8930, 2.00, 0.333, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2720, 3unet, 0.8929, 1.82, 0.338, 243, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2721, 2ku2F, 0.8929, 2.01, 0.333, 247, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2722, 2ku1F, 0.8928, 1.81, 0.341, 242, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2723, 3uneA, 0.8927, 2.00, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2724, 3unbB, 0.8927, 1.76, 0.294, 230, 221, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2725, 5lf4P, 0.8926, 2.00, 0.338, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2726, 5l4gA, 0.8926, 1.76, 0.294, 230, 221, 
2727, 5mp9E, 0.8925, 1.83, 0.338, 243, 225, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2728, 4r67B, 0.8924, 1.64, 0.345, 233, 220, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2729, 5vfsFA, 0.8923, 1.83, 0.338, 243, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2730, 5mpaa, 0.8923, 1.83, 0.338, 243, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2731, 5m32F, 0.8923, 1.83, 0.338, 243, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2732, 3unbO, 0.8923, 2.38, 0.297, 244, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2733, 5lf1P, 0.8921, 2.01, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2734, 4r67r, 0.8921, 1.83, 0.338, 243, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2735, 4r67P, 0.8921, 1.83, 0.338, 243, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2736, 3unec, 0.8921, 2.01, 0.333, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2737, 4r67d, 0.8920, 1.61, 0.321, 233, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2738, 5lf7P, 0.8919, 1.62, 0.321, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2739, 3uneR, 0.8919, 1.99, 0.320, 237, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2740, 3uneq, 0.8919, 1.90, 0.329, 237, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2741, 3unef, 0.8919, 1.60, 0.295, 233, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2742, 3unbc, 0.8919, 2.14, 0.336, 248, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2743, 5wvkBA, 0.8917, 2.03, 0.333, 248, 225, 
2744, 5lf0P, 0.8917, 1.99, 0.242, 244, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2745, 5lezP, 0.8917, 1.86, 0.341, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2746, 5leyP, 0.8917, 1.77, 0.294, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2747, 5dsvJ, 0.8917, 2.14, 0.262, 240, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2748, 3unfR, 0.8916, 2.07, 0.215, 241, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2749, 3unfD, 0.8916, 1.78, 0.270, 232, 222, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2750, 3unbA, 0.8916, 1.77, 0.294, 231, 221, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2751, 3oevB, 0.8916, 2.04, 0.333, 248, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2752, 5lf3P, 0.8915, 1.78, 0.294, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2753, 3unbq, 0.8915, 1.78, 0.294, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2754, 5lf6P, 0.8914, 1.78, 0.294, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2755, 3unhR, 0.8914, 1.78, 0.294, 233, 221, MOUSE 20S IMMUNOPROTEASOME
2756, 3unhD, 0.8914, 2.04, 0.333, 247, 225, MOUSE 20S IMMUNOPROTEASOME
2757, 5lf0O, 0.8912, 1.63, 0.321, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2758, 3mg8B, 0.8912, 1.60, 0.295, 233, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2759, 5mpaG, 0.8911, 1.63, 0.321, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2760, 5lf3O, 0.8911, 1.60, 0.295, 231, 220, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2761, 5lexP, 0.8911, 2.32, 0.289, 244, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2762, 3mg6B, 0.8911, 2.04, 0.333, 248, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2763, 3unbd, 0.8910, 2.04, 0.333, 247, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2764, 5t0gM, 0.8909, 2.04, 0.333, 247, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2765, 1iruP, 0.8909, 1.80, 0.271, 239, 221, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2766, 3sdiP, 0.8908, 1.64, 0.321, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2767, 5lexO, 0.8906, 1.64, 0.321, 233, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2768, 3uneO, 0.8905, 1.61, 0.295, 231, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2769, 3sdkB, 0.8905, 1.60, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2770, 1g0uP, 0.8905, 2.04, 0.333, 248, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2771, 1g0uB, 0.8905, 1.60, 0.295, 231, 220, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2772, 5leyO, 0.8904, 2.05, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2773, 3sdiB, 0.8904, 1.64, 0.321, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2774, 2ku1G, 0.8904, 1.64, 0.321, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2775, 5lf6O, 0.8903, 1.78, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2776, 5lf0A, 0.8903, 1.61, 0.309, 235, 220, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2777, 4r3oP, 0.8903, 2.32, 0.289, 243, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2778, 4r3oB, 0.8903, 1.78, 0.294, 230, 221, HUMAN CONSTITUTIVE 20S PROTEASOME
2779, 3oevP, 0.8903, 2.05, 0.333, 247, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2780, 3oeuP, 0.8903, 1.61, 0.305, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2781, 3oeuB, 0.8903, 2.16, 0.336, 248, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2782, 5mpbQ, 0.8902, 2.18, 0.270, 240, 226, 
2783, 5lf1O, 0.8902, 1.79, 0.294, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2784, 3mg7B, 0.8902, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2785, 3mg6P, 0.8902, 1.79, 0.294, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2786, 5lf4O, 0.8901, 1.80, 0.294, 233, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2787, 3sdkP, 0.8901, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2788, 3mg8P, 0.8901, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2789, 3uneP, 0.8900, 1.61, 0.309, 235, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2790, 3mg7P, 0.8899, 1.79, 0.294, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2791, 5mpaA, 0.8898, 1.62, 0.309, 235, 220, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2792, 5lezO, 0.8898, 1.90, 0.321, 237, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2793, 5lf7O, 0.8897, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2794, 5lf3A, 0.8897, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2795, 5lexA, 0.8897, 1.62, 0.295, 233, 220, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2796, 5le5O, 0.8897, 1.62, 0.295, 233, 220, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2797, 1fntG, 0.8897, 1.61, 0.309, 235, 220, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2798, 5gjqD, 0.8896, 1.61, 0.309, 235, 220, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2799, 1fntU, 0.8896, 1.62, 0.309, 235, 220, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2800, 5mpaE, 0.8895, 1.91, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2801, 4cr2E, 0.8895, 1.79, 0.294, 230, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2802, 1fntP, 0.8894, 1.63, 0.309, 235, 220, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2803, 1fntB, 0.8894, 1.62, 0.309, 235, 220, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2804, 6avoZ, 0.8893, 1.79, 0.294, 230, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2805, 6avoO, 0.8893, 1.62, 0.309, 235, 220, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2806, 5lezA, 0.8893, 1.62, 0.309, 235, 220, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2807, 4cr4E, 0.8893, 2.03, 0.338, 248, 225, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2808, 3uneB, 0.8893, 1.62, 0.309, 235, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2809, 5t0hM, 0.8892, 2.08, 0.215, 241, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2810, 5lf4A, 0.8892, 1.63, 0.295, 230, 220, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2811, 5gjrHA, 0.8891, 1.80, 0.294, 230, 221, 
2812, 2ku1C, 0.8891, 1.80, 0.294, 230, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2813, 5le5A, 0.8890, 1.80, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2814, 5gjrT, 0.8890, 1.80, 0.294, 230, 221, 
2815, 5lf6A, 0.8889, 2.23, 0.292, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2816, 5leyA, 0.8889, 2.05, 0.333, 250, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2817, 1z7qD, 0.8889, 2.23, 0.292, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2818, 5lf1A, 0.8888, 1.73, 0.342, 242, 222, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2819, 5l4gP, 0.8888, 1.93, 0.341, 243, 223, 
2820, 1z7qR, 0.8888, 1.85, 0.280, 247, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2821, 5lf7A, 0.8887, 1.85, 0.280, 247, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2822, 2ku1E, 0.8887, 2.18, 0.332, 240, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2823, 4r67e, 0.8886, 2.18, 0.332, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2824, 3unbr, 0.8886, 1.64, 0.295, 230, 220, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2825, 6avoP, 0.8885, 1.86, 0.345, 243, 223, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2826, 6avob, 0.8885, 2.06, 0.338, 248, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2827, 4r67s, 0.8885, 2.23, 0.270, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2828, 4r67Q, 0.8885, 1.81, 0.294, 230, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2829, 4r67C, 0.8885, 1.81, 0.294, 231, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2830, 3unbP, 0.8882, 1.94, 0.330, 237, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2831, 5l4gB, 0.8881, 1.81, 0.294, 230, 221, 
2832, 5vfuLA, 0.8880, 1.81, 0.294, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2833, 5vftm, 0.8880, 2.89, 0.156, 217, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2834, 4cr2C, 0.8878, 1.81, 0.294, 230, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2835, 3j9iU, 0.8878, 1.81, 0.294, 230, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2836, 3j9iT, 0.8878, 2.07, 0.310, 241, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2837, 3j9iS, 0.8878, 1.81, 0.294, 230, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2838, 3j9iR, 0.8878, 1.81, 0.294, 233, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2839, 3j9iQ, 0.8878, 2.07, 0.310, 241, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2840, 3j9iP, 0.8878, 1.81, 0.294, 230, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2841, 3j9iO, 0.8878, 1.82, 0.323, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2842, 3j9iG, 0.8878, 2.06, 0.333, 250, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2843, 3j9iF, 0.8878, 2.06, 0.338, 248, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2844, 3j9iE, 0.8878, 1.81, 0.294, 230, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2845, 3j9iD, 0.8878, 1.81, 0.294, 230, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2846, 3j9iC, 0.8878, 2.06, 0.333, 250, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2847, 3j9iB, 0.8878, 2.06, 0.333, 250, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2848, 3j9iA, 0.8878, 2.06, 0.333, 250, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2849, 1iruQ, 0.8878, 2.06, 0.338, 248, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2850, 1iruC, 0.8878, 1.65, 0.295, 233, 220, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2851, 4cr2G, 0.8876, 2.15, 0.270, 240, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2852, 3uner, 0.8874, 2.15, 0.270, 240, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2853, 5mpae, 0.8873, 1.86, 0.305, 245, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2854, 4zzgD, 0.8873, 1.70, 0.335, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2855, 1iruB, 0.8873, 1.70, 0.335, 224, 221, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2856, 4r3oQ, 0.8872, 1.70, 0.335, 224, 221, HUMAN CONSTITUTIVE 20S PROTEASOME
2857, 4r3oC, 0.8872, 1.70, 0.335, 224, 221, HUMAN CONSTITUTIVE 20S PROTEASOME
2858, 2ku2G, 0.8872, 1.70, 0.335, 224, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2859, 1rypP, 0.8872, 1.70, 0.335, 224, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2860, 5nifD, 0.8870, 1.70, 0.335, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2861, 4q1sQ, 0.8870, 1.70, 0.335, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2862, 5gjqj, 0.8869, 1.70, 0.335, 224, 221, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2863, 3uned, 0.8869, 1.70, 0.335, 224, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2864, 1g0uD, 0.8869, 1.70, 0.335, 224, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2865, 1rypB, 0.8868, 1.70, 0.335, 224, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2866, 5wvkS, 0.8867, 1.70, 0.335, 224, 221, 
2867, 5m32R, 0.8866, 1.70, 0.335, 224, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2868, 5m32D, 0.8866, 2.06, 0.333, 250, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2869, 6epcG, 0.8864, 2.06, 0.333, 250, 225, GROUND STATE 26S PROTEASOME (GS2)
2870, 4q1sC, 0.8864, 2.33, 0.289, 245, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2871, 3ipmF, 0.8864, 2.08, 0.338, 248, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2872, 3ipmA, 0.8864, 1.70, 0.348, 242, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2873, 4eu2P, 0.8863, 2.00, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2874, 3ipmG, 0.8863, 1.86, 0.294, 233, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2875, 3ipmE, 0.8863, 2.08, 0.333, 250, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2876, 3ipmC, 0.8863, 2.08, 0.333, 250, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2877, 3ipmB, 0.8863, 2.24, 0.320, 237, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2878, 1jd2V, 0.8863, 1.70, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2879, 5nifP, 0.8862, 2.00, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2880, 3ipmD, 0.8862, 2.01, 0.305, 241, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2881, 1yauG, 0.8862, 2.09, 0.333, 250, 225, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2882, 5dsvM, 0.8861, 2.08, 0.338, 248, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2883, 3bdmO, 0.8861, 1.47, 0.350, 230, 217, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2884, 3bdmA, 0.8861, 1.71, 0.285, 250, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2885, 5mpcC, 0.8860, 1.88, 0.341, 242, 223, 
2886, 2zcyO, 0.8860, 1.92, 0.305, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2887, 2zcyA, 0.8860, 1.92, 0.305, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2888, 1g0uA, 0.8860, 2.10, 0.265, 245, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2889, 4zzgP, 0.8859, 2.02, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2890, 3mg8O, 0.8859, 1.86, 0.332, 227, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2891, 3gpjA, 0.8859, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2892, 3dy4C, 0.8859, 1.71, 0.285, 249, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2893, 1g0uR, 0.8859, 1.86, 0.332, 227, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2894, 4x6zP, 0.8858, 1.86, 0.332, 227, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2895, 4cr2A, 0.8858, 1.86, 0.332, 227, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2896, 3mg4O, 0.8858, 1.86, 0.332, 227, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2897, 3gpjO, 0.8858, 1.71, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2898, 3dy4Q, 0.8858, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2899, 2gplA, 0.8858, 1.86, 0.332, 227, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2900, 4qv5O, 0.8857, 1.61, 0.333, 222, 219, YCP BETA5-M45I MUTANT
2901, 4qv5A, 0.8857, 2.14, 0.266, 239, 222, YCP BETA5-M45I MUTANT
2902, 3un8O, 0.8857, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2903, 3dy3O, 0.8857, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2904, 3dy3A, 0.8857, 2.04, 0.310, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2905, 2gplO, 0.8857, 1.71, 0.285, 250, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2906, 1jd2A, 0.8856, 1.71, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2907, 1g65A, 0.8856, 1.72, 0.285, 246, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2908, 4ltcO, 0.8855, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2909, 3sdiO, 0.8855, 1.71, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2910, 3oeuO, 0.8855, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2911, 3mg0O, 0.8855, 2.02, 0.305, 241, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2912, 4qv3O, 0.8854, 1.48, 0.350, 230, 217, YCP BETA5-M45V MUTANT
2913, 4qv3A, 0.8854, 1.72, 0.285, 249, 221, YCP BETA5-M45V MUTANT
2914, 4no6O, 0.8854, 2.20, 0.224, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2915, 4no6A, 0.8854, 1.71, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2916, 3sdiA, 0.8854, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2917, 3mg7O, 0.8854, 2.02, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2918, 2zcyC, 0.8854, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2919, 1yauF, 0.8854, 1.72, 0.285, 250, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2920, 1g0uO, 0.8854, 1.72, 0.285, 250, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2921, 5nifR, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2922, 5gjqC, 0.8853, 1.72, 0.285, 250, 221, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2923, 4zzgR, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2924, 4inrA, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2925, 4g4sB, 0.8853, 1.72, 0.285, 250, 221, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2926, 3un8A, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2927, 3mg7A, 0.8853, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2928, 3e47O, 0.8853, 1.72, 0.285, 246, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2929, 3e47A, 0.8853, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2930, 3dy4A, 0.8853, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2931, 2zcyQ, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2932, 4qv4O, 0.8852, 1.72, 0.285, 250, 221, YCP BETA5-M45T MUTANT
2933, 4qv4A, 0.8852, 1.72, 0.285, 250, 221, YCP BETA5-M45T MUTANT
2934, 4no1O, 0.8852, 1.72, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2935, 4no1A, 0.8852, 1.72, 0.285, 246, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2936, 4ltcA, 0.8852, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2937, 4inrO, 0.8852, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2938, 3wxrB, 0.8852, 1.61, 0.333, 222, 219, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2939, 3sdkO, 0.8852, 1.72, 0.285, 246, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2940, 3dy4O, 0.8852, 2.03, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2941, 1g65O, 0.8852, 1.69, 0.295, 233, 220, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2942, 5l55O, 0.8851, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2943, 5l55A, 0.8851, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2944, 4inuO, 0.8851, 1.72, 0.285, 246, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2945, 3d29A, 0.8851, 1.72, 0.285, 250, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
2946, 2fakO, 0.8851, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2947, 2fakA, 0.8851, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2948, 2f16O, 0.8851, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2949, 2f16A, 0.8851, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2950, 5nifB, 0.8850, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2951, 5l52A, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2952, 4zzgB, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2953, 4qv7O, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT
2954, 4qv7A, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT
2955, 4qv1O, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-M45A MUTANT
2956, 4qv1A, 0.8850, 1.72, 0.285, 250, 221, YCP BETA5-M45A MUTANT
2957, 4intO, 0.8850, 1.73, 0.285, 249, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2958, 4hnpA, 0.8850, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2959, 3sdkA, 0.8850, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2960, 3dy3Q, 0.8850, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2961, 3dy3C, 0.8850, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2962, 3d29O, 0.8850, 1.72, 0.285, 250, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
2963, 6avoR, 0.8849, 1.72, 0.285, 250, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2964, 5l52O, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2965, 4y8pO, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2966, 4x6zB, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2967, 4qz7O, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2968, 4qz7A, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2969, 4qz4O, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2970, 4qz4A, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2971, 4qz0O, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2972, 4qz0A, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2973, 4qv9O, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C63F MUTANT
2974, 4qv9A, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C63F MUTANT
2975, 4qv8O, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT
2976, 4qv8A, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT
2977, 4quyO, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S-MUTANT
2978, 4quyA, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S-MUTANT
2979, 4jsqO, 0.8849, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2980, 4jsqA, 0.8849, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2981, 4inuA, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2982, 3okjO, 0.8849, 1.89, 0.247, 240, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2983, 3okjA, 0.8849, 1.73, 0.285, 250, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2984, 3mg6A, 0.8849, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2985, 5l5rO, 0.8848, 1.73, 0.285, 248, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2986, 5jhrA, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2987, 5d0wO, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2988, 5d0wA, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2989, 5cggO, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2990, 4y8pA, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2991, 4qz6O, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2992, 4qz6A, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2993, 4qwxO, 0.8848, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2994, 4qwxA, 0.8848, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2995, 4qv0O, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2996, 4qv0A, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2997, 3mg4A, 0.8848, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2998, 1yarG, 0.8848, 1.73, 0.285, 250, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2999, 6avoK, 0.8847, 1.73, 0.285, 250, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3000, 5t0jM, 0.8847, 1.73, 0.285, 250, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3001, 5l5rA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3002, 5jhrO, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3003, 5fggO, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3004, 5fggA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3005, 5cgiO, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3006, 5cgiA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3007, 5cghO, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3008, 5cghA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3009, 5cggA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3010, 5ahjO, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3011, 5ahjA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3012, 4ya9O, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3013, 4ya9A, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3014, 4ya7O, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3015, 4ya7A, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3016, 4y9yA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3017, 4y8kO, 0.8847, 1.57, 0.339, 221, 218, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3018, 4y8kA, 0.8847, 1.89, 0.247, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3019, 4qzwO, 0.8847, 2.32, 0.274, 240, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3020, 4qzwA, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3021, 4qz3O, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3022, 4qz3A, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3023, 4qz2O, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3024, 4qz2A, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3025, 4no8O, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3026, 4no8A, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3027, 4nnwO, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3028, 4nnwA, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3029, 4nnnO, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH MG132
3030, 4nnnA, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH MG132
3031, 4intA, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3032, 4eu2B, 0.8847, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3033, 3un4O, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3034, 3un4A, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3035, 3sdkC, 0.8847, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3036, 3sdiR, 0.8847, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3037, 3oevA, 0.8847, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3038, 3gpjQ, 0.8847, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3039, 3gpjC, 0.8847, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3040, 6gopO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3041, 6gopA, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3042, 5l5wO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3043, 5l5wA, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3044, 5l5bO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3045, 5l5bA, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3046, 5bxlO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3047, 5bxlA, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3048, 4ya1O, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3049, 4ya1A, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3050, 4y9zO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3051, 4y9zA, 0.8846, 1.74, 0.285, 249, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3052, 4y9yO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3053, 4y8sO, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3054, 4y8sA, 0.8846, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3055, 4y75A, 0.8846, 1.43, 0.352, 229, 216, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3056, 4v7oE, 0.8846, 1.73, 0.285, 250, 221, 
3057, 4v7oAB, 0.8846, 2.03, 0.305, 241, 223, 
3058, 4r00O, 0.8846, 2.03, 0.305, 241, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3059, 4r00A, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3060, 4qwlO, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3061, 4qwlA, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3062, 4qw6O, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3063, 4qw6A, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3064, 3mg8A, 0.8846, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3065, 3mg6O, 0.8846, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3066, 1yauA, 0.8846, 1.73, 0.285, 250, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3067, 5l6aO, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3068, 5l6aA, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3069, 5gjqi, 0.8845, 1.73, 0.285, 250, 221, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3070, 5d0sO, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3071, 5d0sA, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3072, 5czaO, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3073, 5czaA, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3074, 4ya2O, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3075, 4ya2A, 0.8845, 2.06, 0.342, 250, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3076, 4y8rO, 0.8845, 2.06, 0.342, 250, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3077, 4y8rA, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3078, 4y77O, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3079, 4y77A, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3080, 4y75O, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3081, 4v7oMA, 0.8845, 1.73, 0.285, 250, 221, 
3082, 4qzzO, 0.8845, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH OMURALIDE
3083, 4qzzA, 0.8845, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH OMURALIDE
3084, 4qz5O, 0.8845, 1.73, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3085, 4qz5A, 0.8845, 1.63, 0.333, 222, 219, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3086, 4qbyO, 0.8845, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3087, 4qbyA, 0.8845, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3088, 4jt0O, 0.8845, 1.86, 0.294, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3089, 4jt0A, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3090, 3shjC, 0.8845, 1.73, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3091, 3oevO, 0.8845, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3092, 3oeuA, 0.8845, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3093, 3bdmC, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3094, 5l6bO, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3095, 5l6bA, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3096, 5l5uO, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3097, 5l5uA, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3098, 5l5oO, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3099, 5l5hO, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3100, 5l5hA, 0.8844, 2.06, 0.342, 250, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3101, 5fgfO, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3102, 5fgfA, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3103, 5fgaO, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3104, 5fg9O, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3105, 5fg7O, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3106, 5fg7A, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3107, 5d0vO, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3108, 5d0vA, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3109, 5cz9O, 0.8844, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3110, 5cz9A, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3111, 4ya4O, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3112, 4ya4A, 0.8844, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3113, 4v7oS, 0.8844, 1.74, 0.285, 250, 221, 
3114, 4qzxO, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3115, 4qzxA, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3116, 4qwfO, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3117, 4qwfA, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3118, 4qw7O, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3119, 4qw7A, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3120, 4qw5O, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3121, 4qw5A, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3122, 4qv6O, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-A49V MUTANT
3123, 4qv6A, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-A49V MUTANT
3124, 4no9O, 0.8844, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3125, 4no9A, 0.8844, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3126, 4hrcO, 0.8844, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3127, 4gk7O, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3128, 4gk7A, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3129, 3shjQ, 0.8844, 1.74, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3130, 3nzxO, 0.8844, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3131, 3nzxA, 0.8844, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3132, 3d29Q, 0.8844, 2.07, 0.342, 250, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3133, 3d29C, 0.8844, 1.74, 0.285, 250, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3134, 3bdmQ, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3135, 5m2bO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3136, 5lttO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3137, 5l64O, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3138, 5l64A, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3139, 5l63O, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3140, 5l61O, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3141, 5l61A, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3142, 5l5xO, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3143, 5l5xA, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3144, 5l5tO, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3145, 5l5tA, 0.8843, 1.73, 0.285, 249, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3146, 5l5sO, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3147, 5l5sA, 0.8843, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3148, 5l5qO, 0.8843, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3149, 5l5oA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3150, 5l5iO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3151, 5l5iA, 0.8843, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3152, 5l5dO, 0.8843, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3153, 5l5dA, 0.8843, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3154, 5l5aO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3155, 5jhsO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3156, 5jhsA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3157, 5fgaA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3158, 5fg9A, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3159, 5d0zO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3160, 5d0zA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3161, 5cgfO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3162, 5cgfA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3163, 5bxnA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3164, 4y8lO, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3165, 4y8lA, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3166, 4r02O, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3167, 4qwuO, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3168, 4qwuA, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3169, 4qwrO, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3170, 4qwrA, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3171, 4quxO, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT
3172, 4quxA, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT
3173, 4qluO, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3174, 4qluA, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3175, 4qltO, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3176, 4qltA, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3177, 4hnpO, 0.8843, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3178, 4fzcO, 0.8843, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3179, 4fzcA, 0.8843, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3180, 3tddO, 0.8843, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3181, 3shjO, 0.8843, 1.74, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3182, 3shjA, 0.8843, 1.74, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3183, 1yauC, 0.8843, 1.74, 0.285, 250, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3184, 1g0uC, 0.8843, 1.74, 0.285, 250, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3185, 5vfqC, 0.8842, 1.74, 0.285, 250, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3186, 5t0cW, 0.8842, 1.74, 0.285, 250, 221, 
3187, 5t0cCB, 0.8842, 1.74, 0.285, 250, 221, 
3188, 5m2bA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3189, 5lttA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3190, 5l6cO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3191, 5l6cA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3192, 5l67O, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3193, 5l67A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3194, 5l65O, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3195, 5l65A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3196, 5l63A, 0.8842, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3197, 5l62O, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3198, 5l62A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3199, 5l5qA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3200, 5l5jO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3201, 5l5jA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3202, 5l5aA, 0.8842, 1.63, 0.333, 222, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3203, 5fgeO, 0.8842, 2.03, 0.305, 238, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3204, 5fgeA, 0.8842, 2.10, 0.335, 248, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3205, 5cz6O, 0.8842, 2.38, 0.315, 239, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3206, 5cz6A, 0.8842, 1.81, 0.320, 228, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3207, 5bxnO, 0.8842, 1.81, 0.320, 228, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3208, 4y8mO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3209, 4y8mA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3210, 4y8jO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3211, 4y8jA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3212, 4y8iA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3213, 4y82O, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3214, 4y82A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3215, 4y7xO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3216, 4y7xA, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3217, 4y74A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3218, 4y70O, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3219, 4y70A, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3220, 4r17O, 0.8842, 1.74, 0.285, 250, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3221, 4r17A, 0.8842, 1.74, 0.285, 250, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3222, 4qxjO, 0.8842, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3223, 4qxjA, 0.8842, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3224, 4qvlO, 0.8842, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BORTEZOMIB
3225, 4qvlA, 0.8842, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BORTEZOMIB
3226, 4jsuO, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3227, 4j70C, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3228, 4hrcA, 0.8842, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3229, 3tddA, 0.8842, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3230, 2ku1D, 0.8842, 1.74, 0.285, 250, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3231, 5vfoI, 0.8841, 1.74, 0.285, 250, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3232, 5l68O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3233, 5l68A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3234, 5l66O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3235, 5l66A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3236, 5l60O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3237, 5l60A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3238, 5l5zO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3239, 5l5zA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3240, 5l5vO, 0.8841, 1.74, 0.285, 249, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3241, 5l5vA, 0.8841, 1.74, 0.285, 249, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3242, 5l5pO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3243, 5l5pA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3244, 5l54O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3245, 5l54A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3246, 5fgiO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3247, 5fgiA, 0.8841, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3248, 5cz8O, 0.8841, 1.74, 0.285, 249, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3249, 5cz8A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3250, 4z1lO, 0.8841, 1.92, 0.329, 237, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3251, 4z1lA, 0.8841, 2.11, 0.335, 248, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3252, 4y8qO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3253, 4y8qA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3254, 4y8iO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3255, 4y80O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3256, 4y80A, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3257, 4y7yO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3258, 4y7yA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3259, 4y7wO, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3260, 4y7wA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3261, 4y74O, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3262, 4qz1O, 0.8841, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3263, 4qw4O, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH CARFILZOMIB
3264, 4qw4A, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH CARFILZOMIB
3265, 4qw1O, 0.8841, 1.74, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3266, 4qw1A, 0.8841, 1.74, 0.285, 249, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3267, 4qlsO, 0.8841, 1.74, 0.285, 249, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3268, 4qlsA, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3269, 4no6Q, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3270, 4no6C, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3271, 4jsuA, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3272, 4hrdA, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3273, 4hrcC, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3274, 4fzgO, 0.8841, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3275, 4fzgA, 0.8841, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3276, 3un8Q, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3277, 3nzjA, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3278, 3gpwO, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3279, 3gpwA, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3280, 3gptO, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3281, 3gptA, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3282, 6epfG, 0.8840, 1.74, 0.285, 250, 221, GROUND STATE 26S PROTEASOME (GS1)
3283, 5mpcU, 0.8840, 1.74, 0.285, 250, 221, 
3284, 5l69O, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3285, 5l69A, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3286, 5l5yA, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3287, 5fhsO, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3288, 5fhsA, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3289, 5fgdO, 0.8840, 2.04, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3290, 5fgdA, 0.8840, 2.04, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3291, 5cz7O, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3292, 5cz7A, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3293, 5bouO, 0.8840, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3294, 4y8tO, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3295, 4y8tA, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3296, 4y8oO, 0.8840, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3297, 4y8oA, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3298, 4qz1A, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3299, 4qwiO, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3300, 4qwiA, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3301, 4qvyO, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3302, 4qvyA, 0.8840, 2.17, 0.268, 245, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3303, 4qvnO, 0.8840, 2.38, 0.293, 243, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3304, 4qvnA, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3305, 4qlqO, 0.8840, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3306, 4qlqA, 0.8840, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3307, 4q1sO, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3308, 4j70Q, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3309, 4inrC, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3310, 4hrdO, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3311, 3un8C, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3312, 3nzjO, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3313, 3mg8C, 0.8840, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3314, 3mg0A, 0.8840, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3315, 3hyeO, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3316, 3hyeA, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3317, 5l5yO, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3318, 5l5fO, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3319, 5l5fA, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3320, 5bouA, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3321, 4y8hO, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3322, 4y8hA, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3323, 4y8gO, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3324, 4y81O, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3325, 4y81A, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3326, 4y6zO, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3327, 4y6zA, 0.8839, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3328, 4y6vO, 0.8839, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3329, 4y6vA, 0.8839, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3330, 4x6zD, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3331, 4qz5C, 0.8839, 2.05, 0.305, 241, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3332, 4qvwO, 0.8839, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3333, 4qvwA, 0.8839, 2.07, 0.305, 241, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3334, 3mg6C, 0.8839, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3335, 3gptQ, 0.8839, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3336, 3gptC, 0.8839, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3337, 5l5eO, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3338, 5l5eA, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3339, 5cz5O, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3340, 5cz5A, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3341, 4y8gA, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3342, 4rurO, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3343, 4rurA, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3344, 4qz5Q, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3345, 4qwkO, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3346, 4qwkA, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3347, 4qvpO, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3348, 4qvpA, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3349, 4inrQ, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3350, 3nzwO, 0.8838, 2.04, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3351, 3nzwA, 0.8838, 2.05, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3352, 3mg4C, 0.8838, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3353, 5dkjO, 0.8837, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3354, 5dkjA, 0.8837, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3355, 5d0tO, 0.8837, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3356, 5d0tA, 0.8837, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3357, 4y8uO, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3358, 4y8uA, 0.8837, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3359, 4y8sQ, 0.8837, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3360, 4y8sC, 0.8837, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3361, 4y8nO, 0.8837, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3362, 4y8nA, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3363, 4y78O, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3364, 4y78A, 0.8837, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3365, 4y69O, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3366, 4y69A, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3367, 4qwjO, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3368, 4qwjA, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3369, 4qw0O, 0.8837, 2.05, 0.305, 241, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3370, 4qvqO, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3371, 4qvqA, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3372, 4qlvO, 0.8837, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3373, 4qlvA, 0.8837, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3374, 4qlqC, 0.8837, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3375, 4gk7Q, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3376, 4gk7C, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3377, 3oevC, 0.8837, 1.75, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3378, 3oeuC, 0.8837, 1.75, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3379, 1yauB, 0.8837, 2.05, 0.305, 240, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3380, 5vfpC, 0.8836, 2.05, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3381, 5lajO, 0.8836, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3382, 5lajA, 0.8836, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3383, 5l54C, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3384, 4ya5O, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3385, 4ya5A, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3386, 4y84O, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3387, 4y84A, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3388, 4y6aO, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3389, 4y6aA, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3390, 4qz3Q, 0.8836, 1.74, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3391, 4qz3C, 0.8836, 1.74, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3392, 4qwlQ, 0.8836, 1.75, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3393, 4qwlC, 0.8836, 1.75, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3394, 4qw0A, 0.8836, 2.05, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3395, 4qlqQ, 0.8836, 2.05, 0.305, 241, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3396, 4lqiO, 0.8836, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3397, 4lqiA, 0.8836, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3398, 5laiO, 0.8835, 2.07, 0.305, 241, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3399, 5laiA, 0.8835, 1.65, 0.333, 222, 219, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3400, 5l54Q, 0.8835, 2.11, 0.335, 248, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3401, 5fghA, 0.8835, 1.90, 0.324, 228, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3402, 5d0xA, 0.8835, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3403, 4x6zR, 0.8835, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3404, 4r18O, 0.8835, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3405, 4r18A, 0.8835, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3406, 4hrdC, 0.8835, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3407, 4hnpC, 0.8835, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3408, 3sdiC, 0.8835, 1.75, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3409, 1g65C, 0.8835, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3410, 5fghO, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3411, 5d0xO, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3412, 4y9zC, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3413, 4y8jQ, 0.8834, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3414, 4y8jC, 0.8834, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3415, 4y8hQ, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3416, 4y8hC, 0.8834, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3417, 4y7yQ, 0.8834, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3418, 4y7yC, 0.8834, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3419, 4r02A, 0.8834, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3420, 4qz6Q, 0.8834, 1.75, 0.285, 250, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3421, 4qz6C, 0.8834, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3422, 4qwjQ, 0.8834, 1.75, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3423, 4qwjC, 0.8834, 1.75, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3424, 4qltQ, 0.8834, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3425, 4qltC, 0.8834, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3426, 4q1sA, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3427, 4no9Q, 0.8834, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3428, 4no9C, 0.8834, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3429, 4inuC, 0.8834, 2.06, 0.305, 238, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3430, 3tddQ, 0.8834, 2.04, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3431, 3tddC, 0.8834, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3432, 1g0uQ, 0.8834, 1.75, 0.285, 250, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3433, 6gopQ, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3434, 6gopC, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3435, 5dkiA, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3436, 5cz8Q, 0.8833, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3437, 5cz8C, 0.8833, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3438, 5a0qQ, 0.8833, 2.06, 0.305, 240, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3439, 5a0qC, 0.8833, 2.06, 0.305, 240, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3440, 4ya7C, 0.8833, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3441, 4y9zQ, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3442, 4y84Q, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3443, 4y7wQ, 0.8833, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3444, 4y7wC, 0.8833, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3445, 4y70C, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3446, 4qzwQ, 0.8833, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3447, 4qzwC, 0.8833, 1.75, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3448, 4qwsA, 0.8833, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3449, 4qvmO, 0.8833, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3450, 4qvmA, 0.8833, 2.06, 0.305, 241, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3451, 4no1Q, 0.8833, 2.05, 0.305, 241, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3452, 4no1C, 0.8833, 2.05, 0.305, 241, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3453, 4ltcC, 0.8833, 2.04, 0.305, 238, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3454, 4inuQ, 0.8833, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3455, 4eu2R, 0.8833, 2.05, 0.305, 240, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3456, 3nzwC, 0.8833, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3457, 3nzjQ, 0.8833, 2.07, 0.305, 240, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3458, 3nzjC, 0.8833, 2.07, 0.305, 240, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3459, 3e47C, 0.8833, 1.96, 0.333, 237, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3460, 1j2qB, 0.8833, 1.96, 0.333, 237, 222, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3461, 1fntO, 0.8833, 2.06, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3462, 5dkiO, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3463, 5d0sQ, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3464, 5d0sC, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3465, 5cz4O, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3466, 5cz4A, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3467, 4ya7Q, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3468, 4y8lC, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3469, 4y84C, 0.8832, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3470, 4y70Q, 0.8832, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3471, 4r02C, 0.8832, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3472, 4qwsO, 0.8832, 2.05, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3473, 4qwiQ, 0.8832, 2.05, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3474, 4qwiC, 0.8832, 2.07, 0.305, 241, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3475, 4qw7Q, 0.8832, 2.06, 0.305, 241, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3476, 4qw7C, 0.8832, 2.05, 0.305, 241, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3477, 4nnnQ, 0.8832, 2.05, 0.305, 241, 223, YCP IN COMPLEX WITH MG132
3478, 4nnnC, 0.8832, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH MG132
3479, 3okjC, 0.8832, 2.06, 0.305, 241, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3480, 3nzxQ, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3481, 3nzxC, 0.8832, 1.81, 0.344, 237, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3482, 3nzwQ, 0.8832, 1.97, 0.219, 238, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3483, 3hyeC, 0.8832, 1.75, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3484, 3gpwQ, 0.8832, 2.06, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3485, 3gpwC, 0.8832, 2.06, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3486, 3e47Q, 0.8832, 1.76, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3487, 1fntA, 0.8832, 1.76, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3488, 5d0zC, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3489, 4y8lQ, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3490, 4y8gQ, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3491, 4y8gC, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3492, 4y78Q, 0.8831, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3493, 4y78C, 0.8831, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3494, 4qz7Q, 0.8831, 2.07, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3495, 4qz7C, 0.8831, 2.07, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3496, 4qwkQ, 0.8831, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3497, 4qwkC, 0.8831, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3498, 4qv9Q, 0.8831, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT
3499, 4qv9C, 0.8831, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT
3500, 4lqiC, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3501, 4jsuQ, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3502, 4jsuC, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3503, 3wxrP, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3504, 3un4C, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3505, 3okjQ, 0.8831, 2.05, 0.305, 241, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3506, 3hyeQ, 0.8831, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3507, 2fakC, 0.8831, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3508, 5t0cYA, 0.8830, 1.97, 0.219, 238, 224, 
3509, 5lajQ, 0.8830, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3510, 5lajC, 0.8830, 2.07, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3511, 5l55Q, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3512, 5l55C, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3513, 5jhrQ, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3514, 5jhrC, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3515, 5d0zQ, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3516, 4ya3O, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3517, 4ya3A, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3518, 4ya0O, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3519, 4ya0A, 0.8830, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3520, 4y8qC, 0.8830, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3521, 4y8iQ, 0.8830, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3522, 4y8iC, 0.8830, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3523, 4y80C, 0.8830, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3524, 4qw6Q, 0.8830, 1.75, 0.285, 249, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3525, 4qw6C, 0.8830, 2.05, 0.305, 241, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3526, 4qv7Q, 0.8830, 2.05, 0.305, 241, 223, YCP BETA5-A50V MUTANT
3527, 4qv7C, 0.8830, 2.05, 0.305, 241, 223, YCP BETA5-A50V MUTANT
3528, 4qv6Q, 0.8830, 2.06, 0.305, 241, 223, YCP BETA5-A49V MUTANT
3529, 4qv6C, 0.8830, 2.09, 0.230, 240, 226, YCP BETA5-A49V MUTANT
3530, 4qv3C, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-M45V MUTANT
3531, 4lqiQ, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3532, 4jsqQ, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3533, 4jsqC, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3534, 4intC, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3535, 3un4Q, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3536, 3mg0Q, 0.8830, 2.07, 0.305, 240, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3537, 2fakQ, 0.8830, 1.76, 0.285, 250, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3538, 1j2qF, 0.8830, 1.76, 0.285, 250, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3539, 5l52Q, 0.8829, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3540, 5l52C, 0.8829, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3541, 5jhsQ, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3542, 5jhsC, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3543, 5fhsQ, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3544, 5fhsC, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3545, 5fggQ, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3546, 5fggC, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3547, 5cz5Q, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3548, 5cz5C, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3549, 5cgiC, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3550, 5cggC, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3551, 4ya2C, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3552, 4y8qQ, 0.8829, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3553, 4y80Q, 0.8829, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3554, 4qzxC, 0.8829, 2.06, 0.305, 241, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3555, 4qz4Q, 0.8829, 2.06, 0.305, 241, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3556, 4qz4C, 0.8829, 2.05, 0.305, 241, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3557, 4qxjQ, 0.8829, 2.06, 0.305, 241, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3558, 4qxjC, 0.8829, 2.06, 0.305, 241, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3559, 4qwrQ, 0.8829, 1.81, 0.344, 237, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3560, 4qwrC, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3561, 4qw5Q, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3562, 4qw5C, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3563, 4qw4Q, 0.8829, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH CARFILZOMIB
3564, 4qw4C, 0.8829, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH CARFILZOMIB
3565, 4qw3O, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3566, 4qw3A, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3567, 4qvvO, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3568, 4qvvA, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3569, 4qv8Q, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT
3570, 4qv8C, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT
3571, 4qv3Q, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-M45V MUTANT
3572, 4qv0Q, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3573, 4qv0C, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3574, 1j2qD, 0.8829, 2.07, 0.305, 240, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3575, 5vfrI, 0.8828, 2.07, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3576, 5d0vC, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3577, 5cz9Q, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3578, 5cz9C, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3579, 5cgiQ, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3580, 5cggQ, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3581, 5cgfC, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3582, 4ya9Q, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3583, 4ya9C, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3584, 4ya2Q, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3585, 4y8pQ, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3586, 4y8pC, 0.8828, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3587, 4y77C, 0.8828, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3588, 4r00C, 0.8828, 1.76, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3589, 4qzxQ, 0.8828, 1.76, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3590, 4qwgO, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3591, 4qwgA, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3592, 4qw1C, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3593, 4qvvQ, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3594, 4qvvC, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3595, 4no8C, 0.8828, 1.81, 0.344, 237, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3596, 3mg0C, 0.8828, 2.12, 0.335, 248, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3597, 1yauD, 0.8828, 2.07, 0.305, 240, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3598, 1g65Q, 0.8828, 2.07, 0.305, 240, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3599, 5fg7Q, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3600, 5fg7C, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3601, 5d0wQ, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3602, 5d0wC, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3603, 5d0vQ, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3604, 5d0tQ, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3605, 5d0tC, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3606, 5cgfQ, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3607, 5ahjC, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3608, 4y9yC, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3609, 4y8rQ, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3610, 4y8rC, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3611, 4y77Q, 0.8827, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3612, 4y75C, 0.8827, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3613, 4y74Q, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3614, 4y74C, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3615, 4r00Q, 0.8827, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3616, 4qwfQ, 0.8827, 2.06, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3617, 4qwfC, 0.8827, 2.06, 0.305, 241, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3618, 4qw1Q, 0.8827, 1.66, 0.333, 222, 219, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3619, 4qv5Q, 0.8827, 2.05, 0.305, 241, 223, YCP BETA5-M45I MUTANT
3620, 4qv5C, 0.8827, 2.06, 0.305, 240, 223, YCP BETA5-M45I MUTANT
3621, 4qlsC, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3622, 4no8Q, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3623, 4nnwQ, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3624, 4nnwC, 0.8827, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3625, 4intQ, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3626, 3sdiD, 0.8827, 2.07, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3627, 1j2qG, 0.8827, 2.06, 0.305, 240, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3628, 1j2qE, 0.8827, 2.06, 0.305, 240, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3629, 1j2qA, 0.8827, 2.06, 0.305, 240, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3630, 5wvkZ, 0.8826, 2.06, 0.305, 240, 223, 
3631, 5vfsE, 0.8826, 2.06, 0.305, 240, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3632, 5fgaQ, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3633, 5fgaC, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3634, 5cghQ, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3635, 5cghC, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3636, 5ahjQ, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3637, 4z1lQ, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3638, 4z1lC, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3639, 4y9yQ, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3640, 4y8oC, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3641, 4y82Q, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3642, 4y82C, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3643, 4y75Q, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3644, 4r18Q, 0.8826, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3645, 4r18C, 0.8826, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3646, 4qzzQ, 0.8826, 2.06, 0.305, 241, 223, YCP IN COMPLEX WITH OMURALIDE
3647, 4qzzC, 0.8826, 1.39, 0.353, 228, 215, YCP IN COMPLEX WITH OMURALIDE
3648, 4qz2C, 0.8826, 1.81, 0.344, 237, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3649, 4qvpQ, 0.8826, 1.81, 0.344, 237, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3650, 4qvpC, 0.8826, 1.81, 0.344, 237, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3651, 4qvlC, 0.8826, 1.95, 0.341, 242, 223, YCP IN COMPLEX WITH BORTEZOMIB
3652, 4qv4Q, 0.8826, 1.07, 0.528, 238, 229, YCP BETA5-M45T MUTANT
3653, 4qv4C, 0.8826, 1.84, 0.324, 228, 222, YCP BETA5-M45T MUTANT
3654, 4qv1Q, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT
3655, 4qv1C, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT
3656, 4quyQ, 0.8826, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT
3657, 4quyC, 0.8826, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT
3658, 4qlvQ, 0.8826, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3659, 4qlvC, 0.8826, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3660, 4qlsQ, 0.8826, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3661, 4ltcQ, 0.8826, 2.06, 0.305, 240, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3662, 4j70A, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3663, 5fgiQ, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3664, 5fgiC, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3665, 5fgdC, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3666, 5fg9Q, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3667, 5fg9C, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3668, 5d0xQ, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3669, 5d0xC, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3670, 5czaQ, 0.8825, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3671, 5czaC, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3672, 4y8oQ, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3673, 4y81C, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3674, 4y7xQ, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3675, 4y7xC, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3676, 4qz2Q, 0.8825, 2.06, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3677, 4qwxQ, 0.8825, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3678, 4qwxC, 0.8825, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3679, 4qwuC, 0.8825, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3680, 4qvlQ, 0.8825, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BORTEZOMIB
3681, 4jt0Q, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3682, 4jt0C, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3683, 3sdiQ, 0.8825, 2.07, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3684, 3mg4Q, 0.8825, 1.76, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3685, 3c92U, 0.8825, 2.08, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3686, 3c92T, 0.8825, 2.08, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3687, 3c92S, 0.8825, 2.08, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3688, 3c92R, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3689, 3c92Q, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3690, 3c92P, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3691, 3c92O, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3692, 3c92G, 0.8825, 2.06, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3693, 3c92F, 0.8825, 2.06, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3694, 3c92E, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3695, 3c92D, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3696, 3c92C, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3697, 3c92B, 0.8825, 2.07, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3698, 3c92A, 0.8825, 2.08, 0.305, 240, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3699, 1j2qC, 0.8825, 2.07, 0.305, 240, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3700, 5vfsZ, 0.8824, 2.07, 0.305, 240, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3701, 5t0cS, 0.8824, 2.07, 0.305, 240, 223, 
3702, 5fgfQ, 0.8824, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3703, 5fgfC, 0.8824, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3704, 5fgeQ, 0.8824, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3705, 5fgeC, 0.8824, 2.08, 0.305, 238, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3706, 5fgdQ, 0.8824, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3707, 5dkjQ, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3708, 5dkjC, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3709, 5dkiQ, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3710, 5dkiC, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3711, 5bxnC, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3712, 4y81Q, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3713, 4qwuQ, 0.8824, 1.78, 0.330, 224, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3714, 4qvyQ, 0.8824, 1.78, 0.330, 224, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3715, 4qvyC, 0.8824, 1.78, 0.330, 224, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3716, 4qluQ, 0.8824, 1.78, 0.330, 224, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3717, 4qluC, 0.8824, 1.78, 0.330, 224, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3718, 4j70O, 0.8824, 1.78, 0.330, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3719, 4eu2D, 0.8824, 1.78, 0.330, 224, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3720, 2ku2B, 0.8824, 1.78, 0.330, 224, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3721, 5vfsDA, 0.8823, 1.82, 0.344, 237, 221, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3722, 5bxnQ, 0.8823, 2.13, 0.238, 240, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3723, 5bxlQ, 0.8823, 2.15, 0.238, 240, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3724, 5bxlC, 0.8823, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3725, 4ya1Q, 0.8823, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3726, 4ya1C, 0.8823, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3727, 4qz0C, 0.8823, 2.08, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3728, 4qw0Q, 0.8823, 2.08, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3729, 4qw0C, 0.8823, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3730, 4qvqQ, 0.8823, 2.07, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3731, 4qvqC, 0.8823, 2.08, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3732, 4fzcQ, 0.8823, 2.08, 0.305, 240, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3733, 4fzcC, 0.8823, 2.06, 0.305, 240, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3734, 3mg6Q, 0.8823, 2.07, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3735, 2ku1B, 0.8823, 2.07, 0.305, 240, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3736, 5m32U, 0.8822, 2.07, 0.305, 240, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3737, 5fghC, 0.8822, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3738, 5a5bC, 0.8822, 2.06, 0.305, 240, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3739, 4ya4Q, 0.8822, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3740, 4ya4C, 0.8822, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3741, 4ya0C, 0.8822, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3742, 4y8tQ, 0.8822, 1.85, 0.326, 237, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3743, 4y8tC, 0.8822, 1.84, 0.324, 228, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3744, 4y8mC, 0.8822, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3745, 4y6zC, 0.8822, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3746, 4qz0Q, 0.8822, 2.06, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3747, 4qwsQ, 0.8822, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3748, 4qwsC, 0.8822, 2.06, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3749, 4qvwQ, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3750, 4qvwC, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3751, 4quxQ, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT
3752, 4quxC, 0.8822, 2.08, 0.305, 240, 223, YCP BETA5-A49T-MUTANT
3753, 4cr3C, 0.8822, 2.08, 0.305, 240, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3754, 3mg7C, 0.8822, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3755, 2f16C, 0.8822, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3756, 1rypD, 0.8822, 2.08, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3757, 5vfoG, 0.8821, 1.85, 0.326, 237, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3758, 5mpcP, 0.8821, 2.11, 0.248, 241, 226, 
3759, 5fghQ, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3760, 5cz6Q, 0.8821, 1.92, 0.305, 245, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3761, 4ya3C, 0.8821, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3762, 4ya0Q, 0.8821, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3763, 4y8uQ, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3764, 4y8uC, 0.8821, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3765, 4y8mQ, 0.8821, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3766, 4y6zQ, 0.8821, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3767, 4qvnC, 0.8821, 2.08, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3768, 4qbyQ, 0.8821, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3769, 4qbyC, 0.8821, 2.08, 0.305, 240, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3770, 4hnpQ, 0.8821, 2.08, 0.305, 240, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3771, 2ku2C, 0.8821, 2.07, 0.305, 240, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3772, 2ku2A, 0.8821, 2.07, 0.305, 240, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3773, 2ku1A, 0.8821, 2.07, 0.305, 240, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3774, 2f16Q, 0.8821, 2.07, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3775, 1yarF, 0.8821, 1.92, 0.305, 245, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3776, 5mpbC, 0.8820, 2.09, 0.305, 241, 223, 
3777, 5cz6C, 0.8820, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3778, 5cz4Q, 0.8820, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3779, 5cz4C, 0.8820, 2.11, 0.238, 239, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3780, 5a5bG, 0.8820, 1.99, 0.274, 250, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3781, 4ya3Q, 0.8820, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3782, 4y8kC, 0.8820, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3783, 4qvnQ, 0.8820, 2.08, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3784, 4cr4G, 0.8820, 2.08, 0.305, 240, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3785, 4cr3G, 0.8820, 2.08, 0.305, 240, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3786, 3sdkQ, 0.8820, 2.08, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3787, 5cz7Q, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3788, 4ya5C, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3789, 4y8kQ, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3790, 4y6vQ, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3791, 4y6vC, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3792, 4y69Q, 0.8819, 2.08, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3793, 4y69C, 0.8819, 1.86, 0.326, 237, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3794, 4qvmQ, 0.8819, 1.82, 0.326, 237, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3795, 4qvmC, 0.8819, 1.81, 0.326, 237, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3796, 5cz7C, 0.8818, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3797, 4ya5Q, 0.8818, 1.61, 0.339, 221, 218, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3798, 4y8nQ, 0.8818, 1.91, 0.305, 244, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3799, 4y8nC, 0.8818, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3800, 4r02Q, 0.8818, 2.08, 0.305, 240, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3801, 4qz1Q, 0.8818, 2.08, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3802, 4fzgC, 0.8818, 2.43, 0.289, 245, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3803, 5vfog, 0.8817, 2.08, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3804, 4rurQ, 0.8817, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3805, 4rurC, 0.8817, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3806, 4qz1C, 0.8817, 2.42, 0.293, 245, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3807, 4qwgC, 0.8817, 2.43, 0.289, 245, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3808, 4fzgQ, 0.8817, 2.08, 0.305, 241, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3809, 3oevQ, 0.8817, 2.08, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3810, 1rypR, 0.8817, 2.08, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3811, 5vfrG, 0.8816, 2.08, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3812, 5le5C, 0.8816, 2.07, 0.305, 240, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3813, 5bouQ, 0.8816, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3814, 5bouC, 0.8816, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3815, 4qwgQ, 0.8816, 2.08, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3816, 3mg8Q, 0.8816, 2.08, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3817, 2gplQ, 0.8816, 2.08, 0.305, 240, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3818, 2gplC, 0.8816, 2.08, 0.305, 240, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3819, 4y6aQ, 0.8815, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3820, 4y6aC, 0.8815, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3821, 4r17Q, 0.8815, 2.08, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3822, 4r17C, 0.8815, 2.07, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3823, 4qw3Q, 0.8815, 2.09, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3824, 4qw3C, 0.8815, 2.07, 0.305, 241, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3825, 5vfsA, 0.8814, 2.13, 0.238, 240, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3826, 1yarD, 0.8814, 2.08, 0.305, 240, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3827, 5vfsAA, 0.8813, 2.08, 0.305, 240, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3828, 5laiQ, 0.8813, 2.09, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3829, 5laiC, 0.8813, 2.09, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3830, 5l5wQ, 0.8812, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3831, 5l5wC, 0.8812, 2.09, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3832, 4hrdQ, 0.8812, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3833, 4hrcQ, 0.8812, 2.13, 0.238, 239, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3834, 4cr4C, 0.8812, 1.93, 0.317, 236, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3835, 3jcpKA, 0.8811, 2.08, 0.305, 240, 223, 
3836, 3jcpK, 0.8811, 2.08, 0.305, 240, 223, 
3837, 1yarB, 0.8811, 2.09, 0.305, 240, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3838, 6epdC, 0.8810, 2.09, 0.305, 241, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3839, 5vfsB, 0.8810, 2.07, 0.305, 241, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3840, 5mpcO, 0.8810, 2.07, 0.305, 241, 223, 
3841, 3mg8F, 0.8809, 2.08, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3842, 5l5zQ, 0.8808, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3843, 5l5zC, 0.8808, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3844, 5l5xQ, 0.8808, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3845, 5l5xC, 0.8808, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3846, 3mg7F, 0.8808, 2.09, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3847, 5vfqA, 0.8807, 2.15, 0.238, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3848, 3oeuQ, 0.8807, 1.71, 0.295, 232, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3849, 5vfrK, 0.8806, 1.62, 0.339, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3850, 5l64Q, 0.8806, 1.71, 0.295, 232, 220, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3851, 5l64C, 0.8806, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3852, 5l60Q, 0.8806, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3853, 5l60C, 0.8806, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3854, 5l5yQ, 0.8806, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3855, 5l5yC, 0.8806, 2.08, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3856, 5vfqAA, 0.8805, 2.09, 0.305, 241, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3857, 3oeuF, 0.8805, 2.06, 0.308, 245, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3858, 1yarC, 0.8805, 1.78, 0.285, 250, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3859, 5vfoK, 0.8804, 1.78, 0.285, 250, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3860, 5lttC, 0.8804, 1.78, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3861, 5lf7C, 0.8804, 1.63, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3862, 5lf4C, 0.8804, 2.28, 0.339, 249, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3863, 5lf3C, 0.8804, 1.72, 0.295, 232, 220, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3864, 5l62Q, 0.8804, 2.25, 0.333, 250, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3865, 5l62C, 0.8804, 2.17, 0.215, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3866, 5l61Q, 0.8804, 2.21, 0.288, 237, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3867, 5l61C, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3868, 1jd2C, 0.8804, 2.09, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3869, 5vfpA, 0.8803, 2.09, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3870, 5vfok, 0.8803, 2.09, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3871, 5lttQ, 0.8803, 2.24, 0.287, 237, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3872, 5l63Q, 0.8803, 2.13, 0.238, 239, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3873, 5l63C, 0.8803, 1.73, 0.295, 232, 220, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3874, 5l5uQ, 0.8803, 2.11, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3875, 5l5uC, 0.8803, 1.85, 0.320, 228, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3876, 5l5fQ, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3877, 5l5fC, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3878, 5l5eQ, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3879, 5l5eC, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3880, 5l5aQ, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3881, 5l5aC, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3882, 3wxrD, 0.8803, 1.73, 0.295, 232, 220, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3883, 3jcoKA, 0.8803, 2.23, 0.287, 237, 223, 
3884, 3jcoK, 0.8803, 1.63, 0.339, 221, 218, 
3885, 1jd2X, 0.8803, 1.77, 0.317, 228, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3886, 5wviX, 0.8802, 2.09, 0.305, 240, 223, 
3887, 5lf1C, 0.8802, 1.94, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3888, 5leyC, 0.8802, 1.95, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3889, 5l65Q, 0.8802, 1.95, 0.317, 236, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3890, 5l65C, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3891, 5l5rQ, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3892, 5l5rC, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3893, 5l5bQ, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3894, 5l5bC, 0.8802, 2.08, 0.305, 241, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3895, 6epeG, 0.8801, 2.14, 0.238, 239, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3896, 5mpcA, 0.8801, 2.22, 0.333, 250, 225, 
3897, 5l5sQ, 0.8801, 1.88, 0.324, 228, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3898, 5l5sC, 0.8801, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3899, 4v7oQ, 0.8801, 2.09, 0.305, 240, 223, 
3900, 5vfrh, 0.8800, 2.09, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3901, 5vfoh, 0.8800, 2.09, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3902, 5m32O, 0.8800, 2.09, 0.305, 240, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3903, 5m32A, 0.8800, 2.09, 0.305, 240, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3904, 5l6bQ, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3905, 5l6bC, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3906, 5l66Q, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3907, 4v7oYA, 0.8800, 2.09, 0.305, 240, 223, 
3908, 3oevF, 0.8800, 2.09, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3909, 1yauE, 0.8800, 2.09, 0.305, 241, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3910, 5vfuS, 0.8799, 1.95, 0.288, 250, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3911, 5vftH, 0.8799, 1.95, 0.288, 250, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3912, 5vfpZ, 0.8799, 1.95, 0.288, 250, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3913, 5vfpE, 0.8799, 2.08, 0.305, 241, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3914, 5l66C, 0.8799, 2.41, 0.288, 245, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3915, 5l5vQ, 0.8799, 1.96, 0.317, 236, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3916, 5l5vC, 0.8799, 1.95, 0.317, 236, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3917, 5l5qQ, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3918, 5l5qC, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3919, 5l5iQ, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3920, 5l5iC, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3921, 5l5hQ, 0.8799, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3922, 5l5hC, 0.8799, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3923, 4v7oKA, 0.8799, 2.12, 0.263, 245, 224, 
3924, 4v7oC, 0.8799, 2.23, 0.203, 241, 227, 
3925, 5l67Q, 0.8798, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3926, 5l67C, 0.8798, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3927, 3mg6F, 0.8798, 1.57, 0.300, 232, 217, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3928, 5l6cQ, 0.8797, 1.74, 0.295, 232, 220, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3929, 5l6cC, 0.8797, 1.74, 0.295, 232, 220, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3930, 5l6aQ, 0.8797, 1.75, 0.291, 230, 220, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3931, 5l6aC, 0.8797, 1.75, 0.291, 230, 220, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3932, 5l5tQ, 0.8797, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3933, 5l5tC, 0.8797, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3934, 5l5pQ, 0.8797, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3935, 5l5pC, 0.8797, 1.57, 0.300, 232, 217, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3936, 5l5dQ, 0.8797, 2.25, 0.287, 237, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3937, 5l5dC, 0.8797, 1.69, 0.333, 222, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3938, 1yarA, 0.8797, 1.90, 0.294, 232, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3939, 5vfpY, 0.8796, 2.93, 0.156, 215, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3940, 5l5oQ, 0.8796, 1.90, 0.294, 232, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3941, 5l5oC, 0.8796, 1.75, 0.295, 232, 220, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3942, 5l5jQ, 0.8796, 2.14, 0.265, 240, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3943, 5l5jC, 0.8796, 1.78, 0.317, 228, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3944, 5vfqE, 0.8795, 2.09, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3945, 5m2bQ, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3946, 5m2bC, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3947, 5l68Q, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3948, 5l68C, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3949, 3mg7Q, 0.8795, 2.10, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3950, 3oevT, 0.8794, 2.10, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3951, 5mp9b, 0.8793, 2.09, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3952, 3unbQ, 0.8793, 2.09, 0.305, 240, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3953, 5vfuR, 0.8792, 1.57, 0.300, 232, 217, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3954, 4r3oR, 0.8792, 2.28, 0.288, 244, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
3955, 3unbC, 0.8792, 1.57, 0.300, 232, 217, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3956, 5vftG, 0.8791, 2.10, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3957, 5vfqZ, 0.8791, 2.10, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3958, 5lf6C, 0.8791, 2.26, 0.291, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3959, 5lexC, 0.8791, 2.10, 0.305, 240, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3960, 5l69Q, 0.8791, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3961, 5l69C, 0.8791, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3962, 4r3oD, 0.8791, 2.09, 0.305, 240, 223, HUMAN CONSTITUTIVE 20S PROTEASOME
3963, 3unbe, 0.8791, 2.10, 0.305, 240, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3964, 3mg8T, 0.8791, 2.10, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3965, 1fntD, 0.8791, 2.10, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3966, 5wvkX, 0.8790, 2.10, 0.305, 240, 223, 
3967, 3oeuT, 0.8790, 2.10, 0.305, 240, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3968, 1fntR, 0.8790, 2.10, 0.305, 240, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3969, 5vfrg, 0.8789, 1.64, 0.339, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3970, 3uneQ, 0.8789, 2.15, 0.238, 240, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
3971, 5vfpCA, 0.8788, 2.10, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3972, 5mpbG, 0.8788, 2.10, 0.305, 240, 223, 
3973, 4cr4A, 0.8788, 2.10, 0.305, 240, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3974, 3wxrU, 0.8788, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3975, 3unfQ, 0.8788, 1.14, 0.528, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3976, 3unfC, 0.8788, 1.87, 0.320, 228, 222, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3977, 5vfqDA, 0.8787, 2.10, 0.305, 240, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3978, 5mp9B, 0.8787, 2.10, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3979, 3unhQ, 0.8787, 2.10, 0.305, 240, 223, MOUSE 20S IMMUNOPROTEASOME
3980, 3unhC, 0.8787, 2.10, 0.305, 240, 223, MOUSE 20S IMMUNOPROTEASOME
3981, 5lf0C, 0.8786, 2.11, 0.305, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3982, 6epeA, 0.8785, 2.25, 0.288, 237, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3983, 5lezC, 0.8785, 1.79, 0.285, 250, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3984, 3mg6T, 0.8785, 2.00, 0.324, 239, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3985, 3mg7T, 0.8784, 2.19, 0.242, 240, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3986, 5mpbU, 0.8783, 2.00, 0.324, 243, 222, 
3987, 3wxrG, 0.8783, 2.00, 0.324, 239, 222, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3988, 5vfrk, 0.8782, 2.19, 0.242, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3989, 3unbs, 0.8782, 2.16, 0.238, 240, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3990, 5wvkY, 0.8781, 1.96, 0.317, 236, 221, 
3991, 5gjrV, 0.8780, 1.96, 0.317, 236, 221, 
3992, 5gjrJA, 0.8780, 2.10, 0.305, 240, 223, 
3993, 4r67t, 0.8775, 2.11, 0.305, 240, 223, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3994, 4r67f, 0.8775, 2.00, 0.324, 243, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3995, 4r67D, 0.8775, 2.00, 0.324, 239, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3996, 5vftK, 0.8774, 2.29, 0.287, 237, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3997, 6epeB, 0.8773, 2.11, 0.304, 239, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3998, 5t0cZA, 0.8773, 2.04, 0.304, 244, 224, 
3999, 5t0cT, 0.8773, 2.28, 0.287, 237, 223, 
4000, 4r67R, 0.8772, 2.11, 0.304, 239, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4001, 3jcpMA, 0.8772, 2.16, 0.238, 240, 227, 
4002, 3jcpM, 0.8772, 2.00, 0.324, 239, 222, 
4003, 5mpcB, 0.8771, 1.90, 0.324, 228, 222, 
4004, 6avoI, 0.8769, 2.44, 0.294, 243, 228, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4005, 5gjqE, 0.8768, 2.27, 0.227, 243, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4006, 5mpbA, 0.8767, 2.09, 0.297, 237, 222, 
4007, 6epfB, 0.8766, 2.01, 0.324, 238, 222, GROUND STATE 26S PROTEASOME (GS1)
4008, 5vfuV, 0.8766, 2.01, 0.324, 238, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4009, 6avoN, 0.8764, 1.90, 0.324, 228, 222, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4010, 3uneC, 0.8764, 1.81, 0.285, 250, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
4011, 5t0gG, 0.8763, 2.01, 0.324, 238, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4012, 5vfuGA, 0.8762, 2.01, 0.324, 238, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4013, 5vfth, 0.8762, 1.97, 0.317, 236, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4014, 5fmgT, 0.8762, 2.19, 0.241, 246, 228, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4015, 5fmgF, 0.8762, 1.97, 0.317, 236, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4016, 3unee, 0.8762, 2.28, 0.287, 237, 223, MOUSE CONSTITUTIVE 20S PROTEASOME
4017, 5vftk, 0.8761, 2.27, 0.284, 237, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4018, 3jcoMA, 0.8761, 2.32, 0.295, 243, 227, 
4019, 3jcoM, 0.8761, 2.09, 0.297, 237, 222, 
4020, 1yarE, 0.8761, 1.91, 0.324, 228, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4021, 5lexG, 0.8760, 2.02, 0.324, 239, 222, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4022, 3sdkF, 0.8759, 2.08, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4023, 5t0gK, 0.8758, 2.02, 0.324, 243, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4024, 5lf3G, 0.8758, 2.03, 0.324, 243, 222, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4025, 5lf0G, 0.8758, 2.03, 0.320, 243, 222, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4026, 5leyG, 0.8758, 2.03, 0.320, 243, 222, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4027, 5mpab, 0.8757, 2.03, 0.320, 243, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4028, 5ln3G, 0.8757, 1.91, 0.324, 228, 222, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4029, 6epcA, 0.8756, 2.18, 0.290, 234, 224, GROUND STATE 26S PROTEASOME (GS2)
4030, 5t0jG, 0.8756, 1.94, 0.294, 232, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4031, 5vfuFA, 0.8755, 1.94, 0.294, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4032, 5vftg, 0.8755, 2.03, 0.320, 243, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4033, 5lf7G, 0.8755, 2.11, 0.305, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4034, 5vy4Y, 0.8754, 2.11, 0.305, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4035, 5vy4W, 0.8754, 2.11, 0.305, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4036, 5vy4U, 0.8754, 2.05, 0.279, 250, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4037, 5vy4S, 0.8754, 2.01, 0.320, 232, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4038, 5vy4Q, 0.8754, 2.06, 0.324, 243, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4039, 5vy4O, 0.8754, 2.24, 0.215, 241, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4040, 5vy4M, 0.8754, 1.98, 0.294, 234, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4041, 5vy4K, 0.8754, 1.92, 0.324, 228, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4042, 5vy4I, 0.8754, 2.02, 0.320, 232, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4043, 5vy4G, 0.8754, 2.02, 0.324, 239, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4044, 5vy4E, 0.8754, 2.22, 0.238, 240, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4045, 5vy4C, 0.8754, 1.93, 0.294, 232, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4046, 5vy4AA, 0.8754, 1.93, 0.294, 232, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4047, 5vy4A, 0.8754, 1.45, 0.360, 219, 214, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4048, 5vy40, 0.8754, 1.45, 0.360, 219, 214, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4049, 6bdfY, 0.8753, 2.02, 0.324, 239, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4050, 6bdfW, 0.8753, 1.90, 0.324, 228, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4051, 6bdfU, 0.8753, 2.11, 0.305, 241, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4052, 6bdfS, 0.8753, 2.11, 0.305, 241, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4053, 6bdfQ, 0.8753, 2.11, 0.305, 241, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4054, 6bdfO, 0.8753, 1.70, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4055, 6bdfM, 0.8753, 1.92, 0.249, 241, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4056, 6bdfK, 0.8753, 2.24, 0.293, 236, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4057, 6bdfI, 0.8753, 1.93, 0.324, 228, 222, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4058, 6bdfG, 0.8753, 1.92, 0.249, 241, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4059, 6bdfE, 0.8753, 1.92, 0.249, 241, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4060, 6bdfC, 0.8753, 1.93, 0.249, 241, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4061, 6bdfA, 0.8753, 1.84, 0.285, 250, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4062, 6bdf0, 0.8753, 2.30, 0.265, 242, 226, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4063, 5mpcG, 0.8753, 2.20, 0.238, 246, 227, 
4064, 3unes, 0.8753, 2.17, 0.241, 240, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
4065, 5wviD, 0.8751, 2.22, 0.238, 240, 227, 
4066, 3sdkT, 0.8751, 2.22, 0.238, 240, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4067, 5wvkQ, 0.8750, 1.93, 0.249, 241, 221, 
4068, 5m32P, 0.8749, 1.70, 0.339, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4069, 5lf1Q, 0.8749, 1.70, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4070, 5lf1G, 0.8749, 1.70, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4071, 5lezG, 0.8749, 1.70, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4072, 5le5G, 0.8748, 1.70, 0.339, 221, 218, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4073, 5lf4G, 0.8746, 1.70, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4074, 5vy3Y, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4075, 5vy3W, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4076, 5vy3U, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4077, 5vy3S, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4078, 5vy3Q, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4079, 5vy3O, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4080, 5vy3M, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4081, 5vy3K, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4082, 5vy3I, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4083, 5vy3G, 0.8745, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4084, 5vy3E, 0.8745, 1.71, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4085, 5vy3C, 0.8745, 1.71, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4086, 5vy3A, 0.8745, 1.71, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4087, 5vy30, 0.8745, 1.71, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4088, 5lf4Q, 0.8745, 1.71, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4089, 1pmaN, 0.8745, 1.71, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4090, 6epeC, 0.8744, 1.71, 0.339, 221, 218, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4091, 3wxrR, 0.8744, 1.71, 0.339, 221, 218, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4092, 5lf6G, 0.8743, 1.71, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4093, 5vfuJA, 0.8742, 1.71, 0.339, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4094, 1pmaO, 0.8742, 1.71, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4095, 5wviY, 0.8741, 1.71, 0.339, 221, 218, 
4096, 5vfsC, 0.8741, 1.71, 0.339, 221, 218, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4097, 5mp9d, 0.8741, 1.71, 0.339, 221, 218, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4098, 5lf0Q, 0.8741, 2.45, 0.289, 243, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4099, 1pmaH, 0.8740, 2.03, 0.324, 239, 222, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4100, 1pmaD, 0.8740, 2.18, 0.216, 243, 227, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4101, 5leyQ, 0.8739, 2.15, 0.284, 250, 222, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4102, 1pmaL, 0.8739, 2.27, 0.293, 236, 222, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4103, 1pmaJ, 0.8739, 2.10, 0.308, 244, 224, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4104, 5t0gH, 0.8738, 2.22, 0.333, 244, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4105, 5lf6Q, 0.8738, 2.02, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4106, 1pmaM, 0.8738, 1.94, 0.249, 241, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4107, 1pmaG, 0.8738, 1.93, 0.249, 241, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4108, 1pmaE, 0.8738, 1.93, 0.249, 241, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4109, 1pmaC, 0.8738, 1.94, 0.249, 241, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4110, 1pmaK, 0.8737, 1.72, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4111, 5m32G, 0.8736, 1.72, 0.339, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4112, 5lf7Q, 0.8736, 1.72, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4113, 5lf3Q, 0.8736, 1.72, 0.339, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4114, 1pmaI, 0.8736, 1.72, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4115, 1pmaF, 0.8736, 1.72, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4116, 1pmaA, 0.8735, 1.72, 0.339, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4117, 5l4gD, 0.8733, 1.72, 0.339, 221, 218, 
4118, 5m32C, 0.8732, 1.72, 0.339, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4119, 5l4gR, 0.8731, 1.72, 0.339, 221, 218, 
4120, 5wviF, 0.8730, 1.72, 0.339, 221, 218, 
4121, 5dsvC, 0.8727, 1.72, 0.339, 221, 218, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4122, 5vfsBA, 0.8726, 1.72, 0.339, 221, 218, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4123, 5wviH, 0.8722, 1.72, 0.339, 221, 218, 
4124, 5mpad, 0.8720, 2.03, 0.321, 238, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4125, 5m32Q, 0.8720, 1.71, 0.330, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4126, 5t0iM, 0.8719, 2.28, 0.338, 249, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4127, 4cr2B, 0.8718, 2.20, 0.305, 241, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4128, 3h4pA, 0.8717, 1.94, 0.249, 241, 221, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4129, 5wvkW, 0.8716, 1.94, 0.324, 228, 222, 
4130, 3h4pJ, 0.8714, 1.72, 0.335, 221, 218, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4131, 5mpcE, 0.8713, 2.37, 0.227, 243, 229, 
4132, 3h4pE, 0.8713, 2.24, 0.333, 250, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4133, 4cr4B, 0.8712, 2.25, 0.320, 239, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4134, 5t0iH, 0.8711, 2.16, 0.305, 240, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4135, 5mpbO, 0.8711, 2.03, 0.321, 238, 221, 
4136, 3h4pC, 0.8711, 1.73, 0.335, 221, 218, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4137, 5t0jI, 0.8709, 1.72, 0.330, 221, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4138, 5a5bA, 0.8709, 2.03, 0.321, 239, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4139, 4cr3A, 0.8709, 1.72, 0.330, 221, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4140, 5gjqk, 0.8708, 1.72, 0.330, 221, 218, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4141, 3h4pN, 0.8708, 1.82, 0.295, 233, 220, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4142, 3h4pD, 0.8706, 2.03, 0.321, 238, 221, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4143, 3h4pI, 0.8705, 1.72, 0.330, 221, 218, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4144, 5wviBA, 0.8704, 1.73, 0.335, 221, 218, 
4145, 3h4pL, 0.8703, 1.73, 0.330, 221, 218, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4146, 3h4pH, 0.8703, 1.73, 0.330, 221, 218, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4147, 1iruR, 0.8703, 1.73, 0.330, 221, 218, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4148, 1iruD, 0.8703, 2.05, 0.247, 233, 223, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4149, 5vfoi, 0.8702, 2.03, 0.321, 238, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4150, 5vfuT, 0.8701, 2.04, 0.321, 238, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4151, 5vftI, 0.8701, 1.73, 0.330, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4152, 5vfpAA, 0.8699, 1.73, 0.330, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4153, 5t0iG, 0.8697, 1.73, 0.330, 221, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4154, 3h4pF, 0.8696, 2.10, 0.320, 243, 222, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4155, 5mpbE, 0.8694, 2.11, 0.315, 234, 222, 
4156, 3h4pM, 0.8694, 2.08, 0.320, 243, 222, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4157, 5mpaB, 0.8692, 2.48, 0.293, 245, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4158, 5ln3E, 0.8692, 1.76, 0.273, 234, 216, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4159, 5vfqBA, 0.8691, 2.25, 0.333, 250, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4160, 5vfri, 0.8690, 2.01, 0.336, 243, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4161, 5vfrJ, 0.8689, 2.19, 0.305, 240, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4162, 3h4pB, 0.8688, 2.11, 0.320, 235, 222, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4163, 5wvkP, 0.8686, 2.30, 0.267, 240, 225, 
4164, 5mp9D, 0.8686, 2.05, 0.284, 250, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4165, 3h4pG, 0.8684, 1.80, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4166, 5t0hK, 0.8681, 1.87, 0.285, 250, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4167, 5t0jK, 0.8680, 1.81, 0.338, 232, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4168, 6epfA, 0.8679, 1.95, 0.347, 242, 222, GROUND STATE 26S PROTEASOME (GS1)
4169, 3h4pK, 0.8679, 1.81, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4170, 5vfpD, 0.8678, 2.09, 0.279, 250, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4171, 5vfqD, 0.8673, 1.86, 0.295, 233, 220, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4172, 5mpbS, 0.8672, 2.33, 0.215, 241, 228, 
4173, 5vfoJ, 0.8669, 1.81, 0.333, 232, 219, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4174, 5t0iI, 0.8665, 2.31, 0.329, 250, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4175, 5mpcR, 0.8661, 2.26, 0.207, 243, 227, 
4176, 5mpcS, 0.8659, 2.26, 0.207, 243, 227, 
4177, 5a5bB, 0.8658, 2.14, 0.320, 243, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4178, 4cr3B, 0.8658, 1.82, 0.338, 232, 219, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4179, 5a5bE, 0.8657, 1.82, 0.338, 232, 219, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4180, 4cr3E, 0.8657, 1.82, 0.338, 232, 219, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4181, 5wviDA, 0.8655, 2.04, 0.341, 243, 223, 
4182, 5mpbB, 0.8655, 1.82, 0.338, 232, 219, 
4183, 5wviNA, 0.8654, 1.82, 0.338, 232, 219, 
4184, 5wviCA, 0.8654, 2.13, 0.320, 243, 222, 
4185, 5wviOA, 0.8653, 2.13, 0.320, 243, 222, 
4186, 6epfC, 0.8649, 2.23, 0.333, 250, 225, GROUND STATE 26S PROTEASOME (GS1)
4187, 5mpaD, 0.8647, 2.26, 0.333, 250, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4188, 5lexU, 0.8647, 2.26, 0.333, 250, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4189, 6epdB, 0.8644, 2.22, 0.333, 250, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4190, 5vfuHA, 0.8644, 2.27, 0.242, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4191, 5vfti, 0.8644, 1.84, 0.338, 232, 219, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4192, 5lf0U, 0.8644, 2.12, 0.345, 242, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4193, 5lf7U, 0.8643, 1.84, 0.338, 232, 219, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4194, 5wvkR, 0.8641, 1.93, 0.285, 250, 221, 
4195, 5lf3U, 0.8641, 1.99, 0.324, 232, 222, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4196, 5a0qS, 0.8640, 2.23, 0.333, 250, 225, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4197, 5a0qE, 0.8640, 2.23, 0.333, 250, 225, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4198, 5t0gI, 0.8639, 2.06, 0.306, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4199, 5leyU, 0.8639, 1.83, 0.333, 232, 219, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4200, 5lezU, 0.8637, 1.91, 0.285, 250, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4201, 5lf1U, 0.8634, 2.22, 0.305, 240, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4202, 5lf6U, 0.8630, 1.85, 0.338, 232, 219, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4203, 5lf4U, 0.8628, 1.99, 0.324, 228, 222, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4204, 5t0hG, 0.8625, 2.03, 0.320, 228, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4205, 5mpbP, 0.8624, 2.25, 0.243, 246, 226, 
4206, 5t0iK, 0.8618, 1.85, 0.338, 232, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4207, 5vfsD, 0.8617, 1.15, 0.528, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4208, 5t0cV, 0.8609, 2.06, 0.311, 239, 222, 
4209, 5t0cBB, 0.8609, 1.90, 0.324, 228, 222, 
4210, 5t0hI, 0.8602, 2.26, 0.320, 239, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4211, 5vfsCA, 0.8590, 2.16, 0.341, 242, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4212, 5ln3B, 0.8587, 2.26, 0.320, 239, 225, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4213, 5vfuU, 0.8585, 2.35, 0.332, 250, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4214, 5vftJ, 0.8585, 2.36, 0.310, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4215, 5a5bD, 0.8582, 2.04, 0.342, 242, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4216, 4cr3D, 0.8582, 2.01, 0.290, 250, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4217, 4cr2D, 0.8581, 2.01, 0.290, 250, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4218, 5t0hH, 0.8575, 2.23, 0.345, 243, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4219, 6epcC, 0.8571, 2.23, 0.345, 243, 223, GROUND STATE 26S PROTEASOME (GS2)
4220, 5le5U, 0.8571, 2.15, 0.284, 250, 222, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4221, 5lexQ, 0.8564, 2.02, 0.285, 250, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4222, 5ln3A, 0.8563, 2.41, 0.310, 245, 226, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4223, 5lezQ, 0.8563, 2.39, 0.310, 245, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4224, 5le5Q, 0.8561, 2.15, 0.284, 250, 222, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4225, 6epdG, 0.8554, 2.52, 0.336, 249, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4226, 5t0gJ, 0.8544, 2.28, 0.305, 240, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4227, 4cr4D, 0.8543, 1.94, 0.257, 235, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4228, 5vfoj, 0.8527, 2.22, 0.276, 234, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4229, 6epdA, 0.8526, 2.34, 0.333, 250, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4230, 5mpbD, 0.8522, 2.34, 0.333, 250, 225, 
4231, 5fmgS, 0.8516, 1.94, 0.257, 235, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4232, 5fmgE, 0.8516, 1.94, 0.257, 235, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4233, 6epcB, 0.8506, 2.32, 0.305, 241, 223, GROUND STATE 26S PROTEASOME (GS2)
4234, 5vfuIA, 0.8504, 1.94, 0.257, 235, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4235, 5vftj, 0.8504, 1.49, 0.325, 215, 212, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4236, 5vfqCA, 0.8504, 1.49, 0.325, 215, 212, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4237, 5m32B, 0.8502, 2.32, 0.333, 250, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4238, 5vfpBA, 0.8500, 1.94, 0.257, 235, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4239, 5vfrj, 0.8491, 1.95, 0.257, 235, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4240, 6epfD, 0.8482, 1.95, 0.257, 235, 218, GROUND STATE 26S PROTEASOME (GS1)
4241, 5ln3C, 0.8472, 1.95, 0.257, 235, 218, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4242, 5mpcD, 0.8469, 1.96, 0.257, 235, 218, 
4243, 5t0jJ, 0.8463, 2.37, 0.242, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4244, 6epcE, 0.8459, 2.03, 0.285, 250, 221, GROUND STATE 26S PROTEASOME (GS2)
4245, 6epfE, 0.8453, 2.19, 0.323, 228, 223, GROUND STATE 26S PROTEASOME (GS1)
4246, 6epeE, 0.8453, 1.84, 0.324, 228, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4247, 5fmgO, 0.8450, 2.21, 0.320, 239, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4248, 5fmgA, 0.8450, 2.21, 0.320, 239, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4249, 5t0hJ, 0.8435, 2.21, 0.320, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4250, 4g4sD, 0.8433, 2.46, 0.332, 250, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4251, 5mpbR, 0.8424, 2.25, 0.320, 239, 222, 
4252, 5wviI, 0.8417, 2.18, 0.294, 234, 221, 
4253, 5fmgQ, 0.8411, 2.24, 0.320, 239, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4254, 5fmgC, 0.8411, 2.24, 0.320, 239, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4255, 6epdE, 0.8373, 2.26, 0.306, 242, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4256, 5a0qP, 0.8373, 2.26, 0.306, 242, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4257, 5a0qB, 0.8373, 2.29, 0.306, 242, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4258, 6epeD, 0.8358, 2.05, 0.291, 232, 220, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4259, 5wviAA, 0.8357, 2.47, 0.338, 249, 225, 
4260, 4v7oP, 0.8353, 1.82, 0.256, 232, 215, 
4261, 4v7oXA, 0.8351, 2.01, 0.324, 233, 216, 
4262, 4v7oB, 0.8351, 2.40, 0.242, 239, 227, 
4263, 4v7oJA, 0.8350, 2.01, 0.324, 234, 216, 
4264, 4v7oR, 0.8337, 2.09, 0.318, 233, 217, 
4265, 4v7oLA, 0.8337, 2.69, 0.262, 245, 225, 
4266, 4v7oD, 0.8337, 2.28, 0.315, 239, 222, 
4267, 4v7oZA, 0.8336, 2.38, 0.305, 242, 223, 
4268, 5a0qU, 0.8332, 2.34, 0.315, 239, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4269, 5a0qG, 0.8332, 2.42, 0.235, 246, 226, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4270, 5fmgU, 0.8328, 2.29, 0.300, 240, 220, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4271, 5fmgG, 0.8328, 1.79, 0.332, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4272, 5fmgP, 0.8309, 1.79, 0.332, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4273, 5fmgB, 0.8309, 2.39, 0.286, 234, 220, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4274, 6epcD, 0.8294, 2.34, 0.320, 239, 222, GROUND STATE 26S PROTEASOME (GS2)
4275, 5ln3D, 0.8288, 2.34, 0.320, 239, 222, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4276, 5t0jH, 0.8258, 2.38, 0.315, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4277, 5a0qT, 0.8210, 2.07, 0.333, 234, 216, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4278, 5a0qF, 0.8205, 2.36, 0.315, 239, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4279, 5t0iJ, 0.8195, 2.40, 0.315, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4280, 5a0qR, 0.8191, 2.27, 0.326, 246, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4281, 5a0qD, 0.8191, 2.43, 0.326, 261, 224, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4282, 5fmgR, 0.8145, 2.48, 0.306, 240, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4283, 5fmgD, 0.8145, 2.38, 0.321, 239, 224, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4284, 3mkaF, 0.8070, 2.40, 0.314, 233, 223, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4285, 3mi0F, 0.8057, 2.36, 0.306, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4286, 3mkaA, 0.8051, 2.27, 0.314, 233, 220, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4287, 5thoS, 0.8047, 1.81, 0.274, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4288, 5trsA, 0.8035, 1.81, 0.274, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4289, 3h6iQ, 0.8026, 2.39, 0.324, 239, 222, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4290, 5trgP, 0.8025, 1.88, 0.318, 220, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4291, 3mkaK, 0.8023, 2.59, 0.305, 240, 223, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4292, 5ts0G, 0.8021, 2.33, 0.297, 242, 219, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4293, 3mkaQ, 0.8020, 1.84, 0.338, 220, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4294, 3mkaU, 0.8016, 1.84, 0.338, 220, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4295, 5trsD, 0.8013, 2.57, 0.311, 233, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4296, 5thoG, 0.8009, 1.93, 0.295, 214, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4297, 3mkaY, 0.8008, 1.93, 0.295, 214, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4298, 5tryA, 0.8004, 2.61, 0.320, 246, 225, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4299, 5trgA, 0.8004, 2.32, 0.294, 242, 218, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4300, 5thoO, 0.8004, 1.74, 0.273, 231, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4301, 5trrA, 0.8003, 1.74, 0.273, 231, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4302, 5trsP, 0.8001, 0.60, 1.000, 234, 231, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4303, 5ts0P, 0.8000, 1.74, 0.273, 231, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4304, 2fhgW, 0.7999, 1.74, 0.273, 231, 209, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4305, 5tryS, 0.7998, 2.09, 0.297, 227, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4306, 5tryP, 0.7998, 2.09, 0.297, 227, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4307, 2fhgQ, 0.7998, 2.09, 0.297, 227, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4308, 2fhgF, 0.7998, 2.09, 0.297, 227, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4309, 2fhgU, 0.7997, 1.65, 0.273, 209, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4310, 2fhgI, 0.7997, 1.65, 0.273, 209, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4311, 2fhgD, 0.7997, 2.01, 0.203, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4312, 2fhgB, 0.7997, 2.01, 0.203, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4313, 5thoA, 0.7996, 1.90, 0.303, 212, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4314, 3h6iF, 0.7996, 1.90, 0.303, 212, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4315, 2fhgY, 0.7996, 2.63, 0.321, 246, 221, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4316, 2fhgS, 0.7996, 2.51, 0.305, 248, 220, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4317, 2fhgM, 0.7996, 2.81, 0.284, 232, 225, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4318, 2fhgA, 0.7996, 0.96, 0.554, 195, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4319, 2fhg1, 0.7996, 0.97, 0.554, 195, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4320, 2fhgO, 0.7995, 2.60, 0.314, 239, 223, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4321, 2fhgK, 0.7995, 2.03, 0.327, 214, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4322, 5trrP, 0.7994, 2.03, 0.327, 214, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4323, 3mkaD, 0.7992, 1.73, 0.320, 215, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4324, 2fhhW, 0.7992, 1.73, 0.320, 215, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4325, 2fhhD, 0.7992, 2.32, 0.152, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4326, 2fhhU, 0.7991, 2.33, 0.152, 220, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4327, 2fhhO, 0.7991, 2.42, 0.151, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4328, 2fhhM, 0.7991, 2.31, 0.152, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4329, 2fhhI, 0.7991, 2.23, 0.153, 219, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4330, 2fhhY, 0.7990, 2.23, 0.153, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4331, 2fhhS, 0.7990, 2.21, 0.154, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4332, 2fhhF, 0.7990, 2.41, 0.147, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4333, 2fhhQ, 0.7989, 2.26, 0.153, 220, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4334, 2fhhA, 0.7989, 2.44, 0.147, 222, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4335, 2fhhK, 0.7988, 2.45, 0.152, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4336, 2fhhB, 0.7988, 2.23, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4337, 2fhh1, 0.7987, 2.23, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4338, 5trgO, 0.7986, 2.44, 0.152, 224, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4339, 3mkaB, 0.7984, 2.23, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4340, 5lzpD, 0.7983, 2.23, 0.154, 218, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4341, 5ts0A, 0.7982, 2.24, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4342, 5ts0E, 0.7977, 2.22, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4343, 3mfeB, 0.7976, 2.25, 0.154, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4344, 3mka1, 0.7975, 2.26, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4345, 5trrT, 0.7974, 2.23, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4346, 5thoE, 0.7974, 2.25, 0.154, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4347, 3h6fQ, 0.7974, 2.22, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4348, 2h6jB, 0.7974, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4349, 5thoT, 0.7973, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4350, 3mkaM, 0.7973, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4351, 3mfeI, 0.7970, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4352, 3mkaI, 0.7969, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4353, 2h6jF, 0.7969, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4354, 5trgS, 0.7967, 2.23, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4355, 3h6iK, 0.7965, 2.23, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4356, 2h6jA, 0.7965, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4357, 6epdD, 0.7964, 2.23, 0.144, 220, 208, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4358, 5trgG, 0.7964, 2.23, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4359, 2h6jG, 0.7964, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4360, 2h6jE, 0.7964, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4361, 2h6jC, 0.7964, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4362, 5thoR, 0.7963, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4363, 5trrO, 0.7962, 2.27, 0.154, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4364, 5trgE, 0.7962, 2.33, 0.153, 222, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4365, 3mkaS, 0.7962, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4366, 3h6iW, 0.7962, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4367, 5ts0T, 0.7961, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4368, 5ts0R, 0.7961, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4369, 2h6jD, 0.7961, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4370, 5tryE, 0.7960, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4371, 5thoP, 0.7960, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4372, 5ts0U, 0.7959, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4373, 5tryR, 0.7959, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4374, 5trsE, 0.7959, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4375, 5trrE, 0.7958, 2.24, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4376, 5thoD, 0.7958, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4377, 3h6iA, 0.7958, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4378, 5trsT, 0.7957, 2.25, 0.144, 220, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4379, 5tryF, 0.7956, 2.26, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4380, 3mkaO, 0.7956, 2.42, 0.148, 220, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4381, 3mi0Y, 0.7955, 2.24, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4382, 3mi0K, 0.7955, 2.25, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4383, 5ts0D, 0.7954, 2.27, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4384, 5trsC, 0.7954, 2.15, 0.150, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4385, 5trgU, 0.7954, 2.35, 0.153, 219, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4386, 5thoF, 0.7954, 2.22, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4387, 5trrS, 0.7953, 2.27, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4388, 3h6fF, 0.7952, 2.24, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4389, 5trsS, 0.7951, 2.18, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4390, 5trgT, 0.7951, 2.22, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4391, 3mfeK, 0.7951, 2.35, 0.153, 224, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4392, 5ts0C, 0.7950, 2.21, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4393, 3h6fW, 0.7950, 2.30, 0.144, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4394, 5trsF, 0.7948, 2.21, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4395, 5trsR, 0.7946, 2.24, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4396, 3mkaW, 0.7946, 2.26, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4397, 5tryD, 0.7945, 2.19, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4398, 5trsO, 0.7945, 2.93, 0.324, 246, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4399, 5thoC, 0.7945, 2.19, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4400, 5a0qO, 0.7944, 2.22, 0.135, 219, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4401, 5a0qA, 0.7944, 2.19, 0.135, 219, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4402, 3h6iU, 0.7944, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4403, 5tryQ, 0.7943, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4404, 5trrC, 0.7943, 2.23, 0.145, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4405, 5ts0Q, 0.7941, 2.29, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4406, 5trsU, 0.7941, 2.31, 0.149, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4407, 5trrU, 0.7939, 2.29, 0.154, 217, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4408, 5trrD, 0.7939, 2.24, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4409, 3mi0O, 0.7939, 2.26, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4410, 3mi0I, 0.7939, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4411, 5ts0O, 0.7937, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4412, 5ts0F, 0.7936, 2.26, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4413, 5tryC, 0.7936, 2.23, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4414, 3hfaB, 0.7936, 2.25, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4415, 5trgF, 0.7934, 2.24, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4416, 3h6iI, 0.7934, 2.24, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4417, 1q5qG, 0.7934, 2.25, 0.155, 216, 207, THE RHODOCOCCUS 20S PROTEASOME
4418, 1q5qF, 0.7934, 2.23, 0.155, 216, 207, THE RHODOCOCCUS 20S PROTEASOME
4419, 1q5qE, 0.7934, 2.24, 0.155, 217, 207, THE RHODOCOCCUS 20S PROTEASOME
4420, 1q5qD, 0.7934, 2.24, 0.155, 218, 207, THE RHODOCOCCUS 20S PROTEASOME
4421, 1q5qC, 0.7934, 2.35, 0.149, 218, 208, THE RHODOCOCCUS 20S PROTEASOME
4422, 1q5qA, 0.7934, 2.23, 0.155, 216, 207, THE RHODOCOCCUS 20S PROTEASOME
4423, 5ts0S, 0.7933, 2.24, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4424, 3mi0U, 0.7933, 2.25, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4425, 1q5qB, 0.7933, 2.26, 0.155, 218, 207, THE RHODOCOCCUS 20S PROTEASOME
4426, 3h6i1, 0.7932, 2.20, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4427, 5trgD, 0.7931, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4428, 1q5rG, 0.7931, 2.26, 0.155, 218, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4429, 1q5rF, 0.7931, 2.22, 0.155, 216, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4430, 1q5rE, 0.7931, 2.26, 0.155, 218, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4431, 1q5rD, 0.7931, 2.25, 0.155, 217, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4432, 1q5rC, 0.7931, 2.19, 0.155, 216, 206, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4433, 1q5rB, 0.7931, 2.22, 0.155, 217, 206, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4434, 1q5rA, 0.7931, 2.29, 0.154, 217, 208, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4435, 5tryU, 0.7929, 2.26, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4436, 5thoU, 0.7929, 2.27, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4437, 3h6iO, 0.7927, 2.30, 0.150, 221, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4438, 3h6iM, 0.7927, 2.27, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4439, 5tryT, 0.7926, 2.26, 0.145, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4440, 5trgB, 0.7926, 2.22, 0.155, 217, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4441, 3krdY, 0.7926, 1.33, 0.269, 195, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4442, 3krdI, 0.7926, 1.33, 0.269, 195, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4443, 3krd1, 0.7924, 2.20, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4444, 5trrG, 0.7923, 2.27, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4445, 3mi0M, 0.7923, 2.21, 0.155, 217, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4446, 3mi01, 0.7923, 2.27, 0.155, 218, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4447, 3h6f1, 0.7922, 2.22, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4448, 3h6fA, 0.7921, 2.21, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4449, 5trrR, 0.7920, 2.22, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4450, 5ts0B, 0.7918, 2.31, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4451, 5trsG, 0.7917, 2.30, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4452, 3h6fK, 0.7917, 2.24, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4453, 5trrB, 0.7914, 2.21, 0.150, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4454, 5lzpH, 0.7914, 2.20, 0.155, 216, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4455, 3mi0Q, 0.7914, 2.15, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4456, 5tryG, 0.7913, 2.22, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4457, 3mi0S, 0.7913, 2.20, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4458, 5trgR, 0.7912, 2.29, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4459, 5lzp4, 0.7911, 2.29, 0.135, 219, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4460, 3hfaQ, 0.7911, 2.29, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4461, 5trgC, 0.7910, 2.29, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4462, 5lzp2, 0.7910, 2.29, 0.135, 219, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4463, 3h6iS, 0.7910, 2.29, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4464, 3h6fO, 0.7910, 2.29, 0.155, 218, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4465, 5lzpS, 0.7909, 2.32, 0.150, 216, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4466, 5lzp6, 0.7908, 2.29, 0.135, 219, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4467, 5lzp0, 0.7908, 2.21, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4468, 3krdF, 0.7908, 2.23, 0.146, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4469, 3hfaS, 0.7908, 2.26, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4470, 5trrF, 0.7907, 2.26, 0.135, 219, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4471, 3mi0A, 0.7907, 2.26, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4472, 3hfaA, 0.7907, 2.26, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4473, 5lzp8, 0.7906, 2.26, 0.135, 219, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4474, 3krdW, 0.7906, 2.26, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4475, 3hfaK, 0.7906, 2.26, 0.135, 219, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4476, 5lzpY, 0.7905, 2.23, 0.155, 216, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4477, 3hfaW, 0.7905, 2.23, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4478, 5lzpW, 0.7904, 2.22, 0.150, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4479, 3hfaM, 0.7904, 2.29, 0.150, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4480, 3h6fS, 0.7904, 2.23, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4481, 5tryO, 0.7903, 2.18, 0.156, 215, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4482, 3hfaI, 0.7903, 2.22, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4483, 5thoB, 0.7902, 2.23, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4484, 3mfeS, 0.7902, 2.23, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4485, 3hfaF, 0.7902, 2.23, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4486, 5trgQ, 0.7900, 2.31, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4487, 3hfaO, 0.7900, 2.24, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4488, 3hfa1, 0.7900, 2.21, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4489, 5trsB, 0.7899, 2.21, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4490, 5tryB, 0.7898, 2.24, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4491, 3krdO, 0.7898, 2.20, 0.156, 216, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4492, 3hfaY, 0.7898, 2.24, 0.146, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4493, 5lzpJ, 0.7897, 2.22, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4494, 3mfeA, 0.7895, 2.19, 0.156, 215, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4495, 3krdK, 0.7895, 2.23, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4496, 3mfeY, 0.7892, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4497, 3hfaU, 0.7891, 2.25, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4498, 3mi0W, 0.7890, 2.24, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4499, 6bgoM, 0.7884, 2.25, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4500, 3h6fI, 0.7884, 2.25, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4501, 6bgoJ, 0.7883, 2.20, 0.156, 214, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4502, 6bgoA, 0.7883, 2.26, 0.155, 216, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4503, 3h6iB, 0.7882, 2.25, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4504, 3krdA, 0.7879, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4505, 3krdQ, 0.7876, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4506, 3mi0D, 0.7875, 2.24, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4507, 3h6fD, 0.7874, 2.25, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4508, 3krdS, 0.7872, 2.26, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4509, 5trrQ, 0.7871, 2.24, 0.150, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4510, 5lzpM, 0.7870, 2.21, 0.156, 214, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4511, 3h6fB, 0.7869, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4512, 6bgoO, 0.7868, 2.24, 0.150, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4513, 3h6fM, 0.7868, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4514, 6bgoL, 0.7867, 2.26, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4515, 5lzpB, 0.7865, 2.24, 0.150, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4516, 3krdU, 0.7865, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4517, 5thoQ, 0.7864, 2.26, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4518, 3hfaD, 0.7864, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4519, 3h6fU, 0.7864, 2.26, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4520, 6bgoN, 0.7862, 2.21, 0.156, 214, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4521, 5trsQ, 0.7862, 2.25, 0.150, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4522, 5lzpQ, 0.7862, 2.27, 0.146, 216, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4523, 3mfeQ, 0.7860, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4524, 3mfe1, 0.7860, 2.21, 0.156, 215, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4525, 6bgoK, 0.7859, 2.20, 0.151, 215, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4526, 3krdM, 0.7859, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4527, 3mfeD, 0.7857, 2.23, 0.156, 217, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4528, 3h6iD, 0.7855, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4529, 3mi0B, 0.7848, 2.23, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4530, 3krdB, 0.7844, 2.21, 0.156, 216, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4531, 6bgoI, 0.7843, 2.22, 0.156, 215, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4532, 6bgoH, 0.7843, 2.23, 0.151, 214, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4533, 6bgoG, 0.7843, 2.23, 0.156, 214, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4534, 6bgoF, 0.7843, 2.27, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4535, 6bgoE, 0.7843, 2.21, 0.151, 214, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4536, 6bgoD, 0.7843, 2.27, 0.150, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4537, 6bgoC, 0.7843, 2.17, 0.147, 213, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4538, 6bglO, 0.7843, 2.23, 0.156, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4539, 6bglN, 0.7843, 2.44, 0.150, 216, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4540, 6bglM, 0.7843, 2.41, 0.154, 219, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4541, 6bglL, 0.7843, 2.21, 0.156, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4542, 6bglK, 0.7843, 2.44, 0.154, 219, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4543, 6bglJ, 0.7843, 2.42, 0.154, 218, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4544, 6bglI, 0.7843, 2.23, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4545, 6bglH, 0.7843, 2.24, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4546, 6bglG, 0.7843, 2.24, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4547, 6bglF, 0.7843, 2.25, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4548, 6bglE, 0.7843, 2.23, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4549, 6bglD, 0.7843, 2.25, 0.151, 215, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4550, 6bglC, 0.7843, 2.26, 0.156, 215, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4551, 6bglA, 0.7843, 2.24, 0.151, 214, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4552, 3mfeO, 0.7836, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4553, 3h6iY, 0.7832, 2.34, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4554, 3h6fY, 0.7831, 2.32, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4555, 3krdD, 0.7823, 2.34, 0.155, 218, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4556, 3mfeU, 0.7816, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4557, 3hf9s, 0.7816, 2.26, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, 3hf9B, 0.7811, 2.27, 0.156, 216, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, 3hf9f, 0.7808, 2.21, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4560, 3hf9y, 0.7805, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, 3hf9b, 0.7803, 2.66, 0.158, 219, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4562, 3hf9k, 0.7802, 2.28, 0.156, 216, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4563, 3hf9d, 0.7802, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4564, 3hf9A, 0.7799, 2.20, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, 3hf9I, 0.7797, 2.19, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4566, 3hf9K, 0.7796, 2.62, 0.153, 219, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4567, 3hf91, 0.7796, 2.27, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4568, 3hf9U, 0.7795, 2.22, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, 3hf9i, 0.7795, 2.20, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9u, 0.7793, 2.23, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf9S, 0.7792, 2.24, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3hf9a, 0.7792, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4573, 3hf9Q, 0.7787, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 3hf9O, 0.7785, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4575, 3hf9w, 0.7783, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4576, 3hf9q, 0.7781, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4577, 3hf9o, 0.7775, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4578, 3hf93, 0.7766, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4579, 3hf9Y, 0.7750, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, 3hf9D, 0.7748, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4581, 3mfeW, 0.7744, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4582, 3hf9m, 0.7692, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4583, 3hf9M, 0.7610, 2.32, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4584, 5vy3Z, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4585, 5vy3X, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4586, 5vy3V, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4587, 5vy3T, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4588, 5vy3R, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4589, 5vy3P, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4590, 5vy3N, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4591, 5vy3J, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4592, 5vy3H, 0.7444, 2.32, 0.155, 215, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4593, 5vy31, 0.7444, 2.24, 0.152, 214, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4594, 5vy3L, 0.7443, 2.23, 0.152, 213, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4595, 5vy3F, 0.7443, 2.24, 0.152, 213, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4596, 5vy3D, 0.7443, 2.30, 0.152, 213, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4597, 5vy3B, 0.7443, 2.22, 0.153, 212, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4598, 5vy4Z, 0.7441, 2.16, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4599, 5vy4X, 0.7441, 2.16, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4600, 5vy4V, 0.7441, 2.17, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4601, 5vy4T, 0.7441, 2.16, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4602, 5vy4R, 0.7441, 2.17, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4603, 5vy4P, 0.7441, 2.17, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4604, 5vy4N, 0.7441, 2.16, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4605, 5vy4L, 0.7441, 2.18, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4606, 5vy4J, 0.7441, 2.18, 0.149, 212, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4607, 5vy4H, 0.7441, 2.20, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4608, 5vy4F, 0.7441, 2.17, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4609, 5vy4D, 0.7441, 2.18, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4610, 5vy4BA, 0.7441, 2.18, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4611, 5vy4B, 0.7441, 2.18, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4612, 5vy41, 0.7441, 2.18, 0.149, 211, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4613, 6bdfZ, 0.7438, 2.18, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4614, 6bdfX, 0.7438, 2.20, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4615, 6bdfV, 0.7438, 2.18, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4616, 6bdfT, 0.7438, 2.18, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4617, 6bdfR, 0.7438, 2.19, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4618, 6bdfP, 0.7438, 2.19, 0.149, 211, 202, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4619, 6bdfN, 0.7438, 2.16, 0.149, 210, 201, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4620, 6bdfL, 0.7438, 2.18, 0.149, 210, 201, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4621, 6bdfJ, 0.7438, 2.20, 0.149, 210, 201, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4622, 6bdfH, 0.7438, 2.12, 0.150, 209, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4623, 6bdfF, 0.7438, 2.16, 0.151, 208, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4624, 6bdfD, 0.7438, 2.08, 0.153, 205, 196, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4625, 6bdfB, 0.7438, 2.41, 0.224, 203, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4626, 6bdf1, 0.7438, 2.41, 0.224, 203, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4627, 1yauM, 0.7432, 2.41, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4628, 1yarM, 0.7430, 2.41, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4629, 1ya7M, 0.7427, 2.41, 0.224, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4630, 3j9iZ, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4631, 3j9iY, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4632, 3j9iX, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4633, 3j9iW, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4634, 3j9iV, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4635, 3j9iN, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4636, 3j9iM, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4637, 3j9iL, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4638, 3j9iK, 0.7423, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4639, 3j9iJ, 0.7423, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4640, 3j9iI, 0.7423, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4641, 3j9iH, 0.7423, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4642, 3j9i2, 0.7423, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4643, 3j9i1, 0.7423, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4644, 3jseM, 0.7416, 2.40, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4645, 3c92X, 0.7415, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4646, 3c92J, 0.7415, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4647, 3c91X, 0.7415, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4648, 3c91J, 0.7415, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4649, 1pmaQ, 0.7415, 2.40, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4650, 5gjqu, 0.7414, 2.40, 0.224, 203, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4651, 3jrmM, 0.7414, 2.40, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4652, 1pmaX, 0.7414, 2.40, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4653, 1pmaP, 0.7414, 2.40, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4654, 3h4pf, 0.7413, 2.40, 0.224, 203, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4655, 3c92W, 0.7413, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4656, 3c92I, 0.7413, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4657, 3c91W, 0.7413, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4658, 3c91I, 0.7413, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4659, 1pmaZ, 0.7413, 2.42, 0.224, 201, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4660, 1pmaU, 0.7413, 2.42, 0.224, 201, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4661, 3c92N, 0.7412, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4662, 3c922, 0.7412, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4663, 3c91N, 0.7412, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4664, 3c912, 0.7412, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4665, 3c92Z, 0.7411, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4666, 3c92M, 0.7411, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4667, 3c92L, 0.7411, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4668, 3c921, 0.7411, 2.42, 0.224, 201, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4669, 3c91Z, 0.7411, 2.36, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4670, 3c91M, 0.7411, 2.37, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4671, 3c91L, 0.7411, 2.37, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4672, 3c911, 0.7411, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4673, 1yauJ, 0.7411, 2.38, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4674, 1pmaT, 0.7411, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4675, 1pmaS, 0.7411, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4676, 1pma2, 0.7411, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4677, 1pma1, 0.7411, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4678, 3jseK, 0.7410, 2.38, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4679, 3jrmK, 0.7410, 2.38, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4680, 3jrmJ, 0.7410, 2.38, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4681, 3jrmI, 0.7410, 2.38, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4682, 3jrmH, 0.7410, 2.38, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4683, 1ya7J, 0.7410, 2.38, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4684, 1pmaY, 0.7410, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4685, 1pmaV, 0.7410, 2.38, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4686, 3jseL, 0.7409, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4687, 3jseJ, 0.7409, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4688, 3jseI, 0.7409, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4689, 3jrmN, 0.7409, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4690, 3jrmL, 0.7409, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4691, 3jtlM, 0.7408, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4692, 3jseN, 0.7408, 2.84, 0.156, 217, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4693, 3jseH, 0.7408, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4694, 1ya7I, 0.7408, 2.39, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4695, 3jtlI, 0.7407, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4696, 3c92Y, 0.7407, 2.33, 0.246, 202, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4697, 3c92V, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4698, 3c92K, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4699, 3c92H, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4700, 3c91Y, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4701, 3c91V, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4702, 3c91K, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4703, 3c91H, 0.7407, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4704, 1yarK, 0.7407, 2.39, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4705, 1ya7L, 0.7407, 2.39, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4706, 1ya7K, 0.7407, 2.39, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4707, 1pmaR, 0.7407, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4708, 1pmaB, 0.7407, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4709, 3jtlK, 0.7406, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4710, 3h4pk, 0.7406, 2.39, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4711, 1yarJ, 0.7406, 2.39, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4712, 1ya7N, 0.7406, 2.39, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4713, 1ya7H, 0.7406, 2.39, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4714, 3jtlN, 0.7405, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4715, 3jtlL, 0.7405, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4716, 3jtlJ, 0.7405, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4717, 3jtlH, 0.7405, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4718, 3h4pl, 0.7405, 2.39, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4719, 1yarL, 0.7404, 2.39, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4720, 1pmaW, 0.7404, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4721, 1yauK, 0.7403, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4722, 1yauH, 0.7403, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4723, 1yarI, 0.7402, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4724, 1yauI, 0.7401, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4725, 1yarH, 0.7401, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4726, 3h4pn, 0.7400, 2.39, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4727, 3h4pa, 0.7400, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4728, 1yauN, 0.7400, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4729, 1yarN, 0.7400, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4730, 3h4pd, 0.7399, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4731, 1yauL, 0.7399, 2.41, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4732, 3h4pi, 0.7398, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4733, 3h4pg, 0.7398, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4734, 3h4pc, 0.7398, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4735, 3h4ph, 0.7397, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4736, 3h4pm, 0.7396, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4737, 3h4pe, 0.7396, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4738, 3h4pj, 0.7392, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4739, 3h4pb, 0.7391, 2.40, 0.225, 203, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4740, 5l4gK, 0.7384, 2.40, 0.225, 203, 191, 
4741, 5gjqg, 0.7382, 2.40, 0.225, 203, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4742, 5gjrFA, 0.7380, 2.40, 0.225, 203, 191, 
4743, 5gjrTA, 0.7376, 2.40, 0.225, 203, 191, 
4744, 5l4gY, 0.7372, 2.40, 0.225, 203, 191, 
4745, 3ipmK, 0.7367, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4746, 3ipmJ, 0.7367, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4747, 3ipmM, 0.7366, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4748, 3ipmL, 0.7366, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4749, 3ipmI, 0.7366, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4750, 3ipmH, 0.7366, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4751, 3ipmN, 0.7365, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4752, 1j2qJ, 0.7363, 2.33, 0.246, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4753, 1j2qH, 0.7363, 2.40, 0.225, 203, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4754, 1j2qK, 0.7362, 2.41, 0.225, 203, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4755, 5vfoT, 0.7359, 2.40, 0.225, 203, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4756, 5m32a, 0.7359, 2.41, 0.225, 203, 191, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4757, 5vfsMA, 0.7358, 2.40, 0.225, 203, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4758, 6avoW, 0.7357, 2.40, 0.225, 203, 191, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4759, 6avoa, 0.7357, 2.40, 0.225, 203, 191, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4760, 5m32M, 0.7356, 2.33, 0.246, 202, 191, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4761, 5vfpN, 0.7355, 2.40, 0.225, 203, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4762, 5vfot, 0.7355, 2.41, 0.225, 203, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4763, 5t0cLB, 0.7351, 2.40, 0.225, 203, 191, 
4764, 5t0cFA, 0.7351, 2.40, 0.225, 203, 191, 
4765, 1j2qN, 0.7351, 2.40, 0.225, 203, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4766, 5vfpLA, 0.7349, 2.40, 0.225, 203, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4767, 1j2qL, 0.7349, 2.41, 0.225, 203, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4768, 5vfrT, 0.7348, 2.35, 0.251, 202, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4769, 1j2qM, 0.7348, 2.34, 0.246, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4770, 1j2qI, 0.7348, 2.42, 0.225, 203, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4771, 5fgiH, 0.7344, 2.43, 0.225, 203, 191, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4772, 2z5cF, 0.7344, 2.35, 0.246, 202, 191, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4773, 2z5cC, 0.7344, 2.41, 0.225, 203, 191, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4774, 5vfsN, 0.7342, 2.35, 0.246, 202, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4775, 2h6jK, 0.7342, 2.33, 0.246, 202, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4776, 5fgiV, 0.7341, 2.35, 0.251, 202, 191, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4777, 2h6jN, 0.7341, 2.35, 0.246, 202, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4778, 5vfqMA, 0.7340, 2.35, 0.246, 202, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4779, 5t0hT, 0.7340, 2.36, 0.246, 202, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4780, 3unea, 0.7336, 2.29, 0.247, 202, 190, MOUSE CONSTITUTIVE 20S PROTEASOME
4781, 5vfrt, 0.7335, 2.35, 0.246, 202, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4782, 5lf7a, 0.7335, 2.85, 0.156, 217, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4783, 4r3oN, 0.7335, 2.88, 0.156, 216, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
4784, 4r3o2, 0.7335, 3.00, 0.165, 216, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
4785, 5t0jT, 0.7333, 2.89, 0.156, 217, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4786, 3uneo, 0.7333, 2.89, 0.156, 217, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4787, 5vfqN, 0.7332, 2.47, 0.225, 203, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4788, 2h6jM, 0.7331, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4789, 2h6jH, 0.7331, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4790, 5vfuSA, 0.7330, 2.47, 0.225, 203, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4791, 5vftt, 0.7330, 2.47, 0.225, 203, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4792, 3uneM, 0.7330, 2.47, 0.225, 203, 191, MOUSE CONSTITUTIVE 20S PROTEASOME
4793, 2h6jJ, 0.7330, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4794, 5lf3a, 0.7329, 2.50, 0.276, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4795, 5lexa, 0.7329, 2.50, 0.276, 202, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4796, 5le5a, 0.7329, 2.50, 0.276, 202, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4797, 2h6jI, 0.7329, 2.87, 0.156, 215, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4798, 5vfuEA, 0.7328, 2.89, 0.167, 216, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4799, 5vftT, 0.7328, 3.00, 0.165, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4800, 5lf7M, 0.7327, 2.89, 0.156, 216, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4801, 5lexM, 0.7327, 2.89, 0.156, 216, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4802, 3une3, 0.7327, 2.89, 0.167, 216, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
4803, 5lf4M, 0.7326, 2.88, 0.156, 215, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4804, 5lf4a, 0.7326, 2.88, 0.156, 215, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4805, 2h6jL, 0.7326, 2.89, 0.156, 215, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4806, 5leya, 0.7325, 2.89, 0.156, 215, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4807, 4r67N, 0.7325, 2.46, 0.277, 202, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4808, 4r672, 0.7325, 2.88, 0.156, 215, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4809, 5fg9H, 0.7324, 2.46, 0.277, 202, 191, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4810, 4r67p, 0.7324, 2.89, 0.156, 215, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4811, 4r67b, 0.7324, 2.46, 0.277, 202, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4812, 5lf0a, 0.7323, 2.47, 0.277, 202, 191, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4813, 5fg9V, 0.7323, 3.06, 0.207, 234, 198, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4814, 3unfM, 0.7323, 1.31, 0.298, 189, 178, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4815, 5t0iT, 0.7322, 1.31, 0.298, 189, 178, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4816, 5lf1a, 0.7322, 2.91, 0.166, 215, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4817, 5le5M, 0.7322, 2.90, 0.182, 242, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4818, 3unba, 0.7322, 3.08, 0.207, 234, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4819, 5lf3M, 0.7321, 2.90, 0.177, 242, 198, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4820, 3unb3, 0.7320, 2.90, 0.156, 215, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4821, 5lf6a, 0.7319, 2.88, 0.161, 215, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4822, 5lf0M, 0.7319, 2.92, 0.156, 216, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4823, 3unbo, 0.7318, 2.90, 0.166, 215, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4824, 5lf1M, 0.7317, 3.05, 0.165, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4825, 5lezM, 0.7317, 2.93, 0.156, 217, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4826, 5leza, 0.7317, 2.93, 0.156, 217, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4827, 5leyM, 0.7316, 2.75, 0.167, 215, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4828, 3unbM, 0.7316, 2.92, 0.156, 216, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4829, 3unhM, 0.7314, 2.80, 0.157, 215, 198, MOUSE 20S IMMUNOPROTEASOME
4830, 5lf6M, 0.7313, 2.79, 0.178, 242, 197, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4831, 3unha, 0.7313, 2.79, 0.173, 242, 197, MOUSE 20S IMMUNOPROTEASOME
4832, 5fgeY, 0.7312, 2.93, 0.156, 215, 199, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4833, 5t0gT, 0.7309, 2.93, 0.156, 215, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4834, 1iruN, 0.7309, 2.92, 0.156, 216, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4835, 1iru2, 0.7309, 2.80, 0.173, 242, 197, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4836, 3unfa, 0.7308, 2.94, 0.156, 216, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4837, 5fgdY, 0.7305, 3.05, 0.165, 216, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4838, 5fgeK, 0.7300, 3.05, 0.165, 216, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4839, 1q5rN, 0.7295, 2.79, 0.173, 242, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4840, 1q5rM, 0.7295, 2.83, 0.167, 215, 198, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4841, 1q5rH, 0.7295, 2.83, 0.167, 215, 198, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4842, 1q5rL, 0.7294, 3.05, 0.165, 216, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4843, 1q5rK, 0.7294, 3.06, 0.165, 216, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4844, 1q5rJ, 0.7294, 2.93, 0.156, 216, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4845, 1q5rI, 0.7294, 3.05, 0.165, 216, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4846, 5fgdK, 0.7288, 2.94, 0.156, 216, 199, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4847, 5cz7Y, 0.7287, 2.80, 0.173, 242, 197, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4848, 5cz7K, 0.7287, 2.95, 0.156, 216, 199, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4849, 5vfoO, 0.7285, 2.94, 0.156, 217, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4850, 3bdmX, 0.7282, 2.94, 0.156, 217, 199, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4851, 3bdmJ, 0.7282, 2.55, 0.208, 230, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4852, 3gpjX, 0.7280, 2.94, 0.156, 217, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4853, 3gpjJ, 0.7280, 2.94, 0.156, 217, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4854, 3d29X, 0.7280, 2.95, 0.156, 216, 199, PROTEASOME INHIBITION BY FELLUTAMIDE B
4855, 3d29J, 0.7280, 2.55, 0.208, 230, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
4856, 5ts0K, 0.7278, 3.06, 0.165, 216, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4857, 3mkaN, 0.7276, 2.80, 0.157, 215, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4858, 3mkaG, 0.7275, 2.95, 0.156, 216, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4859, 5vfpI, 0.7273, 3.06, 0.165, 216, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4860, 3mkaV, 0.7270, 2.95, 0.156, 216, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4861, 5vfoo, 0.7269, 3.06, 0.165, 216, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4862, 5trgK, 0.7269, 2.95, 0.156, 216, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4863, 5fgfK, 0.7269, 2.95, 0.156, 216, 199, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4864, 3mkaJ, 0.7269, 2.95, 0.156, 216, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4865, 5fg7V, 0.7268, 3.06, 0.165, 216, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4866, 3okjX, 0.7268, 2.95, 0.156, 216, 199, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4867, 3okjJ, 0.7268, 2.96, 0.156, 216, 199, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4868, 2zcyX, 0.7268, 2.96, 0.156, 216, 199, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4869, 5trsK, 0.7267, 2.95, 0.156, 216, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4870, 5fgfY, 0.7267, 2.95, 0.156, 216, 199, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4871, 4jsqX, 0.7267, 3.23, 0.159, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4872, 4jsqJ, 0.7267, 2.96, 0.156, 216, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4873, 4inuX, 0.7267, 3.23, 0.159, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4874, 2zcyJ, 0.7267, 3.10, 0.173, 218, 197, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4875, 5vfqHA, 0.7266, 2.83, 0.157, 215, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4876, 5trgL, 0.7266, 2.96, 0.151, 217, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4877, 4inuJ, 0.7265, 2.96, 0.151, 217, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4878, 4hrcX, 0.7265, 2.87, 0.157, 216, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4879, 1g65X, 0.7265, 2.97, 0.173, 216, 196, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4880, 4intJ, 0.7264, 2.99, 0.173, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4881, 3nzwJ, 0.7264, 2.82, 0.173, 251, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4882, 5vfro, 0.7261, 2.82, 0.173, 251, 197, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4883, 4jsuX, 0.7261, 2.82, 0.173, 251, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4884, 4jsuJ, 0.7261, 2.82, 0.173, 251, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4885, 4intX, 0.7261, 2.82, 0.173, 251, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4886, 4inrX, 0.7261, 2.82, 0.173, 251, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4887, 3nzxX, 0.7261, 2.82, 0.173, 251, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4888, 3nzxJ, 0.7261, 2.90, 0.174, 215, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4889, 3mkaP, 0.7261, 3.04, 0.168, 217, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4890, 5vfrO, 0.7260, 3.05, 0.168, 217, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4891, 4ltcX, 0.7260, 2.43, 0.201, 220, 189, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4892, 4inrJ, 0.7260, 2.47, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4893, 3mkaL, 0.7260, 2.47, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4894, 5vfqI, 0.7259, 2.48, 0.208, 198, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4895, 5vfpGA, 0.7259, 2.48, 0.208, 198, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4896, 5fg7H, 0.7259, 2.50, 0.208, 198, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4897, 4hrdJ, 0.7259, 2.49, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4898, 5l5rY, 0.7258, 2.50, 0.166, 223, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4899, 5l5rK, 0.7258, 2.93, 0.167, 252, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4900, 3un4J, 0.7258, 2.82, 0.168, 251, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4901, 5a5b2, 0.7257, 2.44, 0.201, 220, 189, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4902, 4hrdX, 0.7257, 2.83, 0.168, 249, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4903, 4cr32, 0.7257, 2.44, 0.201, 220, 189, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4904, 3un4X, 0.7257, 2.50, 0.166, 223, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4905, 3mkaH, 0.7257, 2.88, 0.170, 214, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4906, 5thoL, 0.7256, 2.83, 0.168, 252, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4907, 5m2bY, 0.7256, 2.83, 0.212, 228, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4908, 5m2bK, 0.7256, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4909, 4gk7J, 0.7256, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4910, 1g65J, 0.7256, 2.50, 0.208, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4911, 5tryK, 0.7255, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4912, 5trrL, 0.7255, 2.88, 0.170, 214, 194, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4913, 5trrI, 0.7255, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4914, 5trgI, 0.7255, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4915, 4hrcJ, 0.7255, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4916, 4gk7X, 0.7255, 2.50, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4917, 3sdiX, 0.7255, 2.44, 0.201, 220, 189, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4918, 3dy3X, 0.7255, 2.51, 0.166, 223, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4919, 3dy3J, 0.7255, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4920, 5l5bY, 0.7254, 2.50, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4921, 4jt0X, 0.7254, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4922, 4jt0J, 0.7254, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4923, 3mkaT, 0.7254, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4924, 5trsY, 0.7253, 2.44, 0.201, 220, 189, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4925, 5trrK, 0.7253, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4926, 5l5bK, 0.7253, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4927, 3sdiJ, 0.7253, 2.52, 0.208, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4928, 3mkaC, 0.7253, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4929, 3dy4X, 0.7253, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4930, 3dy4J, 0.7253, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4931, 5trgY, 0.7252, 2.83, 0.168, 250, 197, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4932, 5trgV, 0.7252, 2.47, 0.201, 220, 189, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4933, 3mka2, 0.7252, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4934, 3gptX, 0.7252, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4935, 2f16X, 0.7252, 2.84, 0.168, 251, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4936, 2f16J, 0.7252, 2.46, 0.201, 220, 189, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4937, 5trsL, 0.7251, 2.45, 0.201, 220, 189, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4938, 5trrV, 0.7251, 2.71, 0.208, 228, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4939, 5thoK, 0.7251, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4940, 4r3oI, 0.7251, 2.81, 0.156, 211, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
4941, 4fzgX, 0.7251, 2.81, 0.156, 211, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4942, 4fzgJ, 0.7251, 2.51, 0.208, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4943, 3gptJ, 0.7251, 2.47, 0.206, 223, 189, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4944, 5trsN, 0.7250, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4945, 5trgX, 0.7250, 2.47, 0.206, 223, 189, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4946, 4r3oW, 0.7250, 2.52, 0.208, 198, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
4947, 3mkaR, 0.7250, 2.85, 0.168, 249, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4948, 3mg8J, 0.7250, 2.51, 0.166, 223, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4949, 5trga, 0.7249, 2.83, 0.156, 211, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4950, 5l5eY, 0.7249, 2.82, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4951, 5l5eK, 0.7249, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4952, 5gjqp, 0.7249, 2.52, 0.208, 198, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4953, 3nzjX, 0.7249, 2.53, 0.166, 223, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4954, 3nzjJ, 0.7249, 2.51, 0.166, 223, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4955, 3mg0X, 0.7249, 2.52, 0.166, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4956, 3mg0J, 0.7249, 2.52, 0.166, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4957, 5trrY, 0.7248, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4958, 5trrW, 0.7248, 2.52, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4959, 5trrb, 0.7248, 2.53, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4960, 5trrZ, 0.7247, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4961, 5l5aY, 0.7247, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4962, 3sdkX, 0.7247, 2.81, 0.156, 211, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4963, 5thoY, 0.7246, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4964, 5l5aK, 0.7246, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4965, 4hnpJ, 0.7246, 2.84, 0.168, 250, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4966, 3nzwX, 0.7246, 2.52, 0.166, 223, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4967, 3mkaE, 0.7246, 2.52, 0.166, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4968, 3mg6J, 0.7246, 2.81, 0.156, 211, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4969, 3hfaV, 0.7246, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4970, 3hfaE, 0.7246, 2.84, 0.168, 250, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4971, 5ts0L, 0.7245, 2.51, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4972, 5thoI, 0.7245, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4973, 5gjrAA, 0.7245, 2.52, 0.166, 223, 193, 
4974, 4q1sJ, 0.7245, 2.53, 0.166, 223, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4975, 3mi0L, 0.7245, 2.85, 0.168, 246, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4976, 3hfaG, 0.7245, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4977, 5fgiN, 0.7244, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4978, 4hnpX, 0.7244, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4979, 3sdkJ, 0.7244, 2.52, 0.166, 223, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4980, 3oeuX, 0.7244, 2.53, 0.166, 223, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4981, 3mg7J, 0.7244, 2.53, 0.166, 223, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4982, 3mg6X, 0.7244, 2.49, 0.202, 220, 188, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4983, 3hfa2, 0.7244, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4984, 5trsV, 0.7243, 2.52, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4985, 5trra, 0.7243, 2.52, 0.208, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4986, 5gjrOA, 0.7243, 2.53, 0.166, 223, 193, 
4987, 3mg4J, 0.7243, 2.53, 0.166, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4988, 3hfaZ, 0.7243, 2.49, 0.202, 220, 188, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4989, 3hfaL, 0.7243, 2.73, 0.168, 246, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4990, 5fgib, 0.7242, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4991, 5d0vK, 0.7242, 2.53, 0.166, 223, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4992, 3hfaN, 0.7242, 2.82, 0.156, 211, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4993, 3hfaJ, 0.7242, 2.82, 0.156, 211, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4994, 5ts0I, 0.7241, 2.47, 0.202, 220, 188, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4995, 5thoV, 0.7241, 2.53, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4996, 3mg7X, 0.7241, 2.53, 0.208, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4997, 3hfaT, 0.7241, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4998, 3hfaR, 0.7241, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4999, 3hfaP, 0.7241, 2.52, 0.166, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
5000, 3hfaH, 0.7241, 2.52, 0.166, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
